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Abstract 
The research community relies upon biorepositories’ ability to prepare for the scientific 
advancement that can precipitate the discoveries of the future. Furthermore, as the 
complexities, financial pressure, and quality issues biorepositories face continue to unfold, it 
is imperative to explore unmet needs researchers may have for biorepository services as well 
as evaluate the commercial potential, funding, and competitiveness of a new biorepository. 
With the goal of contributing to medical and scientific research and the biorepository field, 
this paper utilizes principles from ISO 9001:2008 “Quality management systems-
Requirements” to outline and explore the challenges in establishing a state-of-the-science, 
accredited, commercial BSL-2 biorepository in order to support academic, clinical, and 
translational research.  In addition, this paper provides detailed quality assurance strategies to 
meet investigator’s needs, ensure high quality, fit-for-purpose biospecimens, and, most 
importantly, protect and preserve the biospecimens entrusted to its care. 
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Chapter 1: Introduction 
In the era of personalized medicine, “Biobanking is recognized as a critical area 
requiring development if progress is to be made in identifying clinically useful markers of 
disease and disease progression, discovering new drug targets and understanding the 
mechanisms of disease” (Carter and Betsou, 2011, p. 157).  Hewitt (2010) defined the term 
“biobank” as “an organized collection of human biological material and associated 
information stored for one or more research purposes” (p. 112).  Carter and Betsou (2011) 
stressed that these collections of “samples need to be collected, processed and stored in 
standardized ways that gives assurance to researchers that they are fit for purpose” (p. 157).  
They furthermore argue that these standardized procedures require standardized collection 
protocols in order to best protect sample integrity.  Most importantly, they remind 
investigators that well-run biorepositories make a vital contribution to scientific achievement 
by collecting, processing, storing, and distributing high-quality, fit-for-purpose biological 
specimens, or biospecimens. 
Biospecimens and their appropriate collection and storage form the basis of modern 
scientific research.  Vaught, Rogers, and Myers (2011) argued that “as the source of 
molecular information, human biospecimens, such as tissue or blood, are both the foundation 
of personalized medicine and the fuel that drives the basic and translational research needed 
to achieve this vision” (p. 1).  Therefore, the needs of the research community require that 
biorepositories prepare for scientific advancement that can precipitate the discoveries of the 
future.  
The quality of a biorepository rests both on attention to emerging science and 
innovative quality assurance strategies as well as adherence to rigorous quality control 
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procedures, Best Practices, and biorepository accreditation requirements.  Only attention to 
these details will ensure the quality of biorepository services and, most importantly, protect 
and preserve the biospecimens entrusted to its care.  
Despite the importance of biospecimen collection, processing, and storage in 
scientific undertakings, these research needs may go unmet in certain geographic areas, 
particularly if regulatory requirements in those locations are not well defined or understood.  
To that end, this paper will examine various types of considerations when establishing a 
commercial biorepository to support academic, clinical, and translational research.  As the 
complexities, financial pressures, and quality issues that biorepositories face continue to 
unfold within the field, potential investors must carefully consider unmet needs investigators 
may have for biorepository services as well as the commercial potential, funding, and 
competitiveness of any new biorepository.  Among these considerations, such investors must 
be prepared to outline the requisite organizational structure, provision of resources (e.g., 
human resources, infrastructure, work environment, safety, and security), emergency 
preparedness, and business continuity, in addition to other regulatory considerations and 
quality methods of assessment, analysis, and continuous quality improvement.  The 
complexity of such factors may discourage potential investors (and the investigators an 
established biorepository may serve) from undertaking the process, particularly without 
guidance from experienced biorepository managers or personnel. 
Need for Practical Guidance in Biorepository Establishment 
Although biorepositories hold a vital place in current scientific practice, the available 
literature on their function has several gaps.  For instance, the biorepository community 
eagerly anticipates the release of a new international standard for biotechnology 
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(biorepositories) by the International Organization of Standardization Technical Committee, 
ISO/TC 276 for Biotechnology, in the near future.  Carter and Betsou (2011) argued that 
“development and implementation of an ISO for biobanks will ensure that samples and data 
collected in any biobank that conforms to the ISO requirements are suitable for use in local, 
national and international research projects” (p. 159).  The anticipated ISO document will 
likely standardize the following: terms and definitions in the field of biotechnology, 
bioresources, and biobanks; biospecimen processing, analytical methods, and data 
processing; and validation, comparability and integration, and analysis and annotation 
(ISO/ICE, 2015).  In the meantime, the biorepository community must look to other technical 
resources.  
Yamada et al. (2013) reported that “a specific, practical ‘instruction manual’ outlining 
each of the required elements of a successful biobank replete with regulatory considerations, 
specific infrastructure recommendations, as well as pitfalls and problems to avoid, does not 
exist” (p. 227).  Furthermore, despite the importance of commercial biorepositories, the 
existing literature regarding the establishment of biorepositories has thus far been directed 
toward community-based hospital biorepositories or academic institutions and university 
medical centers that have established biorepositories to support specific research studies 
within their respective institutions (Mayol, Woo, & Keck, 2010; Olson, Ryu, Johnson, et al., 
2013; Vaught, Rogers, Myers, et al., 2011).   
A developed framework for establishing a state-of-the-science, accredited, Biological 
Safety Level 2 (BSL-2), commercial biorepository and reporting the requisite quality 
assurance strategies would serve the scientific community well and provide a notable 
contribution to its ongoing advancement.  This paper proposes to shrink the gap in the current 
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literature by providing such a framework to those who might consider establishing such a 
biorepository in the future. 
Checklists for Biorepository Development 
Mayol, Woo, and Keck (2010) published a checklist for development of a 
biorepository to aid others in establishing a similar biorepository within a hospital.  However, 
the summary and checklist, by necessity, were brief and small in scope. Potential founders 
and investors of biorepositories need more detailed information, preferably in a single 
location, to best prepare for the difficulties of undertaking such an enterprise.  The current 
paper will expand upon this original checklist in order to provide such a document to those 
who may find it useful. 
The current paper will expand upon a number of items originally outlined in Mayol, 
Woo, and Keck’s (2010) checklist, including: 
• Considering initial and continued funding. 
• Identifying staff, space, equipment and supplies. 
• Selecting between retrospective or prospective collection models (the article 
followed the former model). 
• Conducting an investigator needs assessment.  
• Developing various policies and procedures. 
• Listing biobanking standards (i.e., Best Practices), site visits (as a means of 
gathering information), and software selection.  
• Considering regulatory considerations, including IRB review. 
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• Outlining requirements including remodeling, access security, alarms for 
monitoring equipment, preventive maintenance, and backup power.  
• Identifying safety concerns, including emergency operations plans, fire safety, the 
use of personal protective equipment (PPE), Occupational Safety and Health 
Administration (OSHA) requirements, training in handling biological material, 
labeling, transport, and waste disposal.  
In a later follow-up article, Mayol-Heath, Keck, and Woo (2011) went into further 
detail regarding business considerations for biorepositories, including a discussion of 
stakeholder buy-in, startup costs, funding sources, conducting preliminary site visits to other 
biorepositories, and developing policies and procedures.  They went on to provide a 
summary of important topics regarding the procedures and policies necessary to establish a 
biorepository.  The current paper will also expand upon several of the items included in their 
summary, such as: 
• Facility procedures, including access restrictions, HVAC, alarms, oxygen sensors, 
and (if using liquid nitrogen), backup power and testing. 
• Safety procedures and policies, including regulatory bodies and personnel 
training. 
• Quality control procedures, including protocols, standard operating procedures 
(SOPs), manuals, records and record keeping, database management, and 
specimen and equipment maintenance. 
• Collection and processing procedures for all tasks and services provided including 
logging in specimens for processing. 
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• Data collection procedures, including user-restricted databases, user audit trails, 
coding mechanisms, sample location and volume tracking, and quality control. 
• Database requirements, including barcoding capabilities, specimen tracking, and 
types of storage.  
Dash et al. (2012) outlined the following considerations when establishing a 
biorepository: a business model and plan, space for equipment and operations, processing 
and storage equipment, adequate staffing by trained personnel, Information Technology (IT) 
infrastructure, reagents and supplies, and standard operating procedures (SOPs) that include a 
quality management system (QMS) for quality assurance and continuous quality 
improvement.  
Using the various checklists previously developed above as a starting point for further 
exploration and with the goal of contributing to medical and scientific research and the 
biorepository field, this paper will examine: 
• Business considerations in establishing a biorepository, including questions of 
funding and advertisement. 
• Quality management systems (QMS) for a state-of-the-science, accredited, 
commercial biorepository. 
• Quality assurance (QA) strategies to meet investigator’s needs and ensure high- 
quality, fit-for-purpose biospecimens.  
• Practical information for Biorepository CAP Accreditation, including a list of 
recommendations and practical information on application materials and the 
inspection process. 
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Dash et al. (2012) reminded researchers that many of the considerations for building 
biobanks may be aligned with Clinical Laboratory Improvement Amendments (CLIA): 
“Many of the critical steps to be followed in establishing and running a biorepository fall 
within existing procedures in today’s CLIA-certified laboratories or can be implemented with 
modifications to existing procedures in use in CLIA-certified laboratories” (p. 670). 
Stakeholders or founders, investors, and researchers considering establishing a commercial 
biorepository without the requisite infrastructure, work environment, or policies and 
procedures already in place may benefit from the notable experience provided by an 
operations manager with both a medical technology background and experience in building 
and establishing such a biorepository and laboratory.   
I have worked as an operations manager in a biorepository and lab for over 18 years.  
For the last ten of those years, we maintained a Clinical Laboratory Improvement 
Amendment (CLIA) certified, College of American Pathologists (CAP) accredited 
laboratory.  We were also among the first pilot programs to gain College of American 
Pathologists (CAP) Biorepository accreditation nationwide in 2013.  Throughout these 
advancements, I was responsible for managing the organization, building the infrastructure, 
writing the standard operating procedures (SOPs), designing quality assurance (QA) 
programs, and preparing for certification and accreditation programs in order to meet our 
organizational objectives and service the needs of our clients.  My hope is that other 
researchers will find this guide to be both a practical introduction to the inner workings of 
biorepositories and a guide to reference as they design future biorepositories that serve the 
needs of their own scientific communities.  
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Chapter 2: Study Purposes and Methodology 
Purposes of the Current Study 
The purposes of this study are three-fold: 
1. To construct a quality management system (QMS) utilizing the principles derived 
from ISO 9001:2008 “Quality management systems-Requirements” and provide 
the requisite framework in order to build, operate, and sustain a state-of-the-
science, accredited, Biological Safety Level 2 (BSL-2), commercial biorepository. 
2. To provide detailed quality assurance (QA) strategies for biorepositories to 
onboard new studies; support specimen collection, processing, storage and 
distribution; and provide the highest quality, fit-for-purpose biospecimens for 
academic, clinical, and translational research. 
3. To provide a practical guide to obtaining Biorepository Accreditation by the 
College of American Pathologists (CAP). 
To accomplish these purposes, I will outline the considerations required of a potential 
investor or founder of a new commercial biorepository. 
Proposed Biorepository Model  
For the purposes of this paper, I will propose a biorepository model based upon a 
potential Biosafety Level 2 (BSL-2) facility supporting both retrospective and prospective 
samples.  A BSL-2 facility, containing the appropriate primary barriers and safety equipment, 
is “suitable for work involving agents that pose moderate hazards to personnel and the 
environment” (U.S. Dept. of Health and Human Services, 2009, p. 33).  Biosafety Level 2 
agents are transmissible by ingestion, percutaneous injury, or mucous membrane exposure.  
Therefore, any organization working with these agents must follow BSL-2 procedures, 
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equipment, and facility design.  The proposed facility would accept biospecimens classified 
as Risk Group 2, agents “associated with human disease that is rarely serious and for which 
preventive or therapeutic interventions are often available” (U.S. Dept. of Health and Human 
Services, 2009, p. 10).  Human serum, plasma, DNA, tissue, stool, and urine specimens must 
be accepted according to established acceptance criteria for each type of specimen. 
This proposed biorepository model will: 
• Assist investigators to develop standardized collection protocols to capture and 
report all pre-analytical variables and provide high-quality specimen collection 
methods according to study requirements. 
• Utilize “cradle to grave” sample tracking throughout the collection, processing, 
storage, and distribution life cycle with the support of a robust inventory 
management system. 
• Safely transport or ship (via commercial carrier) samples utilizing communication 
procedures, sample selection, electronic biospecimen chain-of-custody 
management, and risk mitigation strategies (including temperature monitoring) to 
prevent the compromise or loss of biospecimens en route to or from the 
biorepository. 
• Check in, process, and assess samples for quality purposes by evaluating the 
integrity of the sample vial, sample label security and accuracy, barcode legibility, 
and gross sample condition upon receipt; by retrieving samples from a specified 
storage location; by quick-thawing and preparing aliquots or derivatives and 
recording sample observations; and by snap freezing samples and returning 
samples to specified storage locations. 
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• Provide safe, secure, consistently monitored storage conditions as necessitated by 
study requirements to ensure the highest quality specimens for academic as well 
as clinical and translational research. 
Utilization of Quality Management Systems (QMS) 
QMS in current biorepository model.  Quality management is a continuous and 
systematic process whereby key performance indicators of quality are monitored and 
evaluated through a variety of activities in order to detect issues and potential trends, monitor 
progress, and identify opportunities for improvement.  In the context of a biorepository, an 
effective QMS can accomplish the following objectives: 
• Define quality policies, processes, and strategies in order to maintain the highest 
standards of biospecimen quality, integrity, and data throughout the collection, 
processing, storage, and distribution life cycle. 
• Ensure compliance with biorepository policies and procedures; all applicable 
federal, state, and local regulations; Best Practices; and the College of American 
Pathologists (CAP) Accreditation Requirements as applicable to the scope of 
biorepository services. 
• Assure potential stakeholders and clients that operations are performing to the 
highest quality standards. 
A well-designed QMS can prove even more valuable, however, in that it may provide 
a “roadmap” and help guide the establishment, operation, and future sustainability of a 
Biological Safety Level 2 (BSL-2) commercial biorepository. Furthermore, with the addition 
of specific and detailed QA strategies, it may also provide assurance to researchers that 
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samples are collected, processed, and stored in standardized ways to ensure they are of the 
highest quality and fit for purpose.   
ISO 9001.  The International Organization for Standardization, commonly referred to 
as ISO, is comprised of a federation of national standards (member) bodies from around the 
world. Each member body may have representatives on various technical committees that 
have been established in order to draft international standards.  Once adopted, these drafts are 
sent to the member bodies for approval.  If 75% of the member bodies approve the draft, the 
international standard is published (ISO 9001:2008, p. iv). 
For purposes of the current paper, I will be applying principles found in ISO 
9001:2008, “Quality management systems–Requirements,” to the proposed biorepository 
model.  Some of the key principles identified by ISO 9001:2008 include: 
• The importance of QMS design and implementation as considering the particular 
needs of an organization, including: 
o “its particular objectives, 
o the products it employs, 
o the processes it employs, 
o and its size and organizational structure” (p. v). 
• A demonstrable commitment to “consistently provide product or services that 
meets customer and applicable statutory and regulatory requirements and aims to  
enhance customer satisfaction through the effective application of the 
system…and the assurance of conformity to customer and applicable statutory 
and regulatory requirements” (p. 1). 
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• A focus on customer satisfaction with the outputs (products or services) because 
“Customers play a significant role in defining requirements as inputs. Monitoring 
of customer satisfaction requires the evaluation of information relating to 
customer perception as to whether the organization has met the customer 
requirements” (p. vi).  
• The applicability of a QMS to “be used by internal and external parties, including 
certification bodies, to assess the organization’s ability to meet customer, 
statutory and regulatory requirements applicable to the product, and the 
organization’s own requirements” (p. v).   
• Its utilization as “internal application by organizations, certification or for 
contractual purposes” (p. vii).  
For this research, I will examine, expand upon, and specifically tailor the principles 
included in the fourth edition of ISO 9001: 2008 to construct a quality management system 
(QMS) in order to support the objectives, anticipated services, operations (including 
processes employed and infrastructure), and organizational structure of the proposed 
biorepository model.  Business considerations have been added to the QMS to address 
internal requirements regarding establishing the biorepository as ongoing commercial 
viability should be one of the primary concerns when establishing and maintaining a 
commercial biorepository.  
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Additional QMS considerations in current biorepository model.  As Carter and 
Betsou (2011) have argued, “Samples need to be collected, processed and stored in 
standardized ways that gives assurance to researchers that they are fit for purpose” (p. 157).  
However, they further conceded “compliance with ISO 9001 does not, by itself, ensure that 
scientifically valid methods are used and samples and data are fit for purpose because this 
standard does not give any technical requirement for the quality of the samples” (p. 158).  In 
an attempt to ensure that this document presents adequately detailed processes and 
procedures necessary to support biorepository objectives and investigator requirements, the 
proposed biorepository model will examine, expand upon, or formally introduce a number of 
additional quality assurance strategies.  These strategies include: 
• Assisting investigators as they design their studies in order to capture pre-
analytical variables, develop standardized collection protocols, and ensure 
samples are of the highest quality and fit for purpose.  
• On-boarding all new IRB-approved research studies through implementation of a 
study protocol and written commitment to Good Clinical Practice (GCP).  
• Designing and manufacturing study-specific specimen collection kits for 
prospective samples.  
• Determining the research study’s method of sample identification for 
retrospective samples and the appropriate method to incorporate the samples into 
the biorepository. 
• Transporting or shipping samples to the biorepository.  
• Consistently storing academic and clinical research samples in monitored freezers 
and including backup procedures in the chance of freezer failure. 
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• Implementing emergency preparedness, disaster response, and business continuity 
plans using risk assessment and risk mitigation strategies. 
• Processing samples according to rigorous QC and QA procedures. 
• Returning samples to sponsors or investigators or properly disposing of them. 
Research Questions 
In the process of investigating and compiling this information, I attempted to address 
the following questions: 
• Can the principles from ISO 9001:2008 help to establish the framework necessary 
to build, operate, and sustain a state-of-the-science, accredited, commercial, 
Biological Safety Level 2 biorepository? 
• What detailed quality assurance strategies may be applied to procedures for 
onboarding new studies; supporting specimen collection, processing, and storage; 
and providing the highest quality, fit-for-purpose biospecimens for academic, 
clinical, and translational research? 
• How can biorepositories obtain CAP Accreditation?  
Research Design and Methodology 
The research design is based on personal qualitative research, including an extensive 
literature review, development of a QMS for the proposed biorepository model, reporting QA 
strategies, and providing practical information regarding the CAP Accreditation application 
(including the inspection process), as well as providing a recommended list to aid other 
biorepositories in their preparations for CAP inspections.  
The research methodology is as follows: 
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1. The ISO Standard for Quality Management System requirements (ISO 
9001:2008) was purchased and reviewed. QMS principles were carefully 
considered and applied to a requisite framework to meet biorepository 
requirements.  
2. The International Society of Biological and Environmental Repositories (ISBER) 
Best Practices, the National Cancer Institute (NCI) Best Practices, and other 
pertinent literature as well as applicable federal, state, and local regulations were 
reviewed and incorporated into planning the biorepository. 
3. All checklists prepared and disseminated by the College of American Pathologists 
(CAP), including the Biorepository and Laboratory General checklists, may not 
be shared outside an organization seeking accreditation or an accredited 
organization and therefore may not be republished in the context of this paper.  
That being said, in order to support the current research, the application materials 
for CAP Biorepository Accreditation as well as the CAP inspection process were 
reviewed, and a comprehensive list of recommended documentation, safety plans, 
and QC and QA records were prepared for biorepositories seeking accreditation.  
Analysis and Presentation of Data  
As aligned to the ISO 9001:2008, the remaining chapters of this document will 
address the considerations, responsibilities, requirements, and principles as outlined below. 
Chapter 3 will expand upon business considerations in establishing a biorepository, 
including commercial potential, adequate funding and competitiveness, business plan, initial 
capitalization and monthly operating costs, marketing including advertisement, and 
insurance.  ISO:9001 does not directly address business considerations in the context of 
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QMS. I have included this section as a reference for investors who may need specific 
financial information. These examples will include initial investment with respect to 
infrastructure, equipment, and supplies as well as ongoing monthly operating costs as 
potential founders explore establishing a biorepository. 
Chapter 4 covers documentation requirements, including a quality policy; quality 
objectives; a quality manual or manual of operations; documented procedures; guidance 
documents; work instructions, forms, and checklists; quality control (QC) and quality 
assurance (QA) documents; the control of records and documents; a document control plan; 
document control software or other manual method; and record preservation and retention. 
Chapter 5 will address management responsibilities, including authority and 
responsibility, communication, organizational structure, management roles and 
responsibilities, management commitment, and communication.  
Chapters 6 and 7 will consider two aspects of resource management. Chapter 6 will 
deal specifically with human resources (such as staff selection; personnel records; 
competence, training, and awareness; staff evaluation and merit program; and continuing 
education and staff input) and infrastructure (such as facility infrastructure and maintenance; 
equipment selection, qualification, maintenance, and replacement; property control and 
disposition; and procurement and informatics).  Chapter 7 will address work environment 
requirements, including fire safety, electrical safety, engineering controls, administrative and 
work place controls, personal protective equipment (PPE), first aid, emergency shower or 
eyewash stations, chemical hygiene plan, hazard communication program, exposure control 
plan, laboratory biosafety manual, freezer room safety and oxygen monitoring system, 
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evacuation plan, excessive noise monitoring, color vision assessment, ergonomics, workplace 
injuries or accidents, and security measures.  
Chapters 8 and 9 will concern product realization, including customer requirements 
(inputs), customer-related processes, procedures and quality assurance strategies to achieve 
the product or service, and customer satisfaction (output). 
Chapter 10 will consider emergency preparedness, particularly in the context of 
previously published anecdotes and records of both pre-crisis preparation and post-crisis 
management and recovery.  It will also outline emergency preparedness plans within the 
context of the proposed biorepository model. 
Chapter 11 will outline specific methods of assessment, analysis, and improvement, 
including QMS review; key performance indicators, publications and grants, peer review, 
CAP Biorepository Accreditation, customer feedback and surveys, audits, ISBER Self-
Assessment Tool, incident reporting, Corrective and Preventive Action (CAPA), a quality 
risk management program; quality management system certification; and ISO biotechnology 
(biorepository) certification in the future. 
Each of these QMS items will be addressed specifically in reference to the 
establishment of a BSL2 biorepository. However, investors and researchers considering 
establishing any biorepository should be able to apply the methods stated in this research 
paper providing they keep the needs of their potential clients (i.e., sponsors of research and 
individual investigators) in mind as well as all applicable regulatory requirements.  
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Chapter 3: Business Considerations in Establishing a Biorepository 
Commercial Potential 
When considering the commercial potential of a biorepository, potential investors 
should consider a variety of factors. Mayol, Woo, and Keck (2010) proposed the following 
strategies to determine commercial potential:  
• List current providers, their respective services, and if known, the costs of their 
services and their cost recovery methods.  
• Identify potential clients such as universities, academic medical centers, research 
institutes, hospitals, pharmaceutical companies, biotech firms, contract research 
organizations, clinicians and research investigators.  
• Conduct anonymous market surveys.  
• Obtain feedback from investigators in surrounding communities regarding their 
current and future biospecimen storage needs through a needs assessment. 
In a follow-up article, Mayol-Heath, Keck, and Woo (2011) reported the following 
five fundamental considerations in establishing a biorepository: stakeholder buy-in; 
researcher needs; initial facility setup requirements; start-up costs and funding sources; 
biorepository site visits, regulations, and best practices (pp. 253-257).  Potential investors 
must also evaluate several other topics, such as estimates of start-up costs in relation to 
respective categories of services and the position of a proposed biorepository in local and 
regional markets.  (One resource in identifying other providers in the marketplace is the 
Biobanking for Medicine: Technology, Industry and Market 2014-2024. This report is 
available for purchase from Visiongain for a nominal fee/investment.)  
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Before formally opening a biorepository, founders should open communication with 
those most likely to utilize its services.  These founders should obtain appropriate feedback 
from them before opening in order to pre-establish relationships for future collaboration.  
Surveys can be effective tools for obtaining such input and can contribute to the creation of a 
well-designed, quality-driven biorepository.  Organizers must conduct market surveys within 
the scientific community as well as within specific focus groups to clarify current and future 
specimen collection, processing, and storage needs as part of a larger needs assessment.  
Feedback from scientific investigators regarding anticipated future requirements can help the 
operations manager with accurate budget projections and ensure the biorepository will be 
able to accommodate clients’ evolving needs as well as encourage repeat customers.  Similar 
feedback from focus groups can further identify client collection, processing, and storage 
needs as well as help elicit future potential customers.  In combination, these surveys would 
help establish service limits for potential clients and determine how procedures and workflow 
diagrams are designed when the biorepository becomes operational. 
Determining biorepository type.  An overall needs assessment can help determine 
the vision and scope of services of the proposed biorepository and therefore establish the type 
of biorepository needed as well as the types of specimens that will need to be collected, 
processed, and stored. For the purposes of the current discussion, this particular biorepository 
model proposes to accomplish the following: 
• To offer study design consultation and support; custom specimen collection kit 
manufacture; sample pickup and delivery services; safe, consistent, and monitored 
storage conditions; and a strong commitment to customer service and quality 
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
20 
assurance in order to ensure the processing of fit-for-purpose biospecimens for 
academic, clinical, and translational research purposes.  
• To service the following clients: researchers from universities, academic medical 
centers, research institutes, hospitals, pharmaceutical companies, biotech firms, 
contract research organizations, clinicians, and research investigators. 
To that end, the current discussion will focus upon a proposed Biological Safety 
Level (BSL) 2 facility.  BSL-2 agents are associated with human disease. Therefore, all 
biospecimens are considered potentially infectious.  Potential routes of transmission include 
percutaneous injury, ingestion, and mucous membrane exposure (U.S. Dept. of Health and 
Human Services, 2009).  Safety issues and regulatory requirements regarding working with 
potentially infectious biospecimens have been addressed in separate sections of this paper for 
the protection of all biorepository employees.  
Funding and Biorepository Competitiveness 
As the complexity of the collection, processing, and storage of biospecimens 
continues to evolve and expand, potential investors must not only secure initial investment 
capital but also plan for continued operational funding to ensure future sustainability for the 
biorepository.  Dash et al. (2012) reported that founders should begin by defining potential 
sources of initial funding, which may include financing from institutions, government grants, 
and partnerships with industry or businesses. They list several examples of possible funding 
sources, including Angel and Venture capital funding or grant resources such as the Small 
Business Innovation Research or Small Business Tech Transfer Grants.  Research grants 
from federal, state, and local sources may also be available to new business start-ups that 
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provide much-needed employment opportunities in economically depressed areas. Partnering 
directly with commercial end users should also be an important consideration (pp. 668-678). 
Although long-term sustainable financing may be challenging to obtain, investors can 
take steps to achieve a sustainable financial model.  Partnering with institutions to help cover 
costs of employee salaries and operating costs can help the biorepository reach financial 
stability and an acceptable profit margin on an accelerated timeline.  Larger biorepositories 
can be more cost efficient, as the initial cost of set up does not have to be repeated and allows 
for a greater volume of business.  Vaught, Rogers, Myers, et al. (2011) stated that most 
biorepositories are not-for-profit and receive funding through a shared or central funding 
mechanism.  Their objective is often to support research at a local institution, such as a 
hospital, or in a larger integrated program, such as a research or academic setting.  
Partnerships with outside programs in the private or public arena may provide the most 
financially stable model.  The authors further noted that “there may be a shift toward larger 
Biorepositories that have broader applications, are more cost efficient to maintain and are 
more proficient in QA” (p.5).  
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Potential sources of capital.  Biorepositories rarely provide a single service, and 
thus, they rarely depend on a single source of income. Such organizations require a multitude 
of sources to obtain the funding necessary to achieve financial sustainability (Vaught, 
Rogers, Myers, et al., 2011).  Such stability depends on short- and long-term contracts from 
clinical research organizations.  However, other sources may additionally support that 
stability.  For example, a biorepository may find adequate funding through large 
pharmaceutical companies who find biorepositories’ services necessary for research that 
leads to profitable product development.  For instance, Mayol et al. (2010) propose several 
relevant strategies in order to develop a business model that includes academic and 
pharmaceutical research customers.  They suggest a list of current providers and their 
respective services followed by a list of the costs of biorepository services and cost recovery 
methods (pp.139-145).  Grant funding for academic and clinical research should likewise be 
taken into account in budget planning with routine updates and measurable outcomes 
monitored on an ongoing basis. 
Additionally, processing fees may recoup some of operating costs.  The operations 
manager would hold responsibility for developing an overall fee structure.  User fees may be 
difficult to determine initially, as biorepositories often give discounts to academic research 
over pharmaceutical research. Therefore, such fees and costs may be variable.  The 
operations manager may choose to set up a personalized fee structure on a project specific 
basis to allow flexibility and competitiveness in pricing.  The manager should first research 
and evaluate potential competitor’s services and rates.  Once these market rates have been 
researched, an acceptable profit margin should be determined before finalizing any proposed 
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fee structure.  Proposed fees for services and cost recovery should likewise consider 
depreciation of capital equipment. 
Sources of capital for non-profit biorepositories.  Those considering establishing a 
non-profit biorepository may have additional funding opportunities. As reported by Yamada 
et al. (2013), nonprofit biorepositories that serve NIH-funded investigators could seek 
additional support from the NIH through R24, U42 funding mechanisms for the development 
and operation of research infrastructure and resources (p. 226-231).  The Office of 
Biorepositories and Biospecimen Research (OBBR) typically has funding opportunities for 
specific specimen collection types and data resources but not for infrastructure. The National 
Center for Research Resources Division of Research Infrastructure provides grants under the 
Research Facilities Improvement Program that allows the recipient to expand and remodel 
their current space or build new space, but these grants would not fund the purchase of 
equipment.  However, the Shared Instrumentation Grant program provides funding for shared 
equipment purchases to institutions with three or more NIH-supported investigators.  Other 
funding organizations may be able to provide grant funds for research projects other than 
general research resources and infrastructure.  These various funding options for non-profits 
need to be explored as part of a comprehensive business plan.  
Other considerations.   Other financial issues to consider include permanent versus 
temporary funding, staff salaries, facility costs, and safety and regulatory requirements.  
Investors should consider a timeline to recover set-up costs. They must also recognize that 
cost recovery potential will be affected by the number of industry-sponsored research studies 
versus federally-funded academic and clinical research studies using the biorepository’s 
facilities at any given time.   
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Development of an Effective Business Plan 
According to the National Cancer Institute Best Practices for Biospecimen Resources 
(Office of Biorepositories and Biospecimen Research, 2011), “Business plans should be 
specific, measureable, actionable, relevant and time bound” (p. 7).  As such, any 
biorepository that wishes to begin operations should evaluate all potential models and 
business plans by these basic principles. 
Initial capitalization and monthly operating costs.   In order to create an effective 
business plan for the current proposed model, the author created a detailed budget that 
included the initial capitalization costs and monthly operating costs.  The biggest expenses 
include creating infrastructure; purchasing, customizing and implementing the Biobanking 
Information Management System (BIMS); and personnel costs, while monthly operating 
expenses remain quite low.  Refer to Table 1 (pp. 26-28) for an itemization of the potential 
initial capitalization costs of the proposed Biorepository model and Table 2 (pp. 29-30) for 
its monthly operating costs. Specific facility requirements and equipment selection will be 
addressed in Figure 2 (p. 53) as well.  
Insurance.  These initial proposed budgets do not account for insurance.  Sufficient 
insurance must be obtained for the facility (if purchased rather than leased), infrastructure, 
monitoring systems, equipment, supplies, and transport vehicles. Similarly, liability 
insurance for personnel and biological samples would be necessary to protect the 
biorepository against unexpected loss.  Samples collected from clinical research studies may 
very well be irreplaceable; research personnel cannot go back and obtain a sample from that 
same precise point in a specific participant’s life or health status (Simeon-Dubach, Zaayenga, 
& Henderson, 2013).  However, the availability of sufficient insurance coverage may 
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adequately compensate clients for the time, materials, and personnel costs in designing a new 
or revised study, including recruitment of any new participants to obtain future specimen 
collection, compensation for or reimbursement incurred by potential participants, and lost 
productivity on the part of the investigator.  Simeon-Dubach, Zaayenga, and Henderson 
(2013) noted that “a thoroughly conducted risk assessment and contingency plan can be used 
to define insurance premiums, not only for the infrastructure and equipment, but also for the 
biospecimens and data” (p.133).  
Other considerations.  In addition to consideration of these initial budgeting 
estimates, Dash et al. (2012) suggested investors consider the following topics when creating 
an effective business plan: 
• A realistic projection for profit and loss, with three to five year projections, in 
addition to a cash flow analysis.  
• A planned “ramp up” period, clarifying which operational areas may incur a loss as 
business increases.  
• A time frame estimating when operations will break even and become profitable.   
These plans should be reviewed and approved by stakeholders prior to 
implementation (pp. 668-678).
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Table 1 
 
Initial Capitalization Costs 
 
 
Expenditures 
Cost 
Per Unit Total 
Rent $6.00/gsf $90,000 
15000 gsf, with ability to expand further   
   
Initial Construction   
Electrical, HVAC, generator, emergency lighting, lab/IT 
Connectivity, BSC, lab sink 
 $750,000 
LN2 concrete pad, LN2 piped in, internal fill station, oxygen 
monitoring system 
  Princetoncryo.com / Cryogenic Gases 
 $150,000 
   
Security System incl. video surveillance, gated entry   
Installation  $10,000 
   
Fire Prevention System   
Installation  $5,000 
   
Freezer Monitoring System   
Smart-Vue, Fisher Scientific  $50,000 
Lithium batteries required for each freezer per year  $2,000 
wireless, probes unnecessary    
dedicated computer not required   
   
Freezers    
1 Refrigerator, Kelvinator  $8,000 
2 -80 deg C Mechanical Freezers, Revco  $24,000 
LN2 Freezers, 25 initial freezers   
*Chart MVE HEco1892-190* $54,674 $1,366,850 
Obsolescence planning and replacement (1 freezer / 4 years) $50,961 $12,740 
*10% freezer back up space required at all times   
Battery Back up $675 $16,875 
   
Freezer Racks   
2 mL vial Chart MVE 60 racks/freezer $80 $67,200 
5 mL vial  $90 $21,600 
10 mL-50 mL vials  $90 $37,800 
   
Laboratory Information Management Program   
5 stations, license, training and technical support   
LabVantage, BioStorage, Kits $120,000 $120,000 
   
Label Stock, die cut, initial run  $12,000 
   
Barcode Scanners (4 Wasp Barcode Scanners) $360 $1,440 
   
Cryocart (MVE #14448703)  $16,500 
   
Vapor Shipper (Holds 675 2 mL vials, MVE XC20/3V, cat 
#11016649) 
 $1,832 
Protective Shipping Container for Vapor Shipper (cat #10537506)  $402 
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Table 1 
 
Initial Capitalization Costs 
 
 
   
Independent ultralow thermometers (25) $50 $1,250 
   
Computer Stations, Server  $10,000 
UPS Backup Protection  $500 
NetGear Switches  $500 
   
Lab Benches, Desks, Chairs  $40,000 
Printer/ Scanner  $600 
Copier  $4,000 
Centrifuge  $15,000 
Stainless Steel Cart  $600 
Vortex/Shaker  $600 
Finn Pipets, Stand  $2,400 
   
CAP Accreditation  $3,000 
Freezer Mapping (CAP requires periodically, accreditation every 3 
years) 
 $10,000 
   
Waterproof Cryogloves $300 $1200 
Lab Coats $40 $160 
Truck for Biospecimen Pick-up and Delivery  $40,000 
Truck Customization  $10,000 
   
Marketing   
Advertisement  $10,000 
Website Development  $2,500 
Signage  $5,000 
   
Food Refrigerator, Microwave  $1,000 
   
Expenditure Subtotal  $2,922,549 
  
 Cost 
Personnel Per Unit Total 
   
Manager (100%) $120,000 + 
25% benefits 
$150,00 
IT (Contractual)  $100,000 
Lab Tech Level 1(1 hire @ 100%) $40,000 + 
25% Benefits 
$50,000 
Lab Tech Level 2 (2 hires @ 100%) $35,000 + 
25% Benefits 
$87,500 
Lab Tech Level 3 (1 hire @ 100%) $35,000 + 
25% Benefits 
$43,750 
   
Personnel Subtotal  $431,250 
   
Total Expenses  $3,353,799 
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Table 2 
  
Monthly Operational Costs 
  
Budget Line Item Expenses 
Annual Monthly 
LN2 Bulk Tank Lease, Cryogenic Gases $9,600 $800 
Lease includes preventive maintenance, service, emergency response, and telemetry 
3000 gallon tank can support 20-40 large LN2 freezers 
  Note: LN2 Bulk Tank Purchase, $50,000-$150,000 Range, very rare 
  Increasing tank size made easy with lease option 
  
   LN2 Supply $9,450 $788 
Initial fill of 3000 gallon tank, $1200 in Jackson-Ann Arbor Area 
  Subsequent fills $750 in Jackson-Ann Arbor Area 
  
   Dry Ice Supply 
 
$128 
   Utility Costs 
  Electric, Gas 
 
$2,500 
Phones—4 Lines $2,500 $208 
Internet/WiFi /Ethernet Connectivity—High Speed 
 
$600 
   Biohazardous Waste Disposal, Stericycle $2,500 $208 
Regular Waste Disposal, Modern Waste/ Republic $1,500 $125 
Custodial Services $1,800 $150 
   Insurance 
  Equipment, Liability coverage for Biospecimens, Accident $24,000 $2,000 
Vehicle Insurance and Registration $2,200 $183 
   Advertisement, on-going $2,000 $167 
   Fuel for Vehicle, Biospecimen pick-up and delivery 
 
$2,500 
Vehicle Maintenance $1,200 $100 
Reserve for vehicle replacement $5,000 $417 
   Maintenance/Service Contract on A/C $1,500 $125 
Maintenance, Load Testing on Generator $3,000 $250 
   Security System Monitoring Contract $2,500 $208 
   Freezer Service Contracts starting Year 3 $5,000 $417 
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Table 2 
  
Monthly Operational Costs 
  
Budget Line Item Expenses 
Annual Monthly 
   Laboratory Information Management Program license fees in future years  $7,500 $625 
Network Vulnerability Testing $3,000 $250 
Finn Pipet Calibration/Preventive Maintenance $300 $25 
CAP Accreditation, $3000 every 3 years 
 
$0 
External QA/ PT Materials $2,500 $208 
Freezer Mapping starting Year 3 
 
$0 
Freezer Batteries or Charger $2,000 $167 
   ISBER membership, conference $3,708 $308 
   Miscellaneous Supplies 
 
$1,250 
Safety Glasses/ Face Shields 
  Nitrile Gloves 
  Lab Notebooks/iPad 
  Printer Paper 
  Binders 
  Sharpies, Pens, Paper 
  Scotch tape/ Packing tape 
  Blue Pads 
  Pipet Tips 
  Kim Wipes 
  Bleach 
  Cleansers 
  Clear bags 
  Biohazard Bags, Stickers 
  
   Monthly Operating Budget, not including personnel 
 
$14,707 
   Estimate of costs for additional services, kits, check-in, processing, third-party shipments $4,000 
   Total Anticipated Monthly Expenditures, not including personnel 
 
$18,707 
 
 
 
 
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
30 
Marketing and advertisement.  A successful business model incorporates an 
effective marketing strategy that provides outreach to potential clients. As stated earlier, a 
complete needs assessment can help identify possible clients of the biorepository to 
determine which marketing strategies would be most effective in reaching both local and 
national markets.  A successful marketing campaign would include implementing a 
marketing survey specifically targeted to the scientific community, soliciting the needs of 
other potential users, and providing information on the mission and services of the proposed 
biorepository.  Surveys would be directed to academic medical centers, hospital systems, 
reference laboratories, pharmaceutical companies, biotech firms, contract research 
organizations, academic institutions, and specific researchers and clinicians.  Management 
may also consider conducting focus groups as another method of soliciting input and the 
needs of potential users. 
Marketing of the biorepository should ideally provide awareness and understanding 
of the purposes of the biorepository.  Therefore, appropriate marketing strategies should take 
a multi-lateral approach, including word-of-mouth, direct mail, and print and website 
advertising to raise such awareness.  Specific services, quality of service assurance, and 
competitive pricing would be addressed in more specifically directed marketing efforts.   
While primary advertising regarding the benefits of the biorepository would be 
accomplished through direct mailing of brochures and press releases to identifiable clients, 
white papers may also be written and widely disseminated to address relevant topics in 
research that may be tied to the unique benefits of the biorepository.  Similarly, media 
outreach might include representation at professional events such as seminars, conferences, 
and lectures as well as advertising in respected and well-read trade journals within the 
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scientific community. These advertising models would to promote the biorepository on a 
more national level.  On a local level, participation of biorepository staff in community 
events and local organizations would provide an opportunity to demonstrate the benefit of 
having the biorepository within the community. 
Once clients are established, good business practices and marketing efforts would 
continue through emphasis of the quality of services and friendly collaboration. These efforts 
would ideally establish a loyal customer base and retain a large percentage of potential repeat 
customers.  Overall, a number of marketing strategies and public relations campaigns may be 
utilized with both new and existing clients to promote the biorepository, ensuring its 
profitability and utilizing its potential to contribute to the advancement of scientific research. 
Business continuity 
Business continuity planning ensures critical business functions will continue should 
adverse conditions interrupt the flow of operations.  The foundation of a successful business 
continuity plan includes the requisite policies, procedures, and guidelines to ensure the 
continuation of services in the event of any emergency.  The biorepository must prioritize 
which of its functions are most essential and then implement documented policies and 
procedures to maintain continuity and recovery of essential functions after any internal or 
external event impacts the organization.  
A complete business continuity strategy will incorporate a risk analysis identifying all 
possible risk scenarios.  Any event that has the potential to interrupt normal operations, such 
as geographic disaster, loss of supplies, or damage to equipment, must be anticipated and 
included in a risk management plan. Henderson, Simeon-Dubach, and Zaayenga (2013) 
suggested that a “specific focus on risk management and risk mitigation in the case of 
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disasters and unexpected occurrences” must be an integral part in planning for biorepository 
infrastructures and processes (p. 193).  They assert that these plans need to be developed for 
“when bad things happen” as part of a core-competency for all biorepositories (p. 193).  
Risk assessment.   Based on principles from ISO 22301:2012, “Societal continuity- 
business continuity management systems-Requirements,” standard operating procedures of 
the current biorepository model will address risk assessment planning including the 
following: 
1. Identify risks of disruption to the organization’s prioritized activities and outline 
all the processes, systems, information, people, assets, outsource partners, and 
other resources that support them 
2. Systematically analyze each risk. 
3. Evaluate which disruption related risks require treatment. 
4. Identify treatments commensurate with business continuity objectives. 
Establishing business continuity plan.  In order to maintain readiness to resume 
operations, the current biorepository model must use the results of the risk assessment to 
establish a business continuity plan.  As part of this plan, biorepository management shall 
define the “minimum level of products and services that is acceptable to the organization to 
achieve its objectives” (ISO 22301:2012, page 5). An inclusive business continuity plan will 
define: 
• Operating dependencies: identify what must be in place before operations can 
resume. 
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• Steps to return to normal: identify tasks that must be performed before business 
can normalize.  These tasks may include restoring network services, 
communication, and information technology systems. 
• Time frames: prioritize tasks so services can resume in the correct order and in the 
most efficient and expeditious manner. 
• Necessary resources: identify required staff, alternate vendors for supplies (as 
necessary), and methods for protecting information and data.  The organization 
should also identify resources for restoring stability of building facilities and 
utilities if necessary. 
Biorepository personnel must take proactive measures not only to prevent any event 
from affecting services but also to shorten the duration of any disruptive event in order for 
business to resume as quickly as possible.  Applying these organizational principles specific 
to a biorepository will help to minimize events that can potentially interrupt critical functions 
and allow critical functions to continue.  See “Chapter 10: Emergency Preparedness and 
Disaster Response” (p. 146) for more information.  
Specific business continuity plans of the proposed Biorepository model.   In the 
current biorepository model, the business continuity plan must address a number of issues in 
order to maintain continuity of service. 
LabVantage.  If LabVantage software is not functional or operational, an established 
LabVantage downtime procedure must be established and documented.  Critical functions 
must be maintained via paper processes until LabVantage function has been restored and 
verified.  Short- and long-term scenarios must be considered and should include pre-designed 
procedures and templates for data capture when LabVantage becomes unavailable. These 
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procedures must address application support, backup, recovery, and restoration procedures as 
well as system management, problem management, and a Service Level Agreement for 
outside contracts.  
Record keeping.  In the event of fire or flood, records within the biorepository 
facility may become damaged or destroyed.  Therefore, any business continuity plan should 
include procedures for storing redundant business records off site.  To that end, electronic 
copies of business records will be backed up and maintained off site in case data recovery is 
required.  Such business records necessary for operation may include: 
• Documentation critical to biorepository functions, including research protocols, 
IRB approval applications and amendments, document control software, SOPs, 
reference manuals, and other laboratory records. 
• An inventory of equipment, hardware, and software, including make, model 
number, serial number, ID tag, and version number as appropriate. 
• Client contact list. 
• Contact information, including names, addresses, phone numbers, and contract 
numbers for all maintenance providers, equipment manufacturers, and suppliers. 
• Copies of invoices, purchase orders, credit card statements, contracts, and service 
agreements. 
These records that are maintained offsite must be routinely backed up from data 
housed in the biorepository.  Precise locations of all documented data must be recorded, and 
all such scheduled backups must have documented confirmation of completion. 
Finally, defining staff responsibilities in the event of an emergency and providing 
training that prepares for all potential scenarios will develop a successful business continuity 
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management system that can ensure the biorepository maintains critical functions and meets 
its responsibility of protecting the biospecimens in its care, even in the event of unforeseen 
interruption of biorepository functions. 
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
36 
Chapter 4: Documentation Requirements 
ISO 9001:2008 identifies several requirements for documentation within a quality 
management system.  Specifically, this documentation should include statements of policy 
and objectives, a quality manual, and written procedures and record-keeping processes in line 
with the aims of the organization. 
Biorepository Policies and Objectives 
According to ISO 9001:2008, a quality policy “is appropriate to the purpose of the 
organization, includes a commitment to comply with requirements and continually improve 
the effectiveness of the quality management system, provides a framework for establishing 
and reviewing quality objections, is communicated and understood within the organization, 
and is reviewed for continuing suitability” (p. 4).  Therefore, the proposed biorepository’s 
policies must define the biorepository’s direction, processes, and values. Such policies will 
include a quality policy and an infectious disease policy. 
Quality policy and quality objectives.  Simeon-Dubach et al. (2013) argued that “a 
quality biobank stands on three pillars: the number of biospecimens; the quality of the 
collection and storage; and the amount and richness of the associated stored data” (p.133).  
The biorepository, therefore, should establish a number of quality objectives by which all 
policies should be upheld.  For this particular biorepository, such quality objectives shall 
include: 
• To provide the highest level of customer service and support. 
• To develop standardized collection protocols and capture and report all pre-
analytical variables. 
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• To support standardized collection processes by offering design and manufacture 
of specimen collection kits. 
• To utilize Biospecimen Evidence-based Practices and SOPs. 
• To incorporate the latest advances in biospecimen research and cryopreservation 
to ensure the highest quality, fit-for-purpose biospecimens for clinical and 
translational research. 
• To utilize and incorporate ISBER and NCI Best Practices into biorepository 
operations as appropriate. 
• To keep current with the latest technological advancements and quality assurance 
strategies (e.g., ISO/TC 276 for biotechnology standards to include biobanking 
currently being developed). 
• To obtain College of American Pathologists (CAP) Accreditation for 
Biorepositories within a specified time frame. 
• To obtain ISO 9001:2008 QMS Certification. 
• To join the International Society of Biological and Environmental Repositories 
(ISBER) and participate in conferences, sponsored activities, and working groups. 
• To consider joining Cooperative Alliances to share resources and expertise as 
appropriate. 
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Quality manual.   The quality manual or operations manual for a biorepository 
should outline the scope, procedures, and interactions of processes within the pre-determined 
quality management system.  Practically, it should therefore contain all policies, standard 
operating procedures (SOPs), guidance documents, work instructions, forms, and checklists 
necessary for biorepository operations.   
Once established, this operations manual and the QMS it outlines should be 
applicable to all operational activities performed by the biorepository.  Following all policies 
and procedures within the designated QMS will ensure compliance with biorepository 
policies and procedures as well as all applicable federal, state, and local regulations; the 
International Society of Biological and Environmental Repositories (ISBER) Best Practices; 
the National Cancer Institute (NCI) Best Practices; and the College of American 
Pathologists’ (CAP) Accreditation Requirements.  The extent of these requirements will be 
determined as applicable to the scope of biorepository services. 
A limited number of hardcopies of the operations manual should be controlled and 
maintained by management (see “Authority and Responsibility” for further information on 
management structure).  These hardcopies can then be made be readily available for staff, the 
director, operations manager, and any internal or external inspectors. Electronic copies 
should also be available on the biorepository website with read-only and printing privileges 
for staff, clients, and inspectors.  Editing privileges should be granted to the director and 
operations manager only.  
Biorepository Documented Procedures  
Documented procedures, such as those outlined in the operations manual, ensure “the 
effective planning, operation and control of the Biorepository processes” (ISO 9001:2008, 
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p.2).  Standard Operating Procedures (SOPs) should therefore describe tasks or processes and 
be sufficiently detailed to reflect the complexity of the task or process and the requisite skills 
and training of the personnel performing it.  These SOPs will provide uniformity and 
consistency in all biorepository activities and will incorporate all quality standards.  Each 
new or revised procedure will be tested and approved prior to implementation.  Per ISO 
9001:2008 requirements, all records and documents must remain “legible, readily 
identifiable, and retrievable” (p. 3). 
Guidance documents, work instructions, forms, and checklists.  Guidance 
documents, work instructions, forms, and checklists should be created for all appropriate 
tasks within the biorepository’s structure.  These documents should be controlled, 
maintained, and readily available at all appropriate workstations.  
Quality control (QC) and quality assurance (QA) documents.   QC and QA 
documents should include information on chemical hygiene, exposure control, hazard 
communication, laboratory biosafety, competency evaluation, training, safety, education, and 
proficiency testing.  These records must be controlled, maintained, and securely stored and 
made readily available for internal and external audits or review.   
Control of Records and Documents 
Records and historical documents must be consistently controlled, maintained, 
securely stored, and made readily available for internal and external audits or review.  In 
addition to QC or QA documents or other documents established via standard operating 
procedures, the biorepository must also retain records of specific study processes, procedures 
and results.  In this proposed model, such records will include laboratorians’ notebooks, 
which will serve as important source documents subject to review by management.  
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
40 
Instructions for record keeping and maintaining such a laboratory notebook would be 
provided in the operations manual. 
Document control plan.  The document control plan should outline all procedures 
regarding document creation and control within the biorepository. It should include methods 
for managing the biorepository’s standard operating procedures, from creation and 
development to maintenance, review, and revision as well as documenting approved protocol 
deviations.  It would also identify methods for locating SOPs as well as proper protocol for 
distributing them to staff.   
All SOP documents should undergo a routine review process to ensure the most up-
to-date information is included in SOPs; therefore, the documents should be reviewed, 
modified as appropriate, and approved at least every two years by both the biorepository 
director and operations manager (see “Authority and Responsibility” for further information).  
All new policies and SOPs or substantial changes with respect to documentation will be 
reviewed and approved prior to implementation.  Although outdated versions will not be in 
circulation to prevent unintended use, documents that have been designated obsolete will be 
retained in the records.  The date of obsolescence and the version number will be recorded.  
Methods of document control.   Document control may be adequately accomplished 
manually, e.g., through a list of controlled documents in Microsoft Excel or another software 
program. For larger biorepositories, particularly those that offer a multitude of laboratory 
services, a document control software program may better serve the organization. 
A document control software program can effectively manage and control all 
document versions and revisions with a complete audit history in a secure, centralized 
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location.  Documents are organized in an intuitive manner with full text or metadata 
searching options available.   
A configured workflow can also automate the review and approval process.  
Documents can be restricted and automatically routed to the appropriate personnel for review 
and approval.  Users are alerted to take appropriate action for document review via email 
notification.  Escalation procedures can be implemented if assigned actions are not 
completed in a timely manner. Parallel, sequential, and voting options may also be utilized 
for routing and managing documents.  Upon approval, automatic sequential numbering may 
be utilized and electronic signatures recorded and displayed.  Documents may be distributed 
electronically.  Outdated versions will be tracked and archived automatically; archived 
documents will be easily accessed for reference purposes.  
Regardless of the method chosen, management should maintain an SOP log that 
contains the date of all document revisions and disseminations, document identification 
numbers, and the title of the SOP in question, and the modification and the reason for the 
modification.  Maintaining an effective SOP log is crucial in tracking the historical 
development of an SOP (and the corresponding scientific findings based upon those 
procedures) and preventing unintended use of outdated or obsolete procedures. 
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
42 
Record preservation and retention.  Hard copy records must be protected from loss, 
damage, or deterioration and should be stored according to documented procedures in such a 
manner that they may easily be referenced and retrieved from any specified storage locations.  
Electronic records will be backed up and archived at regular intervals according to 
documented procedures. 
Records should be retained for established retention times. For instance, employment 
records will need to be maintained indefinitely.  Should biorepository operations cease, 
policy should dictate that records be retained for five years minimum at a secure, safe 
location deemed appropriate by the biorepository director.  This pre-approved location 
should also be provided to the operations manager for additional tracking purposes. 
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Chapter 5: Management Requirements 
Regardless of how the QMS is configured in any given biorepository, it is the 
responsibility of management to ensure both that “the planning of the quality management 
system is carried out in order to meet the requirements” of the ISO standard and the 
establishment in question and that “the integrity of the quality management system is 
maintained when changes to the quality management system are planned and implemented” 
(ISO 9001:2008, p. 4).  Therefore, the establishment of a management structure and 
philosophy are central to creating a working QMS. 
Organizational Structure 
A readily available organizational chart should define the organizational structure of 
the biorepository.  This organizational chart should also outline the chain of command and 
reporting relationships within the organization (NCI Best Practices, 2011). Although this 
chart can be as detailed or as simple as necessary for the biorepository in question, there are a 
few staff positions that are crucial to this model’s biorepository functioning. These positions 
will also be referenced throughout the current document. 
Authority and Responsibility 
The biorepository director.  In the current model, the director holds ultimate 
responsibility for the biorepository.  These responsibilities include defining its mission and 
organizational objectives, identifying the scope of its services, and securing its funding.  The 
qualifications of the director, therefore, must be appropriate for the scope of activities and 
services envisioned for and provided by the biorepository.  In addition, the director will 
review the quality management system (QMS) on an annual basis and will review all policies 
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
44 
and procedures according to the document control plan at least once every two years.  These 
systems may be reviewed more frequently if appropriate.   
In the event the director works at the biorepository while maintaining an appointment 
at an academic institution, the director will document time spent and activities performed at 
the biorepository as opposed to time spent in his or her primary academic capacity.  In such 
circumstances (or as necessary), the director may elect to delegate certain high-level 
administrative and biorepository tasks; instances of this delegation of authority will be 
documented and made available for review.   
In the event of a change in directorship, the new director will review and become well 
acquainted with the standard operating procedures.  The new director will also establish 
policy (if applicable), provide guidance and oversight to staff and delegate responsibilities 
accordingly, and review and work to improve the quality management system.  
The operations manager.  In the current model, the operations manager will work in 
concord with the director to manage daily operations of the biorepository and, therefore, 
must have the training and expertise necessary to do so.  One of the manager’s primary 
responsibilities will revolve around review and implementation of all aspects of the QMS and 
document control plan.  For instance, the manager will review all policies and procedures 
according to the document control plan every two years or more frequently, if appropriate.  
The manager will also establish, implement, and maintain the QMS, its documentation, and 
processes.  In addition, the manager will ensure all personnel are trained to comply with the 
QMS as it relates to their individual duties.  The manager will maintain records of all such 
education, demonstration of skills, and training.  The manager will also conduct audits, 
collect data on the performance of the QMS, and report the subsequent findings, including 
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recommendations for improvement, to the director for review.  Larger organizations may 
consider appointing a quality assurance manager in addition to the operations manager in 
order to provide an independent assessment of quality assurance activities.  Other overall 
responsibilities of the operations manager would include hiring, training and evaluating key 
personnel, managing all operations and workflow, communicating with clients, and 
overseeing all business activities.  
Staff.  Per ISO 9001:2008, management should always “ensure personnel are aware 
of the relevance and importance of their activities and how they contribute to the 
achievement of quality objectives” (p. 6). Staff should therefore be appropriately trained to 
be proficient in and conduct tasks according to established policies and procedures.  
Minimum requirements of job classifications and respective roles must also be clearly 
defined and well-documented, and staff will be certified for individual tasks associated with 
their respective positions. 
Communication with staff must be considered of highest importance in any proposed 
biorepository. In addition to management communicating assignments and policies to staff, 
staff should feel comfortable making suggestions to management.  Staff should be 
responsible for identifying and reporting noncompliance or inadequate quality control or 
quality assurance to the operations manager.  The director and operations manager should 
encourage staff to communicate any relevant information to other staff members wherever it 
may be helpful in ensuring the effectiveness of the QMS.  Furthermore, with experience and 
encouragement, staff may contribute significantly to continual improvement in services, 
processes, and systems by providing feedback and suggestions to management for 
consideration.   
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Management Commitment 
In the proposed biorepository model, the director and operations manager will be 
committed to utilizing Biospecimen Evidence-based Practices and SOPs as well as 
incorporating the latest advances in biospecimen research and cryopreservation to ensure the 
highest quality, fit-for-purpose biospecimens.  Management will also be committed to 
implementing and maintaining a complete and effective QMS, continually improving it, and 
ensuring all personnel are aware of the importance of compliance with the QMS.  
Management will establish quality policy, ensure quality objectives are established, conduct 
management reviews, ensure the availability of sufficient resources, implement customer 
requirements, and work toward continual review and improvement of the QMS.  
Best Practices.  As part of its commitment to quality, management will ensure the 
biorepository follows designated Best Practices:  the International Society for Biological and 
Environmental Repositories (ISBER) Best Practices: Collection, Storage, Retrieval and 
Distribution of Biological Materials for Research (2011) and the National Cancer Institute’s 
Best Practices for Biospecimen Resources (2011).  
Accreditation.  The proposed biorepository model will also seek accreditation and 
certification from several industry leading organizations.  First and foremost, the 
biorepository will obtain College of American Pathologists (CAP) Accreditation for 
Biorepositories.  After the CAP has confirmed acceptance of the biorepository’s application 
materials, the Laboratory General and Biorepository Checklists will be sent to the 
biorepository.  Barring any unforeseen circumstances, the first inspection will be scheduled 
within six months of the time of the application.  
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The biorepository will also seek ISO 9001: Quality Management System 
Certification. Currently the ISO 9001:2008 QMS is under review. The revised standard 
should be finalized by the end of this year (International Organization for Standardization, 
2015).  After the revision is published, organizations that are currently certified will have 
three years to transition to the new standard.  
The ISO Technical Committee, TC 276, is currently developing a biotechnology 
standard to include biobanking. Once it is released, the biorepository will make certification 
to this ISO standard a top priority. 
Networking.  In order to keep current in the field of biobanking, the operations 
manager will be a member of International Society of Biological and Environmental 
Repositories (ISBER) and will participate in ISBER conferences and working groups.  
Networking in forums such as these leads to opportunities to join or form cooperative 
alliances in order to share resources and expertise. 
Communication.  Effective communication is essential to the success of any 
organization. At the proposed biorepository, such communication will be facilitated through 
an open door policy, regular staff meetings, email, and other means as appropriate. 
Management will foster an environment where all individuals are treated in a respectful, 
professional, and courteous manner and will encourage staff to ask questions and contribute 
ideas and insights as well as suggest improvements.  The biorepository will also highly 
recommend implementation of a formal communication plan both for emergency response 
measures as well as to communicate important information to clients and stakeholders. 
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Chapter 6: Resource Management-Human Resources and Infrastructure 
ISO 9001:2008 specifies parameters by which an organization should identify and 
provide resources, both in terms of human resources and in terms of physical structure (p. 6).  
The proposed biorepository will be committed to ensuring the highest quality and integrity of 
biospecimens throughout the collection, processing, storage, and distribution life cycle.  To 
that end, the biorepository will provide the requisite infrastructure, safe working 
environment, and necessary resources for effective operation and quality management.  By 
maintaining awareness of potential resourcing issues, the biorepository will attempt “to 
implement and maintain the quality management system and continually improve its 
effectiveness, and to enhance customer satisfaction by meeting customer requirements” (ISO 
9001:2008, p. 6).  
Human Resources  
Human resource practices will be governed by federal, state, and local laws as well as 
by policies and procedures outlined in the biorepository employee handbook.  A list of 
employment policies and procedures is provided in Figure 1. 
Staff selection.   Well-qualified staff will be recruited, selected, and employed by 
virtue of their education, training, skills, and experience for their respective duties.  Once 
selected, staff members will be subject to continual review and personnel files will reflect all 
pre-selection and post-employment records.  These files will be restricted and organized in a 
systematic fashion for expedited review.  Personnel records must contain all staff members’ 
curriculum vitae, references, letters of recommendation, copies of academic degrees, 
certifications, and licenses; continuing education records; current job description; a summary 
of qualifications; a list of specific procedures and tasks the employee is authorized to 
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perform; previous evaluations; emergency contact information; work-related incidents, 
accidents, and excuses from work (for significant illnesses only); and dates of employment. 
 
 
 
Figure 1. List of documented employment policies and procedures. 
Competence, training, and awareness.   Mandatory training programs will be 
conducted on an initial as well as an annual basis.  Training documentation will be 
maintained for all administrative and laboratory personnel.  Staff members must satisfactorily 
complete initial training prior to performing work with specific instruments or methods.  
Annual competence assessments will be performed using various methods including but not 
limited to direct observation, review of records, or an evaluation of problem-solving skills.  
Staff must demonstrate appropriate knowledge of relevant policies and procedures.  Training 
records will include the date of the training, the training subject, materials, methods of 
ü Employment Process 
o Recruitment 
o Background Screening 
o Work Eligibility (Visa, I9 Form) 
o Employment Oath 
o Orientation 
ü Non-Discrimination / Affirmative Action 
Policy 
ü General Policies 
o Rules 
o Schedules 
o Lunch & Break Periods 
ü Employment Benefits 
o Health Benefits 
o Holidays 
o Retirement 
o Tuition Reimbursement 
ü Injury Prevention/Documentation 
o Personal Protective Equipment 
o Illness/Injury Reporting to OSHA 
o Workman Compensation 
ü Pay Policies 
o On-Call Time 
o Overtime/Compensation Time 
o Garnishment 
o Employment Taxes/Social Security 
 
ü Professional Development 
o Career Development 
o Tuition Support 
ü Absences 
o Illness Reporting to Management 
o Sick Time 
o Leaves of Absence (Paid/Unpaid) 
o Funeral Time 
o Vacation 
o Jury Duty 
ü Employee Evaluation 
o Evaluation Process 
o Salary Increase 
o Promotion or Reclassification 
o Fitness for Duty 
ü Termination of Employment 
o Unemployment Compensation 
ü Employee Grievances 
ü Discrimination or Harassment 
o Mediation 
ü Conflict of Interest 
ü Employment Records 
ü Travel Pay 
o Per Diem 
o Allowable Costs/Limits 
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review and subsequent outcomes as well as the signatures of trainer and participating staff.  If 
there is evidence of unsatisfactory performance, retraining and re-evaluation will be 
mandated with documentation of results.  A plan of action may also be implemented.  The 
operations manager will conduct laboratory-specific and administrative training.  
Occupational Safety and Health Administration (OSHA) as well as law enforcement 
personnel will conduct in-service training, consultation, and assistance as requested and 
required.  
Staff evaluation and merit program.  Employee supervisors will conduct 
performance evaluations for all staff members on an annual basis, or more frequently if 
required.  The evaluation process will be an opportunity for a supervisor and staff member to 
review progress, accomplishments, and the staff member’s current job description; to discuss 
issues that may be preventing progress; to work together to identify short- and long-term 
career goals; to identify staff development opportunities; and to encourage open and 
productive dialogue.  
Competency evaluations specific to operational activities will also be performed 
annually.  Evaluators will generate a subsequent summary of qualifications form to reflect 
the results of the evaluation.  Both documents will be maintained in the personnel files. 
Continuing education.  Continuing education will be an important component in not 
only promoting staff development but also improving biorepository services, quality control, 
quality assurance, and quality improvement practices.  Continuing education will be fully 
supported, encouraged, and facilitated through participation in research seminars, 
conferences, training and certification programs, management initiatives, participation in 
literature reviews, research activities, and presentations at staff meetings.  Staff presentations, 
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
51 
for the purposes of promoting cross-training or implementing new projects, will be strongly 
encouraged.  The director or operations manager will be available to mentor staff in 
preparing for such presentations.  Academic study and certification will be encouraged.  For 
instance, staff members might attend a specific training seminar on pertinent regulations for 
clinical research, such as those found in the Code of Federal Regulations, the Federal 
Registrar, or training with respect to evidence-based practices.  Continuing education will be 
documented and these records will be made available for review.  
Staff input.   The biorepository will strongly encourage staff input.  The organization 
will therefore provide a formal mechanism for employee concerns, suggestions, or 
complaints with respect to laboratory safety, quality of services, research misconduct, or 
other procedural concerns. 
The success of any organization depends upon TEAMWORK: Together, Everyone 
Achieves More.  At the biorepository, steps for creating and maintaining a productive team 
will require fostering a collegial work environment where no questions or ideas are 
considered silly or frivolous.  Every staff member will be treated in a courteous, respectful 
manner. Furthermore, the biorepository will strictly prohibit any harassment or punitive 
action against any staff member for expressing concerns, suggestions, or complaints of any 
kind.  
Infrastructure 
ISO 9001:2008 requires that organizations “determine, provide and maintain the 
infrastructure needed to achieve conformity to product requirements” (p. 6). Such 
infrastructure may include physical buildings, equipment, or support services as needed. 
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Facility infrastructure and maintenance.  The director will evaluate the facility and 
infrastructure on a routine basis through the director’s assessment of facility report.  A copy 
of this report will be available to inspectors for review.  The director or operations manager 
will continually monitor biorepository resources to ensure a clean, safe working environment 
as well as adequate facilities and infrastructure in order to meet organizational objectives and 
customer requirements.  
Once established, the biorepository will maintain posted and electronic copies of the 
most current biorepository floor plan. This schematic diagram will include equipment 
identification and corresponding electrical information such as panel locations and circuit 
identification.  It will serve as a valuable tool for strategic planning purposes, for 
constructing workflow diagrams, for preparing for preventive maintenance or upgrades, and 
as a quick reference in case of unanticipated difficulties. 
The biorepository will contract a reputable company, with appropriate licensure and 
insurance, to provide general maintenance of the facility and infrastructure.  This company 
will implement a procedure for placing work order requests and tracking their resolution.  
Licensed electricians will provide generator maintenance and load testing per approved 
procedures. The operations manager will ensure these activities are performed on a routine 
basis through the use of a checklist and will escalate requests if these procedural 
requirements are not met in a timely fashion.  Climate control, temperature, and humidity 
will be controlled by a Heating, Ventilation, Air Conditioning (HVAC) system that is 
properly serviced, functioning and has a documented maintenance log.  The work 
environment will be clean and well-maintained at all times. A list of facility requirements, 
including necessary backup and monitoring systems is available in Figure 2 (p. 54).  
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Figure 2.  Facility requirements, including security, electrical backups, and monitoring systems. 
Equipment selection, qualification, maintenance, and replacement.   Laboratory 
equipment will be selected based on the ability to perform specific tasks as well as to meet 
the following performance requirements: precision, accuracy, sensitivity, specificity, 
recovery, efficiency, reliability, method comparison, and cost accounting principles. 
Management will also seek out industry references or recommendations from experienced 
colleagues in similar organizations prior to purchase or leasing of equipment. 
Laboratory equipment will be installed, operated, and maintained according to 
manufacturer’s requirements and guidelines.  Equipment will be validated prior to 
implementation to ensure it adequately meets functional requirements.  Validation 
documentation will be subject to document control and will be readily available to all 
personnel and inspectors.  In addition, a log of all laboratory equipment will be maintained.  
This log will include the model number, serial number, assigned equipment identification 
ü Size, including square footage necessary to 
expand as business grows 
ü Separate office and freezer/lab space 
ü In rooms larger than 1000 square feet, two 
exit access doors leading directly to exit route 
ü Hard flooring in labs/freezer rooms for ease 
of moving equipment 
ü Dock door for equipment 
ü Room to pour concrete pad close to the 
building for LN2 tank 
ü Ability to pipe in Liquid Nitrogen with a 
manual control valve 
ü Temperature control, Humidity control 
(ideally) 
ü Telecommunication lines & IT ports 
ü Electrical outlets (labeled) and easily 
accessible electrical panels 
ü Security system 
ü Biological safety cabinet 
ü Freezer monitoring system 
ü Oxygen monitoring system / oxygen sensors 
for LN2 
ü Gated generator (preferably natural gas) 
directly connected for two -80 degree C 
mechanical freezers and one refrigerator 
ü Electrical hook up for a portable generator on 
a trailer, secondary backup 
ü Heating, Ventilation, and Air Condition 
(HVAC) to ensure proper climate control & 
exhaust system 
ü Emergency lighting 
ü Adequate water supply 
ü Eye wash stations & emergency showers 
ü Separate sink for biologicals 
ü Floor drain (not required, but preferred) 
ü Waste disposal, including Stericycle for 
biohazards and a local reputable service for 
trash 
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number, electrical requirements, and the corresponding electrical outlet and circuit panel 
identified for each piece of equipment.  
Daily, weekly, and monthly maintenance procedures will be performed and 
documented as needed. Calibration procedures will be performed at recommended intervals. 
These procedures may be performed more frequently when reagent lots change, for example, 
or when service has been performed.  Reference manuals will be located in close proximity 
to equipment or instrumentation so staff members have readily available access to the 
information.  These reference manuals will be reviewed annually to ensure procedures 
accurately reflect manufacturer’s requirements and guidelines with respect to operation and 
maintenance.  Documentation of these reviews will be maintained in the document control 
software program.  Appropriately trained technicians or field service engineers will perform 
and document routine service and preventive maintenance certifications as appropriate.  
Technical bulletins and service reports will be promptly reviewed and stored near the 
equipment or instrumentation. Service contracts will be maintained and documented.  
Obsolescence and subsequent replacement of equipment will be planned and incorporated 
into the biorepository budget and supported through the cost of its services. 
Equipment and freezer keys will be organized, labeled, and secured in a key lockbox 
located in a central location.  The key lockbox will contain a list of equipment and freezer 
identification numbers along with the corresponding key. Keys will be controlled by 
management and will be made accessible to appropriate staff members. 
Property control and disposition.  The operations manager or other designated staff 
member will be responsible for tracking, tagging, and inventory control of all capital 
equipment with a dollar value of $200 USD or more.  Equipment inventories will be 
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
55 
reviewed and maintained on an annual basis.  Any academic equipment (e.g., National 
Institute of Health or investigator-owned freezers) that may be stored at the biorepository 
will be valued by government agencies according to the Office of Management and Budget 
(OMB) Circular A21: Cost Principles for Educational Institutions according to 2 CFR Part 
220. 
The operations manager will also be responsible for the final disposition of property 
designated as surplus through appropriate recycling, selling, or disposal mechanisms. A 
declaration of surplus form will be utilized to process and track final disposition of 
equipment. 
Procurement.  The operations manager will provide support and training on policies 
and procedures to ensure approved buying methods and payment processes are followed.  
These procedures will ensure that the biorepository selects vendors and acquires quality 
goods and services that conform to product requirements at competitive pricing.  Products 
will be inspected upon receipt. Packing slips will be signed and dated indicating the 
appropriate quantity of supplies received. Product specification sheets will be maintained. 
The terms of service contracts will be negotiated based on current market rates and 
thoroughly reviewed prior to approval.  
Informatics.  As a state-of-the-science biorepository, all data maintained within the 
organization should be protected with a carefully selected information technology (IT) 
system.  This system must not only function properly, but it must also be maintained and 
secured according to rigorous procedures.  Although a number of biobanking software 
products currently appear in the market, few meet all requirements needed by the current 
proposed biorepository model.  
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Dash et al. (2012) briefly reported on several examples of biobanking software 
products.  Regardless of the needs of a biorepository, Mayol, Woo, and Keck (2010) strongly 
cautioned biorepositories to conduct site visits to current users of the software prior to 
purchase.  These site visits would allow potential users to gain insight and perspectives into 
the software’s advantages and disadvantages with respect to the software itself, its technical 
support, and its level of customization.  
LabVantage.  For purposes of the current study, the proposed biorepository has 
already selected the biobanking information management system, LabVantage, as its primary 
database.  LabVantage was selected through a process of identifying functional requirements 
and negotiating with the vendor.   
LabVantage supports all necessary data and tracking activities required by the 
biorepository.  These valuable functions include:  
• Tracking biospecimens through the collection, processing, storage and 
distribution life cycle. 
• Providing the means and mechanisms to manufacture specimen collection kits. 
• Recording shipment and sample data (see “Figure 3. List of data fields in 
LabVantage for tracking purposes,” page 127).  
• Linking samples with derivatives and aliquots. 
• Maintaining a robust inventory of biospecimen freezer locations and distribution 
records. 
• Recording freeze/ thaw cycles. 
• Recording temperature deviations associated with specific biospecimens. 
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• Allowing for recording sample observations that may affect biospecimen quality, 
integrity, and selection. 
• Recording overall sample volume, including minimum vial and volume warnings 
before quantities fall below collection specified quantities. 
• Producing storage capacity reports.  
• Supporting configuration of temperature monitoring services.  (N.B.: I have 
limited experience with LabVantage. Temperature monitoring records were 
supported through another mechanism, not the BIMS/LIMS system maintained by 
my previous biorepository organization.) 
When purchased, the full-scale model of LabVantage has the capability to annotate 
biospecimens' clinical and laboratory data if required in future. The biorepository also 
preferred LabVantage’s training and potential for customization of the program for the 
biorepository and that of its stakeholders.   
LabVantage will be supported technologically as detailed in the 
LabVantage/Biorepository Support Plan and IT policies and procedures detailed in the 
biorepository operations manual. These policies and procedures will be approved and 
routinely reviewed by the biorepository director, operations manager and IT staff.  Once 
LabVantage is operational, its maintenance of the biospecimen inventory will be validated 
and subject to regular audits.  IT and laboratory staff will validate the accuracy of data 
transmitted to LabVantage prior to implementation to ensure data integrity. Audits of data 
integrity will be conducted every year by IT according to established procedures.  
Other biorepository software.  All software programs (including custom programs) 
and hardware used in the biorepository must be tested for proper functioning when installed 
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and modified. Installation or modification of authorized software is controlled. Software 
programs are tested for proper functioning when installed or modified and an audit log is 
utilized. In addition, documentation for all custom programs must include the purpose of the 
custom program, how it functions, and how it interacts with other programs trouble-shooting 
and system modifications.  
System security.  Computer access codes will be defined, maintained, and secured to 
prevent unauthorized access.  Computers will be installed with timeout programs and lock-
out mechanisms.  Installation or modification of authorized software will be controlled 
through IT administrators.  Policies will define which personnel can enter, access, or alter 
data or programs.  A written policy will likewise define all requirements for data 
confidentiality and accuracy.  Software programs will be tested for proper functioning when 
installed or modified and an audit log will be utilized. Systems will be routinely tested to 
identify and correct vulnerabilities. 
Data integrity and auditing.   Although LabVantage and other software programs 
have been proven to be reliable products, all inventory and data must be validated and subject 
to regular quality assurance audits to ensure data integrity.  Software issues will be tracked 
for identification and correction.  Data will be routinely backed up and tested periodically for 
accuracy.  Interface shutdown and recovery procedures will include verifying the integrity of 
the system after any necessary restoration of backup data.  
Additionally, an audit trail should be established to identify all individuals who enter 
or modify any data at the time of entry, and all data must be archived and accessible in a 
timely manner.  Similarly, an adequate tracking system will identify and report any software 
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issues; an audit log will reflect all corrections made and identify all persons adding or 
modifying software. The same will be true for hardware. 
Finally, systems should be routinely tested to identify and correct vulnerabilities 
particularly as it relates to network security. An independent service will be contracted or 
utilized on a monthly basis and should provide a formal reports with recommendations for 
improvement wherever applicable. 
Personnel training.  Approved procedures and work instructions for all biorepository 
systems will be established prior to personnel training.  Once these procedures have been 
developed, personnel will undergo initial instruction and then future training for any 
modifications or installation of software.  Training records will be maintained for all 
personnel. 
Emergency data retrieval.  A written plan should outline procedures for data 
retrieval and preservation in the event of unexpected circumstances.  These procedures 
should ensure that both data and equipment are protected and data integrity maintained.  Any 
systems used to back up programs and data should to be tested periodically for effectiveness, 
and backups of all files should be stored off site. See “Specific Business Continuity plans of 
the proposed Biorepository model” (p. 33) for information regarding software downtime 
procedures.  
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Chapter 7: Resource Management-Work Environment 
ISO 9001:2008 defines work environment as relating “to those conditions under 
which work is performed including physical, environment and other factors (such as noise, 
temperature, humidity, lighting or weather)” (p. 6).  It is the responsibility of any 
biorepository to manage the work environment necessary to maintain consistency across all 
quality objectives, policies, and standards.  The proposed biorepository model places high 
priority on the work environment for its personnel. 
Specific Safety Measures   
 Any biorepository should be dedicated to a safe working environment for its staff.  
Therefore, safety procedures must begin locally within the biorepository itself.  The 
operations manager will be responsible for training in safety practices, policies, and 
procedures.  To ensure these trainings have been effective, the operations manager will also 
routinely conduct self-inspections of the biorepository utilizing a self-inspection checklist, 
modeled after the University of Michigan OSEH Self-inspection Checklist (University of 
Michigan, n.d.).  An appointed safety committee will also review all procedures annually.   
In case of emergency, the operations manager or an appointed designee will be on 
call at all times, including after hours and overnight.  Emergency contact information as well 
as a list of staff contact information will be maintained and posted throughout the facility.  
The local police department, a full service law enforcement agency, and fire department will 
be available around the clock for emergency response, consultation and assistance, and thus 
their contact information should be posted throughout the facility.   
Individual staff must also be held accountable for proper safety.  Safety training for 
staff will include first aid, cardiopulmonary resuscitation (CPR), fire safety, fire extinguisher 
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training, fire drills, severe weather, evacuation, biological spill response, chemical spill 
response, freezer room safety, and evacuation. 
Finally, the biorepository will also refer to external individuals and agencies when 
appropriate to ensure the safety of its personnel.  The Occupational Safety and Health Act of 
1970 established guidelines under which OSHA personnel strive “to assure safe and healthful 
working conditions for working men and women; by authorizing enforcement of the 
standards developed under the Act; by assisting and encouraging the States in their efforts to 
assure safe and healthful working conditions; by providing for research, information, 
education and training in the field of occupational safety and health” (para. 1).  Therefore, 
OSHA personnel will perform inspections of the biorepository annually.   
Biorepository staff may also contact OSHA directly for assistance. The OSHA can 
provide information and safety publications or answer specific questions as appropriate. They 
can also provide free workplace consultations to small employers to help identify and correct 
hazards and improve injury and illness prevention programs. They will also assist with 
compliance, voluntary protection programs, strategic partnerships, alliances, training, and 
education. Biorepository staff may also contact OSHA to file a confidential complaint.   
Contact information will remain available on the OSHA website (www.osha.gov). 
I have specifically modeled the proposed biorepository based upon Michigan specific 
regulations. Potential biorepository founders should research state and local regulations as 
appropriate.  
Exterior and interior signage.  Door signage will include identification of the 
proposed biorepository as a BSL-2 designated facility.  Emergency contact information will 
be posted where appropriate.  Signs identifying hazards in the biorepository, such as 
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biohazard signs, will be placed where appropriate. Signs banning food or drink will be posted 
in appropriate areas. 
Inside the biorepository, signs with the following safety information will be posted: 
• Emergency contact information. 
• The evacuation plan diagram, which will show fire alarm pull stations, fire 
extinguishers, and exits. 
• The Michigan Safety and Health Protection on the Job Document by the Michigan 
Occupational Safety and Health Administration (MIOSHA). This document 
details employer requirements, complaints, citations, employee requirements, 
inspections, investigations, voluntary activity, and compliance assistance as well 
as MIOSHA contact information. 
• The location of Safety Data Sheets (SDSs). 
• New or revised Safety Data Sheets, including the receipt date, posting date, and 
location of the new or revised SDS. 
• Universal Precautions. 
• Biohazards. 
• Chemical spill kit instructions. 
• Biohazard spill instructions.  
Hazard communication program.  A written hazard communication program 
ensures a safe work environment by informing and protecting non-research personnel, 
outside contractors, and maintenance providers from chemicals used in their work and 
chemicals present in the work environment.  The program will specify all appropriate 
procedures and ensure compliance with the Hazard Communication Standard, 29 CFR 
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1910.1200.  This amended federal regulation was adopted by reference in December of 2012 
in the Michigan Occupational Safety and Health Act 154, commonly referred to as 
“Michigan’s Right to Know Law.”  It includes the Construction Safety Standard Part 42 
Hazard Communication, the General Industry Standard Part 92 Hazard Communication, and 
finally the Occupational Health Standard Part 430 Hazard Communication.  Based upon the 
requirements set forth in these laws, a hazard communication program for the biorepository 
will include the following information: 
• Documentation of the hazard communication program annual review. 
• The designated roles and responsibilities of the director, operations manager, 
staff, and outside contractors or maintenance providers.  
• A current list of hazardous chemicals present in the biorepository (specifics 
regarding the content and maintenance of the list will be discussed in the 
“Chemical Hygiene Plan”).  
• The proper identification, through labels (including identity of the chemical, 
pictograms, etc.) and hazard warnings, of the hazardous chemicals present in the 
biorepository. 
• The availability of Safety Data Sheets for every hazardous chemical and their 
respective locations as specified on the MIOSHA SDS Location Poster. 
Notification of new or revised SDSs, using the MIOSHA New or Revised SDS 
Poster, will be made readily available and posted for five days after receipt of 
hazardous chemical and present for a minimum of ten days.  As previously noted, 
Safety Data Sheets are required to be maintained for 30 years. 
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• Procedures for fire safety and evacuation, freezer room safety and oxygen 
monitoring (if work is performed in that area), the proper handling of chemical 
hazards, chemical spill and response, and hazardous waste disposal. 
• The location of the first aid kit, chemical spill kit, fire alarm pull stations, fire 
extinguishers, and fire blankets.  
• Training in safe work practices, emergency procedures, and required PPE. 
When preparing specifications for contracted work or hiring contractors, 
communications will include a complete list of hazardous chemicals present in the 
workplace; corresponding Safety Data Sheets; and necessary training, emergency procedures, 
and required PPE to the contractor. In turn the contractor must provide a list of hazardous 
chemicals they will utilize and the corresponding SDSs.  All pipes and piping containing 
hazardous substances must be appropriately labeled to identify materials that may be released 
in the event of a leak or rupture (e.g., natural gas or LN2). 
Universal Precautions.   Universal Precautions are a means of infection control 
required to prevent employee contact with blood or other potentially infectious material 
(OPIM).  All blood and OPIM must be considered potentially infectious and capable of 
transmitting bloodborne pathogens regardless of the source of the material.  Universal 
Precautions will be required as part of the Bloodborne Pathogens Standard, specifically in 29 
CFR 1910.1030(d)(1). 
Engineering controls.   Engineering controls may be defined as facility planning and 
design as well as the appropriate selection and utilization of equipment to isolate, remove, or 
reduce the hazard and establish barriers from the hazard.  Examples of engineering controls 
include chemical fume hoods (see page 84) and biological safety cabinets (see page 77). 
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Administrative and work place controls.  Administrative or work place controls 
may be defined as safety policies, training and supervision to minimize exposure to hazards. 
These controls may include procedures for the safe handling of hazards and maintaining a 
safe laboratory environment.  Examples of administrative and work place controls include 
implementing chemical hygiene plans (page 83) and exposure control plans (page 89), 
modifying work schedules and tasks, or rotating staff assignments in order to reduce the 
frequency, duration, or intensity of exposure (Occupational Safety and Health 
Administration, 2011).  Refer to section titled “Administrative controls.” (page 85) for more 
information. 
Personal protective equipment (PPE).  Personal protective equipment (PPE) will be 
utilized in order to protect employees from exposure through physical contact, skin 
absorption, inhalation, or ingestion of hazards in the workplace.  Examples of PPE will 
include lab coats, non-latex gloves, waterproof thermal gloves, safety glasses, and full-face 
shields in order to protect staff’s mucous membranes from potential splashes when handling 
hazardous material.  PPE is selected based upon the requirements of the specific hazard, 
supplied by the organization, and utilized only after proper instruction and training 
appropriate to the assigned task.  PPE must properly fit the staff member who will utilize it.  
Whenever specific PPE is required for a particular task, management must ensure that its 
proper utilization, limitation, and care and maintenance are thoroughly explained to the 
personnel who will be performing the task (Occupational Safety and Health Administration, 
2011).  
Regulations pertaining to PPE include the following: 
• The PPE Standard, 29 CFR 1910.132.  
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• The Eye and Face Protection Standard, 29 CFR 1910.133.  
• The Hand Protection Standard, 29 CFR 1910.138.  
• Non-latex gloves are utilized to protect those with latex (derived from plants) 
allergies or sensitivity according to 29 CFR 1910.1030 (c)(3)(iii).   
• Gloves when handling blood or working in contaminated areas: 29 CFR 
1910.1030(d)(3)(ix). 
First aid kit.  A basic first aid kit must include the following items: bandages, tape, 
Band-Aids, hydrocortisone cream, pain relievers, and the like. First aid and cardiopulmonary 
resuscitation (CPR) training shall be provided to all personnel as part of laboratory safety to 
help ensure a safe workplace. 
Emergency shower or eyewash stations.   Emergency showers and eyewash stations 
are designed to be located in close proximity to areas where hazardous chemicals are present 
and utilized with readily apparent signage posted for easy identification. Such stations 
installed at the biorepository will be routinely maintained and tested on a weekly basis with 
all results documented.  Staff must be provided with an unobstructed path to these areas at all 
times.  Eyewash stations must be capable of delivering ample amounts of tepid water for 15 
minutes with water flow dispensed to both eyes simultaneously. Once activated, employees 
should be able to operate these stations without the use of their hands.  Covers will be 
utilized to protect eyewash stations from airborne contaminants.  Plumbed eyewash stations 
will be activated weekly and protected from unauthorized shut off.  Self-contained units will 
be visually examined on a weekly basis.  
Workplace injuries or accidents.  The Michigan Occupational Safety and Health 
Administration (MIOSHA) works with both employers and employees to prevent workplace 
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injuries, illnesses, and fatalities. MIOSHA establishes and enforces occupational safety and 
health standards, provides extensive safety and health education and training, develops 
innovative procedures and programs to prevent workplace hazards, and mandates the 
reporting and recording of work-related incidents (Department of Licensing and Regulatory 
Affairs (LARA), 2015)  
Should a workplace injury or illness occur, staff and management may quickly 
reference pre-established procedures for the appropriate actions.  If an emergency response is 
necessary, staff will call 911 or report to the local emergency room for medical treatment.  
After affected staff have received appropriate medical treatment, the operations manager will 
review the incident with the staff member, discuss current procedures or procedural changes 
that may be necessary, and summarize the follow up steps taken to prevent the incident from 
recurring.  Reports will be filed in the Employee Accident/Illness notebook.  Copies of these 
reports will be filed in the staff member’s personnel file.  In addition, workplace injuries and 
illnesses will be routinely tracked and monitored in order to raise awareness regarding where 
workplace hazards may be occurring and what corrective action might be taken. 
Serious injuries or illnesses at the biorepository will be reported according to 
MIOSHA requirements.  New federal regulations were implemented in January of 2015 (79 
Fed. Reg. 181, September 18, 2014).  All employers, regardless of size or industry 
classification, are now required to file a detailed report to OSHA within eight hours of fatal 
workplace accidents. Severe injuries that do not result in death but require hospitalization, 
such as amputations or loss of an eye, must be reported within 24 hours.  Previously the 
regulations required such reports only if either a single worker was killed or three or more 
workers were hospitalized as a result of a workplace accident.  The new federal regulations 
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maintain the current exemption for any employer with 10 or fewer workers from the 
requirement to maintain The 300 Logs of Worker Injuries and Illnesses.  The State of 
Michigan, managing its own OSHA program, intends to adopt these standards within six 
months (Department of Licensing and Regulatory Affairs (LARA), 2015).   
Security.  Perimeter and access security will ensure the safety and security of 
personnel, study records, and consistent storage conditions (temperature and physical 
location). This security will also maintain the custody of clinical research samples, as those 
that have been entrusted to our care will likely be irreplaceable.   
The biorepository building shall remain locked after hours and shall employ a reliable 
security system with around-the-clock monitoring. This system will include security, fire 
detection and prevention, and a temperature monitoring system (detailed thoroughly in 
Chapter 9).  In addition, a locked gate will protect the generator and external liquid nitrogen 
tanks. If the biorepository is housed in an independent building, the operations manager may 
consider installing a locked gate.  The biorepository may also install security cameras to 
monitor external and internal activities. 
The biorepository will be restricted to authorized individuals only. Staff members will 
be required to wear identification badges at all times. Strict enforcement of a visitor’s sign-in 
log will be required. The operations manager will review this log on a routine basis. Any 
visitor including inspectors, investigators, project managers, study coordinators, and project 
staff; delivery personnel from Federal Express, UPS, as well as all other carriers; and sales 
representatives, field service engineers, and vendors will be required to sign their name, date, 
and time when entering and exiting the biorepository. Visitors will be issued a temporary 
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identification badge and will be escorted by authorized personnel at all times while in the 
facility. 
To prevent visitors or other non-laboratory personnel from entering the lab without 
supervision, the last member of personnel in the room will be required to close and lock the 
door.  Freezers will be required to remain locked at all times. The only exceptions are to be 
when samples are being pulled from or placed into the freezers.  Freezers shall be checked at 
the end of each day to ensure they are locked and the keys are stored in the designated lock-
box.  
All sensitive documents, such as personnel files and study records, will be kept under 
lock and key. 
Good Practice Day.  The biorepository shall designate one day each month as “Good 
Practice Day” for scientific or technical training and education of staff.  All training and 
educational activities will be documented.  Training records will reflect the results of Good 
Practice Day, and competency assessments may be performed, if applicable.  
Fire safety.  The biorepository will have an automatic fire detection system, 
consisting of smoke alarms and fire alarm stations wired to the security system, and a 
sprinkler system as detailed in the fire safety plan.  Exits shall remain unobstructed at all 
times. Large rooms, defined as greater than 1,000 square feet, will require two separate exits, 
one of which must directly open to an exit route.  
Fire inspectors from the local fire department or the State of Michigan Bureau of Fire 
Safety Services will routinely inspect the facility for fire and life safety, occupant capacity, 
and egress evaluations. They will be responsible for enforcing the Fire Prevention Code, Act 
207 of 1941. 
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All personnel must participate in fire safety training and a fire drill at least once a 
year.  Fire safety training will include discussion of the RACE acronym (instructions in the 
event of a fire) and the PASS acronym (instructions to safely utilize a fire extinguisher) as 
well as a review of the evacuation plan.  
RACE.  The RACE acronym identifies the primary steps employees should take in 
the event of a fire:  
1. Rescue or remove all individuals. 
2. Activate the alarm. 
3. Confine the fire by closing doors. 
4. Extinguish the fire, if possible to do so safely, and evacuate the building.  
When applying these steps, safety must be the first priority. The most important step should 
be to safely evacuate the building and protect the lives of the individuals within it.  
PASS.   The PASS acronym identifies the steps of safely utilizing a fire extinguisher. 
1. Pull the safety pin. 
2. Aim the nozzle at the base of fire. 
3. Squeeze the handle. 
4. Sweep or move the extinguisher from one side of the fire to the other side.  
See “Evacuation plan” (page 72) for instructions on assisting others in the event of a 
fire or other emergency situation. 
Fire safety training will also include instruction on proper procedures in the event that 
an individual’s clothing catches on fire, such as how to apply “stop, drop, and roll”; the 
proper use of a fire blanket; the use of emergency showers if appropriate; and the avoidance 
of chemicals or electricity. For instance, if an affected individual panics, a bystander should 
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stop and smother the individual with a fire blanket as quickly as possible.  Additionally, 
trainees will be introduced to the different classes of fires in order to determine the best 
methods for extinguishing them.  These classes of fire include:  
• CLASS A: Combustibles that produce “Ash.” 
• CLASS B: Flammable liquids and gases. 
• CLASS C: Electrical. 
• CLASS D: Oxidizing metals. 
Staff members must participate in fire extinguisher training. Under close supervision 
from a trained firefighter or fire safety expert, staff will practice using a fire extinguisher to 
ensure they can operate the device in case of an emergency. They will practice using 
extinguishers identical to those available in the biorepository (specifically, ABC 
Extinguishers, pressurized dry chemical and carbon dioxide extinguishers that can extinguish 
CLASS A, B, and C fires). 
Additional information regarding fire extinguishers (placement, use, maintenance, 
and testing) may be acquired by accessing the Portable Fire Extinguishers Standard, 29 CFR 
1910.157.  Fire extinguishers will be checked annually, and all fire safety training will be 
documented.  
As part of the annual competency evaluation, staff must be able to describe the 
location of fire extinguishers, fire blanket(s), and fire alarm pulls.  They must also be able to 
identify the designated meeting location inside the building in the event of severe weather as 
well as the pre-arranged meeting place outside of the building in case evacuation is 
necessary.  (This exterior meeting place will be located a sufficient distance from the 
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building to ensure personnel are not in harm’s way and do not impede emergency 
responders.) 
Evacuation plan.  A comprehensive evacuation plan will provide the necessary 
procedures and tools for orderly and efficient evacuation of the biorepository facility in the 
event of fire emergencies, severe weather, and disruptive or potentially dangerous situations, 
e.g., a hazardous materials release.  In addition to instructions on how to safely exit affected 
premises, the evacuation plan will include procedures for other emergency situations, such as 
the immediate treatment of an individual overcome by toxic fumes.  In the event of a liquid 
nitrogen spill from a bulk source, as another example, the evacuation plan will detail a 
specific cleanup plan.   
The evacuation plan will include designated roles and responsibilities; instructions for 
what to do in an evacuation; posted diagrams showing the location of exits and evacuation 
routes, fire alarm pull stations, and fire extinguishers; and a designated meeting place. Once 
at the designated location, a head count will be performed to ensure all personnel and visitors 
have safely evacuated the facility. Staff shall obey law enforcement direction and re-enter the 
building or area only when directed by authorities. 
Furthermore, the evacuation plan includes procedures for assisting staff and visitors 
who may require additional assistance in the event of emergency evacuation.  The operations 
manager will be responsible for assigning several staff members who are committed, 
responsible, adequately trained, and physically able to provide assistance to individuals who 
may require it during an evacuation. The operations manager will document those 
responsible for providing such assistance in the evacuation plan. In the event the assigned 
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
73 
“buddies” are not available, the operations manager or other designated person in authority 
will serve as a backup.  
Finally, management must maintain emergency lighting, which is required in the 
event of power outage or for safe evacuation of the premises. 
Freezer Room Safety and Oxygen Monitoring System   
Freezer rooms, if not properly maintained, can create highly dangerous situations for 
personnel, particularly should oxygen levels drop below established parameters.  Therefore, 
the proposed biorepository will employ an oxygen monitoring system in any designated 
freezer room. Such systems will alert personnel to evacuate if the oxygen level in the room is 
insufficient.  This system will consist of oxygen sensors, a controller, horns, and strobe 
lights.  The oxygen sensors will monitor the room’s air for oxygen content and transmit the 
values to the controller located outside the freezer room door.  The controller will 
continuously monitor the sensors and display their values on the controller display to the left 
or right of the freezer room door.  Should any of the sensor values fall below 19.5% oxygen, 
the controller will activate the horns and the strobe lights, send an alarm, and automatically 
shut off the liquid nitrogen to the freezers.  
In the event that the oxygen monitoring system is activated and horns sound or strobe 
lights turn on, staff must evacuate the freezer room and notify the operations manager or 
other designee immediately.  Staff must not re-enter the freezer room to investigate the 
situation under any circumstances.  Personnel may quickly look through the window to 
ensure no other personnel are trapped in the freezer room.  If staff are in the freezer room and 
unable to exit, staff must immediately call 911 for assistance.  Trained responders will 
investigate the situation and proceed accordingly.  The audible alarm may be silenced at the 
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controller, but the strobe lights will continue to flash until the controller has been manually 
reset.  The controller will not accept a reset until the oxygen level in the room rises above 
19.8% and emergency personnel have determined that the situation has been adequately 
resolved.  
The freezer room will also contain an emergency liquid nitrogen manual stop button 
to stop the flow of liquid nitrogen through the isolation valve from the external LN2 tanks to 
the freezers.  If the freezers sustain an LN2 leak, staff must immediately alert personnel 
working in the room, press the manual stop button, and exit the freezer room.  When the 
manual stop button is pressed, an alarm notification will be sent.  The push button should be 
reset only after the circumstances for the alarm have been clarified and the situation has been 
deemed resolved and safe.  Trained responders will investigate all such occurrences, and 
repairs will either be made immediately or scheduled at the earliest opportunity.  The push 
button must be pulled back to the normal position to return the flow of LN2 to the freezers 
and to turn off the strobe lights. 
Laboratory Biosafety Manual  
Biosafety must be of primary concern for all individuals working within any 
biorepository.  Therefore, the proposed model biorepository outlined in this study must 
include a laboratory biosafety manual appropriate for a BSL2-level facility. 
A Biological Safety Level (BSL) refers to a “combination of safety practices, safety 
equipment and facility design used to contain the hazards associated with specific risk groups 
of microorganisms and is based on risk assessment” (University of Michigan, 2013, p.8). 
BSL-2 agents are considered of moderate risk and are associated primarily with human 
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disease.  Routes of transmission include mucous membrane exposure, ingestion, and 
percutaneous injury (U.S. Dept. of Health and Human Services, 2009). 
Because of the similarities between the proposed model and current facilities at the 
University of Michigan, the proposed biorepository’s laboratory biosafety manual will be 
modeled after the manual currently in use at the University of Michigan (University of 
Michigan, 2013). The proposed manual will include the following principle information:  
• The designated roles and responsibilities of the director, operations manager, and 
staff. 
• A commitment to safety and safe work practices through rigorous documented 
procedures, the use of proper safety equipment, and personnel training. 
• A reference to the biorepository Chemical Hygiene Plan (see p.78). 
• The specified infectious agents approved for use.  (N.B.: Select agents require 
special registration in order to comply with the Public Health Security and 
Bioterrorism Preparedness Response Act of 2002 (Public Law 107-188) and 
Select Agents regulations from the Centers for Disease Control 42 CFR 73 and 
USDA 9 CFR 121, 7 CFR 331. These requirements are referenced for 
informational purposes only; the proposed biorepository model will not work with 
these agents.) 
• Pathogen Safety Data Sheets (PSDS) for infectious agents, including information 
regarding characteristics, hazard identifications (pathogenicity or toxicity, 
epidemiology, host range, infectious dose, mode of transmission, incubation 
period, and communicability), dissemination, stability and viability, first aid and 
medical information, lab hazards, and exposure controls (including PPE, 
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handling, and storage), and regulatory information and references (Public Health 
Agency of Canada, 2015).  
In addition to these generic items, the biorepository laboratory biosafety manual will 
include a number of other specific items as addressed in subsections below. 
Potentially infectious agents.   All biospecimens that meet established acceptance 
criteria will be considered and treated as if potentially infectious.  Research samples may be 
collected without the benefit of laboratory analyses or screening. Furthermore, the health 
status of participants may be incomplete due to self-reporting; therefore, the presence of an 
infectious agent or disease state may be unknown.  Examples of such infectious agents in a 
BSL-2 facility include Human Immunodeficiency Virus (HIV) or the Hepatitis B Virus 
(HBV).  
Security procedures and access.  Security measures were previously addressed in 
“Security.” (refer to p. 68).  Access to all biorepository facilities and labs will be restricted 
when work with potentially infectious agents is in progress as well as in afterhours or when 
personnel are not otherwise available. 
Signage and labeling requirements.  Entrance doors must display caution signs, 
biohazard labels (incorporating the Universal Biohazard symbol), the Biological Safety Level 
of the lab (i.e. BSL-2), name and contact information of biorepository director and operations 
manager in case of emergency, and required procedures for entering and exiting the lab. 
Biohazard warning labels must identify containers of infectious materials and will be 
necessary for all refrigerators, freezers, centrifuges, and other equipment utilized in 
processing and storing biohazard materials. 
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Facility requirements.  All biorepository facilities must include open benches 
impervious to absorption, laboratory chairs that are not made from fabric, sink(s) for 
biological material, and an autoclave or other available waste disposal service. 
Safety equipment.  A Class II Biological Safety Cabinet (BSC) is a partial barrier 
system that relies on the laminar flow principle, “unidirectional air moving at fixed velocity 
along parallel lines to reduce turbulence resulting in predictable particulate behavior or 
movement,” in order to provide containment protecting both staff and the product (U.S. Dept. 
of Health and Human Services, 2009, p.293).  A HEPA filter, coupled with the laminar air 
flow, aids in the “capture and removal of airborne contaminants from the air stream” (U.S. 
Dept. of Health and Human Services, 2009, p.293).  It protects both staff and work 
environment from potentially infectious aerosols generated in the BSC and provides product 
protection as well.  The biorepository will also utilize other physical devices such as 
pipetting aids and sharps containers to contain biological agents and to prevent spills and 
splashes or the generation of aerosols. 
Biosafety training.  All personnel must undergo initial biosafety training and must 
also complete follow up training on an annual basis.  Training records must include copies of 
the training materials, the date of training, and the name and title of the individual conducting 
the training. 
Other procedures.  Other procedures documented in the laboratory biosafety manual 
may include:  
• Required personal protective equipment (PPE), including protective lab clothing, 
lab coats, non-latex gloves, and face and eye protection.  The selection of PPE is 
based on the specific biological or chemical hazard and the task at hand.  
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• A copy of “Appendix A: Personnel Sanitation and Safety” (see page 185). 
• Biological safety cabinet use, verification of proper function (such as sufficient 
airflow and properly functioning filters), and records of testing. 
• All biospecimen collection and processing procedures, as well as storage 
requirements. 
Biospecimen receipt, transport, and shipping procedures (see “Retrospective 
samples. page 117). 
• Biohazard waste disposal SOP, including documentation that procedures for 
disposal are fully compliant with all applicable federal, state, and local 
regulations. 
• Proper disposal of non-contaminated and contaminated sharps. 
• Workplace injuries or accident reporting and medical surveillance. 
• Hepatitis B vaccination program for staff, addressed in the Exposure Control Plan 
(see page 89). 
• Documentation of annual review of the laboratory biosafety manual, workplace 
injuries or accidents, corrective action reports, and inspection reports. 
Chemical Hygiene Plan   
A chemical hygiene plan will protect staff from exposure to hazardous chemicals 
(i.e., chemicals that may cause acute or chronic health effects in exposed individuals); 
promote safe work practices, policies and procedures through appropriate training and 
controls; and ensure compliance with the Michigan Occupational Safety and Health Act, Part 
431, Hazardous Work in Laboratories Standard R 325.70101 and the OSHA Standard 29 
CFR Part 1910.1450, Occupational Exposure to Hazardous Chemicals in Laboratories 
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(commonly referred to as the “Laboratory Standard”).  A chemical hygiene plan (CHP) must 
include the following principle information: 
• Location of facility and specific room designation information. 
• Emergency Contact information, including management, staff, OSHA, and 
emergency response information. This information must also be posted at key 
locations throughout the biorepository.   
• An up-to-date chemical inventory and hazard identification and assessment that 
includes the chemical name, quantity, hazard class, carcinogenic potential, 
reproductive and acute toxicity, storage location, date of inventory, date removed, 
and instructions should accidental contact occur.     
• Safety Data Sheets (SDSs) for all chemicals. SDSs provide the specific physical 
and toxicological hazard information for a chemical and include the following: 
identification, hazard identification, composition, first aid measures, firefighting 
measures, accidental release measures, handling and storage, exposure controls 
(PPE), physical and chemical properties, stability and reactivity, and other 
toxicological information. Optional SDS information may include ecological 
information, disposal considerations, transport information, regulatory 
information, and other appropriate information (e.g., date of preparation). 
• Designated roles and responsibilities with respect to the chemical hygiene plan, 
including the designation of a chemical hygiene officer (CHO). 
The CHO will provide technical expertise in developing and implementing the CHP.  
The CHO should not necessarily be the operations manager.  Instead, the CHO will help the 
operations manager develop precautions and adequate facilities, know current legal 
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
80 
requirements concerning regulated chemical hazards, and be qualified by training and 
experience perform the functions necessary of the position.  However, even if the CHO is not 
the operations manager, the operations manager must still be responsible for the CHP. 
Furthermore, the operations manager must ensure all staff are trained in and adhere to the 
CHP, and that required PPE are not only available but utilized.  
The operations manager will be responsible for performing self inspections and 
facilitating OSHA inspections, ensuring emergency procedures and equipment are in place 
and functioning properly, and knowing the current legal requirements concerning regulated 
substances. In addition, he or she must ensure the appropriate engineering and administrative 
controls, work practices, and established procedures are followed. The Manager must also 
ensure that all accidents and potential exposures are immediately reported. 
If a breach in any aspect of the CHP is identified, all staff, regardless of level, possess 
the authority to stop or suspend work until it is safe to proceed. 
Safety Data Sheets (SDSs).   The location of Safety Data Sheets will be specified on 
the MIOSHA SDS Location Poster. Notification of new or revised Safety Data Sheets must 
be readily available and listed on the MIOSHA New or Revised DSD Poster for five days 
after receipt of hazardous chemical.  Safety Data Sheets are required to be maintained 
indefinitely as they provide a historical record of the chemicals in the biorepository.  
Chemical procurement, labeling, and storage.  Procurement considerations must 
include ordering minimum quantities of chemicals so excess chemicals are not present.  
Management must also ensure the lab is ready to accept any chemical upon arrival and that 
an approved SOP addresses proper handling, storage, and disposal of the chemical in 
question.  Furthermore, any personnel who receives a chemical shipment must check the 
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chemical for an identification label, signs of breakage or leakage, and, in the event of a spill, 
flood or fire, evaluate whether special containment may be necessary (University of 
Michigan, 2010).   
Proper labeling of chemicals includes all information necessary for its proper 
handling, storage, use, and disposal.  The MIOSHA Hazard Communication Standard is 
aligned with the Globally Harmonized System (GHS) of Classification and Labeling of 
Chemicals (University of Michigan, 2010).  All primary container labels must have the 
following information: the product identifier (the common product name or number); the 
chemical’s concentration; the primary hazard; the manufacturer or supplier’s name, address 
and phone number; hazard statements; signal words and pictograms; and precautionary 
statements.  If chemical labels are missing, damaged or incomplete, they must be replaced 
immediately. 
Precautionary statements, hazard statements, signal words, and pictograms.   A 
precautionary statement is a “phrase that describes recommended measure to be taken to 
minimize or prevent adverse effects resulting from exposure to a hazardous chemical or 
improper storage or handling of a hazardous chemical” (University of Michigan, 2010, p. 
39).  Precautionary statements include first aid measures and recommendations to prevent 
adverse effects.  Examples of precautionary statements may include “avoid breathing fumes,” 
“keep away from heat,” or “store in a well-ventilated space.”  
A hazard statement is a “statement assigned to a hazard class and category that 
describes the nature of the hazard(s) of a chemical, including, where appropriate, the degree 
of hazard” (University of Michigan, 2010, p.38).  Hazard statements are based on the hazard 
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classification and the nature of the chemical hazard. Examples of hazard statements include 
“causes skin irritation” or “may cause liver damage.”  
A harmonized signal word may be defined as a “single word used to indicate the 
relative level of severity of hazard and alert the reader to a potential hazard on the label” 
(University of Michigan, 2010, p.38).  “Danger” is appropriate for the more severe hazards 
and “Warning” is used for less severe hazards.  Signal words are not necessarily required; 
however, they are useful as they indicate the level of severity of the hazard.  
A pictogram is a “symbol plus other graphic elements, such as a border, background, 
pattern or color that is intended to convey specific information about the hazards of a 
chemical” (University of Michigan, 2010, p. 38).  As outlined by the University of Michigan 
(2010): 
There are eight required standardized pictograms (Health Hazard, Flame, 
Exclamation Mark, Gas Cylinder, Corrosion, Exploding Bomb, Flame over Circle, 
and Skull and Crossbones) and one optional pictogram (Environment), under the 
GHS. Each pictogram consists of a different symbol on a white background within a 
red square frame set on a point (i.e., a red diamond). All pictograms are diamond 
shaped with a red border and black image. (p. 38) 
There are three systems for labeling chemical hazards: 
• The Global Harmonized System utilizes severity rankings for each of the hazard 
classifications. Categories range from 1 to 4, with 1 indicating the most severe 
and 4 indicating the least severe. (N.B.: This ranking system conflicts with the 
National Fire Protection Association System and the Hazardous Material 
Information System where the number 4 indicates a severe hazard.) 
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• The National Fire Protection Association (NFPA) system utilizes a hazard 
warning diamond and is designed for emergency response personnel. The color 
blue signifies health, red signifies flammability, yellow signifies instability or 
reactivity, and white signifies unique hazards. The number within the color stands 
for least hazardous (0) to most hazardous (4) designation. 
• The Hazardous Material Information System (HMIS) utilizes a box of blue for 
health, red for fire, yellow for reactivity, and white for unique hazards. 
Other labeling systems.  Secondary reagent labels are necessary for chemical 
solutions prepared in the lab (e.g., a 10% bleach solution).  Biorepositories may choose to 
label secondary containers with label alternatives that still meet the requirements for 
standards such as NFPA or HMIS.  The information must be consistent, however, and no 
conflicting hazard warnings or pictograms may be utilized.  Mandatory information for 
secondary reagent labels includes product identifier and health and physical hazards; 
pictograms and graphics are optional.  In the proposed biorepository model, a procedural 
worksheet will label secondary reagent labels and contains necessary information and quality 
assurance check.  These QA measures must be performed on a monthly basis and will 
determine whether all secondary reagent containers are properly labeled or require corrective 
action.  
Chemical storage.  Chemicals must be stored according to hazard category and 
compatibility.  Common categories include corrosives, flammable solvents, toxic chemicals, 
carcinogens, oxidizers, explosives, and compressed gasses.  Less common categories include 
pyrophoric, organic peroxides, and water reactive chemicals.  All chemical containers must 
be closed or capped, stored with compatible chemicals (acids and bases are stored separately, 
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for example), and inspected weekly to ensure containers are in good condition.  At the 
proposed biorepository, sodium hypochlorite (common household bleach) would be the only 
corrosive chemical stored.  As such, it must be stored in a spill-proof tray and may be stored 
in a chemical storage cabinet, if available; a separate cabinet, however, would not be 
necessary. 
CHP training.  CHP training for the proposed biorepository would include lab safety 
and bloodborne pathogens, chemical lab safety training, lab specific training, PPE 
instruction, centrifuge training, and training on the shipping of dangerous goods and 
transportation of hazardous chemicals.  The operations manager would be responsible for 
maintaining training records, including all handouts, PowerPoint presentations, copies of 
policies and procedures (or the name of the policy identified by version number), training 
date, name of the instructor, and names of the staff in attendance. 
Controls to reduce exposure to hazardous chemicals.  Engineering controls may 
include a fume hood in order to contain hazardous chemicals, particularly those that are 
volatile. Fume hoods are to be maintained according to 29 CFR 1910.1450(e)(3)(iii) and 
certified by trained OSHA personnel.   Documentation of all such certifications must be kept 
on file. 
For this proposed biorepository, these specific hazards will not necessary; therefore, a 
fume hood is not included in Figure 2. Facility requirements, including security, electrical 
backups, and monitoring systems (page 53). However, should additional chemicals be added 
at a later date for additional laboratory services, a fume hood may become necessary.   
Compressed gas cylinders must be secured in an upright position in order to prevent 
them from falling and damaging the regulator or valve.  A chain, bracket, or other self-
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standing restraining device must be used to secure the cylinder at all times.  The valve cap 
must be in place at all times, including during transport and storage, unless the cylinder is 
connected for use.  Compressed gas cylinders must also be positioned away from 
combustible materials and excessive heat.  
Chemical spill kit.  The proposed biorepository must obtain a current comprehensive 
chemical spill kit, if an expiration date is not indicated on the kit, it must be assessed for 
viability on a routine basis. Such assessments should be conducted at least every six months.  
Management should ensure that instruction sheets are posted for the containment of chemical 
spills and the emergency treatment of chemical splashes or injuries at all work stations.  
Administrative controls.  Administrative controls must include policies and 
procedures reducing the quantity of hazardous chemicals, substituting a less hazardous 
chemical (whenever possible), or correcting hazards through proper labeling.  Examples of 
administrative and work place controls include implementing the chemical hygiene plan, 
modifying work schedules and tasks, or rotating staff assignments in order to reduce the 
frequency, duration or intensity of exposure (Occupational Safety and Health Administration, 
2011, p.8).  
The Occupational Safety and Health Administration Laboratory Safety Guidance 
(2011) outlined the proper measure of exposure by the Permissible Exposure Limit (PEL) :  
The chemical-specific concentration in inhaled air that is intended to represent what 
the average, healthy worker may be exposed to daily for a lifetime of work without 
significant adverse health effects. The employer must ensure that workers’ exposures 
to OSHA-regulated substances do not exceed the PEL. (p. 11) 
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Permissible Exposure Limits for hazardous chemicals are specified in 29 CFR 1910, subpart 
Z. 
Additionally, approved standard operating procedures must include chemical 
location, special precautions, labeling, chemical spill and response procedures, storage and 
transportation requirements, chemical inventory, hazardous waste management, and 
procedures for reporting workplace injuries or accidents. Hazardous waste operations and 
emergency response regulations may be referenced in 29 CFR 1910.120. 
Personal protective equipment (PPE).  Required PPE for chemical use will include 
a lab coat, safety goggles, a face shield (if there is the potential for splashing), and the 
appropriate selection of gloves. (N.B.: Specific chemicals often require a particular glove for 
safe handling.  SOPs for any given procedure must identify the requisite glove to be used.) 
Staff must be trained in the appropriate use of PPE, and PPE must be readily available at all 
times. 
Additional documentation.  Additional documentation in the chemical hygiene plan 
may include: 
• OSHA inspection reports. 
• OSHA correspondence and communications. 
• The results of self-inspections.  
• The annual report and review of safety policies, procedures, and work practices. 
• Workplace injury or accident reports, as well as any corrective action reports.  
It would be highly beneficial to print the OSHA Standard 29 CFR Part 1910.1450, 
Occupational Exposure to Hazardous Chemicals in Laboratories and keep a copy in the 
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chemical hygiene notebook for reference purposes.  Finally, documentation of annual CHP 
review is required.  
Principle Chemical Hazards in this Biorepository Model   
This specific biorepository model will have two principle hazards: liquid nitrogen 
(LN2) and dry ice.  Proper training in the use of these hazardous materials must be performed 
and documented before staff members will be allowed to work with these hazards and in the 
Biorepository.  All work with these hazards must be conducted in a well-ventilated room and 
staff must always wear the appropriate PPE (see “LN2 hazards” and Dry ice hazards”). 
Safety Data Sheets will be available on these and all other potentially hazardous materials. 
LN2 hazards.  LN2 may cause cryogenic burns or injury and may result in severe 
frostbite.  LN2 also displaces oxygen (an asphyxiant in high concentrations) and can cause 
rapid suffocation.  These hazards will be addressed by installing an oxygen monitoring 
system in the freezer room (see “Freezer Room Safety and Oxygen Monitoring System”) as 
well as requiring staff to wear personal oxygen monitors.  All work shall be conducted in 
well-ventilated rooms, and special containers (designed and constructed to withstand these 
extremely cold temperatures) will be required.   
The appropriate PPE for handling LN2 includes a lab coat, safety goggles, full-face 
shield, insulated cryogenic gloves, and proper foot attire (i.e., closed-toe shoes to protect 
against potential splashing and spilling).   Extreme care must be exercised when dispensing 
LN2; never over-fill containers and follow manufacturer and lab-specific instructions.  
Biospecimens for this facility would be stored primarily in vapor-phase LN2, so a 
bulk source of LN2 is necessary for that purpose. Safety and operational training must 
include freezer room safety, freezer safety and operation, LN2 training (including required 
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PPE), training in evacuation, clean up in the event of an LN2 spill from a bulk source, and 
the immediate treatment of an individual overcome by toxic fumes.  The cryogenic system 
(encompassing the bulk source of LN2) and the delivery system (pipes to individual LN2 
freezers, shut off valves, and the filling station) must be properly designed, constructed, and 
maintained.  Records and results of inspections, maintenance and repairs on the system must 
be reviewed and documented. 
LN2 hazards exist due to the properties of LN2 itself as well as the pressure of the 
cylinder containing it.  If LN2 tanks (180L for example) are utilized, they must be secured 
(via wall mount or self-standing apparatus) to prevent falling over and damaging the 
regulator and the valve.  Cylinders can quickly become rockets should the valve break.  Wall 
mount restraints should be no lower than one-third the distance from the top of the cylinder. 
LN2 tanks must be transported in an upright manner utilizing a secured dolly. 
Dry ice hazards.   Dry ice may cause cryogenic burns or injury such as frostbite.  
Dry ice sublimes to carbon dioxide vapor at -78 degrees C, and the vapor may displace 
oxygen and cause rapid suffocation.  Work must be conducted in a well-ventilated room. The 
appropriate PPE includes a lab coat, safety goggles, and insulated cryogenic gloves.  Tongs 
or a scoop may be used to transfer dry ice into appropriately insulated storage or shipping 
containers.   
Dry ice is considered a hazardous material; training and specific procedures must be 
followed when shipping and receiving shipments of biological materials with dry ice in order 
to comply with the U.S. Department of Transportation (DOT) and the International Air 
Transport Association (IATA) regulations.  Certified shipping containers for Category B, 
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Biological Substances must be utilized, and management must require training in 
transporting or shipping of dry ice for any personnel member likely to handle it. 
Chemical waste.  As the proposed model currently exists, chemical waste would not 
be generated in this Biorepository.  Should that change, chemical waste would be properly 
segregated and manifested to ensure proper disposal according to established procedures as 
well as federal, state, and local regulations. 
Exposure Control Plan 
The Occupational Safety and Health Administration (2011) identified two bloodborne 
diseases as particular concerns for researchers: 
The Centers for Disease Control and Prevention (CDC) notes that although more than 
200 different diseases can be transmitted from exposure to blood, the most serious 
infections are Hepatitis B virus (HBV), Hepatitis C Virus (HCV) and human 
immunodeficiency virus (HIV)… Many factors influence the risk of becoming 
infected after a needle stick or cut exposure to HBV, HCV or HIB-contaminated 
blood. These factors include the health status of the individual, the volume of the 
blood exchanged, the concentration of the virus in the blood, the extent of the cut or 
the depth of penetration of the needle stick, etc. (p.17) 
In order to minimize employee risk from exposure and infection from bloodborne 
pathogens in the biorepository and comply with OSHA Standard 29 CFR 1910.1030, 
Occupational Exposure to Bloodborne Pathogens, the Needlestick Safety and Prevention Act 
of 2001, and MIOSHA Standard R 325.70001-325.70018, Bloodborne Infectious Diseases, 
management will implement an official Exposure Control Plan (ECP).  The ECP will be 
routinely updated as appropriately as well as reviewed on an annual basis.   
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Exposure determination.  An exposure determination will identify staff members 
who are or may be exposed to blood and other potentially infectious materials by virtue of 
their job classification and the specific tasks and procedures they perform on a routine or 
infrequent basis.  This determination will dictate the requisite training staff members are 
required to obtain prior to performing any related task or other potential exposure. However, 
the operations manager will train all personnel, regardless of their potential for exposure, in 
laboratory safety, Bloodborne Pathogens and Hazard Communication in order to ensure 
everyone’s safety in the workplace.  This training would be necessary even for those 
personnel who work solely in administration. 
Risk assessment.  A risk assessment will be conducted on proposed research studies 
as well as on the risks associated with the type and quality of biospecimens considered for 
processing and storage.  Biospecimens will be accepted according to established acceptance 
criteria; the biorepository will have procedures in place for specimen rejection if appropriate.  
Protocol for exposure prevention.  Methods of compliance with the exposure 
control plan include the following: 
• All personnel must follow Universal Precautions when handling biohazard 
material, regardless of the source.  Biohazard material includes blood, body 
fluids, Other Potentially Infectious Materials (OPIM; e.g., unfixed tissue or 
organs or cell or tissue cultures) and reagents, quality control preparations and 
pools from all sources. All of these biohazard materials must be considered and 
treated as potentially infectious. 
• The Hepatitis B Immunization Program will be mandatory.  This program will be 
offered to all personnel prior to working in the biorepository (after information 
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and training has been made available regarding biological hazards but before 
work in the lab commences), and the vaccinations will be provided free of charge, 
in accordance with 29 CFR 1910.1030(f)(1)(ii)(A)-(C).  The program consists of 
a series of three vaccinations; one vaccination at the initial visit, the second one 
month later, and the final vaccination six months later.  A titer check may also be 
performed to check on hepatitis B immunity upon request.  Staff may request to 
opt out of the hepatitis B vaccine; however, they must sign a waiver that will be 
kept on file. 
• All personnel may be subject to policies regarding screening for tuberculosis 
(TB).  However, if the biorepository is not located in a patient care building and 
staff do not have patient contact or work with sputum samples, TB screening may 
not be necessary. 
• Management will document procedures for biohazard spill and response that 
includes requisite PPE, spill decontamination, and determination of biohazard 
exposure. 
• Management will implement a procedure for any workplace injuries or accidents. 
• Management will document a procedure for disposal of biohazard waste, 
including contaminated needles and sharps.  
• General housekeeping and waste disposal procedures will include scheduled 
laboratory cleaning, the designation of clean or potentially contaminated 
equipment or computer surfaces, and the proper decontamination of equipment. 
Other engineering controls. A CLASS II Biological Safety Cabinet (BSC) may be 
used to further prevent personnel exposure to potentially infectious agents.  BSCs protect 
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staff and the work environment from potentially infectious biohazard materials that may 
result in splashing, spraying, or generating aerosols or droplets. These cabinets contain 
biological aerosols but also protect the biospecimens.  Any obtained BSC must be certified at 
installation, on an annual basis, and at anytime it is relocated according to 29 CFR 
1030(e)(2)(iii)(B).  An approved SOP will specify how work may be performed in the BSC. 
Autoclaves will not be employed in this Biorepository model; a reputable vendor 
instead will be selected to provide these services.  
Communication to staff.  Sources of potential infection and other hazards will be 
communicated to staff via the following methods: 
• Pathogen Safety Data Sheets (PSDS) for infectious agents (as developed by the 
Canadian Public Health Agency.)  PSDSs include information on pathogen 
characteristics, hazard identification (including pathogenicity and toxicity, 
epidemiology, host range, infectious dose, mode of transmission, incubation 
period, and communicability), dissemination, stability and viability, first aid and 
medical information, lab hazards, exposure controls (with appropriate uses of 
PPE), handling and storage, regulatory information, and references (Public Health 
Agency of Canada, 2015). These PSDSs will be available to staff at all times and 
will be reviewed as part of the biosafety training program. 
• Lab safety and bloodborne pathogen training. These trainings will cover methods 
that prevent or reduce exposure, such as utilization of PPE, Personnel Sanitation 
and Safety (see “Appendix A: Personnel Sanitation and Safety,” page 180), and 
approved specimen vials and storage containers. Training will also cover PSDS 
data, including the risks associated with biohazard material and specific infectious 
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agents.  Personnel will be subject to initial training and competency assessments 
with respect to all procedures and equipment that may involve exposure before 
they will be permitted to perform any such tasks. 
• Additional training and procedures, including centrifuge training, usage, clean up, 
maintenance, calibration, and verification of centrifuge speeds. 
Documentation of compliance.   Biorepository records will, by necessity include 
documented evidence of compliance with applicable federal, state, and local regulations.  
Required documentation regarding the exposure control plan will include the annual review 
and approval of the ECP, staff training records, hepatitis B vaccination or declination 
records, exposure records, an illness and injury log, and a sharps injury log.  
If a staff member sustains an occupational exposure to a biospecimen or biohazard 
material, a medical evaluation with a surveillance or monitoring program will be required 
according to the procedure for workplace injuries or accidents. A complete review of the 
incident with appropriate follow up action, additional training, corrective or preventive action 
will be conducted and documented. 
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Other Work Environment Considerations 
Ergonomics program.  An ergonomics program will be essential for the prevention 
of musculoskeletal disorders (MSDs) in the workplace.  All personnel will be required to 
obtain ergonomic training.  This training will discuss risk factors, identify physical work 
activities or conditions of the job commonly associated with work-related MSDs, and 
implement recommendations for eliminating MSD hazards.  Documentation of training and 
training materials will be maintained and made readily available for review.   
In addition to standardized personnel training, an occupational therapist may inspect 
the laboratory in order to make recommendations regarding equipment, engineering controls, 
and areas for improvement.  The operations manager will document and then review these 
recommendations for implementation.  The manager will also document any specific 
equipment that has been evaluated or purchased to prevent MSDs.  In addition to these 
precautions, staff will be strongly encouraged to find a comfortable position in which to 
work, to regularly leave their desks to stretch, to look away from computer screens in order 
prevent eye strain, and to make recommendations regarding equipment, engineering controls 
and ideas for improvement. The operations manager will review any such recommendations 
for possible implementation.  For example, ISBER’s Best Practices referenced automatic 
pulley mechanisms to aid personnel in removing heavy racks from chest freezers (ISBER, 
2011, p.40). 
Excessive noise monitoring.   To ensure all laboratory personnel are protected 
against the effects of excessive and potentially damaging noise exposure, sound levels will be 
routinely monitored using a calibrated sound level device, such as a decibel meter, and 
recorded.  The biorepository will define excessive and potentially damaging noise exposure 
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as sound levels that are equal to or exceed a weighted average sound level of 85 decibels in 
each working area or room per working shift of eight hours.  Should sound levels equal or 
exceed that level, the requisite ear protection will be provided to laboratory workers 
immediately.  Such ear protection will also be made available to laboratory workers upon 
request. Regulations regarding hearing protection may be found at 29 CFR 1920.95. When 
designing or selecting the biorepository facility, planners should give consideration and 
deliberate planning to placing work stations away from loud equipment, e.g., freezers or 
laboratory instrumentation, to the extent possible. 
Electrical safety.  Lab instruments and equipment must be adequately grounded and 
checked for current leakage before initial use, after repair or modification, and when a 
problem is suspected. These checks must be documented.  Grounding configurations may not 
be bypassed.  Equipment requiring 240 volts will be checked for ground integrity only.  
Extension cords will be prohibited.  Power cords of portable electrical equipment must be 
visually inspected for external defects whenever relocated. The biorepository will also 
strongly recommend inspection of power cords on a routine basis for overall wear and tear.  
Field service engineers or contracted electricians may be consulted as necessary. The 
operations manager may also contact the manufacturers of the lab equipment for additional 
information as appropriate.  The manager may also reference 29 CFR 1910 Subpart S-
Electrical for electrical safety. 
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Color vision assessment.  Specimen collection kit manufacture, sample collection, 
processing, and analysis all require proper color vision in order to correctly identify 
collection components with their respective sample type.  Therefore, staff members must 
submit to color vision tests, such as the Ishihara 38 Plates Color Vision Deficiency Test 
available on-line (Colblinder, 2014).  During this test, staff members will read each plate, 
record the information on-line, and submit the final results. Staff must print, sign, date, and 
submit these results to the Operations Manager for review.  Another such test is available at 
http://www.egopont.com/colorvision.php (Egopont, 2013).  If these tests detect a potential 
color vision deficiency or impairment, personnel must contact a qualified eye care specialist 
for further testing. The results of these tests will also be documented.  Should testing identify 
a deficiency, a staff member’s tasks will be assigned to reflect that member’s ability to 
perform the task. 
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Chapter 8: Product Realization 
According to the standard published in ISO 9001:2008, Quality management system- 
Requirements (2008), product realization encompasses the following organizational 
activities: communicating with the customer and determining their product requirements; 
evaluating whether the organization itself possesses the resources, technical expertise, and 
management of its processes to accept the proposed work; developing plans and processes in 
order to meet customer requirements while abiding by applicable regulatory requirements; 
validating and monitoring the requisite processes and equipment to deliver the product; and 
then evaluating the final product and providing evidence of compliance and quality with 
respect to the realization processes, the product, and the product requirements (ISO 
9001:2008, pp.7-12).  
In the context of biorepository services, the product is a high-quality, fit-for-purpose 
biospecimen or collection of biospecimens, available to the investigator at any time upon 
request for the purposes of scientific investigation. Product realization for the biorepository 
therefore encompasses research support services starting from initial contact with the 
prospective client (i.e., investigator inquiries into biorepository services and the first meeting 
to discuss their research study needs) all the way through the life cycle of collected 
biospecimen samples to final distribution disposition. These processes and procedures will be 
thoroughly addressed in Chapter 9: Processes, Procedures, and QA Strategies with Respect to 
Product Realization. 
Product realization coupled with management responsibility, resource management, 
measurement, analysis, and improvement will provide a process-based quality management 
system for this proposed biorepository model.  
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Chapter 9:  Processes, Procedures, and QA Strategies with Respect to Product 
Realization 
Appropriate quality assurance (QA) strategies must form the backbone of any 
scientific undertaking, including the creation of a biorepository.  To this end, potential 
directors or operational managers of newly developed biorepositories must consider ways to 
strictly manage the quality of all processes and procedures, from the onboarding of new 
studies to the final transfer or disposition of samples.  The following suggestions represent a 
selection of considerations, processes, procedures, and QA strategies for newly created or 
currently operational biorepositories. 
Regulatory Considerations 
Sponsors, investigators, study personnel, and Contract Research Organizations 
(CROs; i.e., the proposed biorepository among others) must conduct clinical studies 
according to federal, state, and local regulations. Therefore, all policies and procedures of the 
proposed biorepository must comply with all such regulations.  A number of resources for 
biorepositories already address federal regulations and guidelines pertaining to protections 
for human subjects participating in research, such as informed consent, confidentiality, 
security, institutional review boards, electronic records, and financial disclosure by clinical 
investigators and institutions (National Cancer Institute Best Practices for Biospecimen 
Resources, U.S. Dept. of Health and Human Services, 2011, and International Society of 
Biological and Environmental Repositories Best Practices, 2011 among them). 
For the purposes of accepting, on-boarding, and supporting the conduct of clinical 
research studies, the following regulations and guidelines must be discussed in order for the 
biorepository to fulfill regulatory requirements.   
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The International Conference of Harmonization (ICH) E6 Good Clinical 
Practice (GCP), and the compilation of federal regulations comprising GCP.  Good 
Clinical Practices (GCPs) encompass several internationally recognized standards that form 
the basis for acceptable conduct of clinical research.  They are designed to protect the rights, 
safety, and welfare of human trial subjects; to ensure reliability, quality, and scientific 
integrity of clinical research data; and to provide standards and guidelines for the conduct of 
clinical research.  Not only do GCP guidelines reflect the minimum standards necessary for 
conducting clinical trials, they also have the full “force of law” in some countries, such as 
Japan.  
In 1990, the International Conference of Harmonization (ICH) was created to 
establish internationally recognized clinical research standards in the following three major 
world pharmaceutical markets: the European Union, the United States, and Japan.  Six years 
later, the ICH Harmonised Tripartite Guideline for GCP was written to provide unified 
standards and mutual acceptance of clinical data by regulatory authorities in these countries.  
This guideline provides comprehensive information of the GCP procedures, related 
responsibilities, and the use of relevant documents in the conduct of clinical trials. 
In the U.S., the Food and Drug Administration adopted the ICH GCP Guideline and 
published it in the Federal Register and the Code of Federal Regulations (CFR). In the U.S., 
GCP is defined from current U.S. regulations as well as U.S. and global guidelines published 
in the CFR, including the ICH GCP Guideline. 
The compilation of federal regulations comprising GCP includes but is not limited to 
the following regulations: 
• 21 CFR Part 11 Electronic Records and Signatures. 
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• 21 CFR Part 50 Protection of Human Subjects. 
• 21 CFR Part 54 Financial Disclosure. 
• 21 CFR Part 56 Institutional Review Boards. 
For study sponsors, compliance with GCP improves the acceptance of trial data by 
regulatory authorities.  It also helps sponsors advance drug development quickly while 
maintaining safe, ethical, and scientific standards.  
For the investigator, compliance with GCP can increase the probability of successful 
trial results, enhance the investigator’s reputation in the scientific community, and may help 
reduce the investigator’s risk of legal action by authorities or subjects.  
Furthermore, GCP assists subjects in understanding risks and potential benefits of 
participation.  Participation must be voluntary and the information presented in the consent 
form must be clear and complete. A clinician must continue to offer to provide the same 
quality of treatment regardless of whether a subject withdraws from the clinical study.  
For a biorepository that serves as a Contract Research Organization (CRO), GCP may 
be defined as a quality standard for the design, conduct, performance, monitoring, auditing, 
recording, analysis (if applicable), and reporting of clinical trial data.  Ethical conduct of a 
clinical trial implies several assumptions: that the benefits of the study outweigh risks; that 
the rights, safety, and well-being of participants are protected; that investigators will maintain 
compliance with protocol; that IRB approval is obtained prior to study initiation; that study 
personnel are qualified by education, training, and experience to perform necessary work; 
that informed consent must be given by subjects on a voluntary basis; that study personnel 
will ensure accurate reporting and analysis of data; and that confidentiality will be upheld.  
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Compliance with approved policies and procedures will therefore ensure the overall quality 
of any clinical study. 
For the purposes of on-boarding clinical research studies, investigators will be 
responsible for obtaining and maintaining the documentation of each participant’s consent 
and all corresponding study records.  Sponsors will be responsible for monitoring clinical site 
documentation.  The proposed biorepository will therefore require all investigators to sign a 
statement attesting to the following: 
• Studies will be conducted according to all applicable federal, state, and local 
regulations and guidelines, including GCP.  
• Ethical standards related to biospecimen collection and utilization will be upheld. 
• Clinical care will not be compromised in the process of procuring biospecimens. 
• Documentation of participant’s consent and corresponding study records will be 
obtained and maintained at the clinical site and subject to inspection by the 
sponsor of the research. 
In the event that the biorepository chooses to offer laboratory analyses in the future, 
ICH E6 GCP Guidelines require certification, accreditation, established quality control or 
quality assessment, and other methods to validate and document the competence of a facility 
to perform required tests and support the reliability of results.  If laboratory analyses are 
offered as part of future services, clinical studies will require CLIA certification through the 
Clinical Laboratory Improvement Amendments of 1988; final rule. Federal Register. 1992 
(Feb 28): 42 CFR 493.1407(e)(2), 42 CFR 493.1445(e)(2). 
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Institutional review board.  An IRB is an independent body made up of medical, 
scientific, and non-scientific professionals whose responsibilities include ensuring the 
protection of the rights, safety, and welfare of human subjects in a clinical trial.  An IRB 
must consist of at least five members who are collectively qualified to review and evaluate 
the science, medical aspects, and ethics of proposed trials. The board must include at least 
one physician and at least one member who has no affiliation with the institution.  An IRB 
may not be composed entirely of individuals from one profession, and at least one member 
must be a nonscientist. 
Among their responsibilities, IRBs must obtain, review, and approve all trial or study 
documents, including the informed consent document, prior to the initiation of a trial. They 
review this document as well as all protocol, protocol amendments, investigator brochures, 
subject recruitment procedures, collection forms related to the trial, as well as the suitability 
of the investigator to conduct the trial.  The IRB conducts continuing reviews of ongoing 
clinical trials on an annual basis and documents all materials and findings. 
Investigators interested in biorepository services must provide documentation of 
project-specific IRB approval in order for biorepository management to consider approving 
and onboarding the study. The biorepository must obtain IRB approval for its general 
protocol in collecting, processing, storing and distributing clinical research samples prior to 
offering any services to research studies. In addition, the biorepository must submit an IRB 
application and receive its own IRB approval for each project-specific research study prior to 
the initiation of services. 
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Onboarding New Studies 
Prior to initiation of services, each biorepository study must complete an appropriate 
Research Study Protocol template, which will be utilized to capture, review, and approve 
specific protocol information.  This information must include an introduction, a description 
of the study’s scope and purpose, project specifications, procedures, project workflows (both 
retrospective and prospective), IRB Approval, and written approval from both the 
investigator and the biorepository director.  These research protocols will be reviewed on an 
annual basis to ensure that: 
• IRB protocols and policies are upheld. 
• Informed consent is consistent with proposed uses.  
• HIPAA is not violated. 
• Clinical care is not compromised in the process of procuring biospecimens.  
• Ethical standards related to biospecimen collection and utilization are upheld. 
• Adequate research participant protection is in place in terms of confidentiality, safety, 
health, risk-benefit ratio, and security. 
• Procedures define the safety level of biospecimens as appropriate for the 
biorepository. 
• Information includes parameters for specimen acceptance criteria and data, labeling, 
collection, preservation, processing, conditions for transportation (including chain of 
custody, check-in and storage, and retrieval), any necessary further processing, final 
analysis and shipment, planned duration of storage, and final disposition. 
Furthermore, the Research Study Protocol will clarify and define the roles and 
responsibilities of the biorepository with respect to the specific client.  Written 
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communications between the organizations involved may be appended to the protocol as 
documentation of the study design process.  
In addition, the biorepository shall obtain a written commitment from the principal 
investigator stating he or she will protect research participants and adhere to Good Clinical 
Practice (GCP) guidelines and all applicable federal, state and local regulations. The 
Research Study Protocol template, the specific protocol, and the written commitment will be 
retained as appropriate in biorepository records. 
Pre-Analytic Variables 
Biospecimen Reporting for Improved Study Quality (BRISQ).  As Pelagio, 
Pistillo, and Mottolese (2011) reported, “Keeping records of pre-analytical variables is a gold 
standard that can allow proper utilization of biospecimens according to study requirements” 
(p. 144).  Moore, Kelly, Jewell, et al. (2011) published a widely applied standard for 
documenting these variables in Biospecimen Reporting for Improved Study Quality, or 
BRISQ.  This document defines biospecimen characteristics and pre-analytical variables that 
may influence biospecimen quality (such as composition, structural integrity, and 
characterization) and that may subsequently affect the reliability of assay results.  Moore et 
al. (2011) advocated improved tracking and reporting of these particular characteristics and 
variables in intended publications rather than reporting only the final data.  Reporting more 
consistent and standardized data will allow researchers to “better evaluate, interpret, 
compare, and reproduce experimental results” (p. 57).  For the purposes of their paper, 
biospecimens were defined as solid tissues and bodily fluids; however, biospecimen 
characteristics and pre-analytical variables may be interpreted, modified, or applied to any 
study as appropriate.  
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BRISQ and potential publication of client studies.  The current proposed 
biorepository model will support the accumulation of BRISQ data standards to ensure the 
highest quality, fit-for-purpose biospecimens and increase its desirability among researchers 
intending to publish.  Simeon-Dubach and Moore (2014) reported that reviewers for the 
journal Biopreservation and Biobanking will take the inclusion of BRISQ guidelines into 
account when reviewing manuscripts for publication.  They further suggest that authors of 
studies using retrospective samples obtain biospecimen annotation to the greatest extent 
possible.  Authors of prospective studies should likewise collect similar biospecimen data.  
Should a study use biospecimens provided by a particular biorepository, Simeon-Dubach and 
Moore (2014) recommend that researchers select a biorepository able to support and provide 
BRISQ data.  Several other journals and articles have reported the importance of using 
BRISQ data in research. 
The Biorepository and BRISQ data collection.   The biorepository will support the 
collection of the following BRISQ data elements (as adapted from Table 2 of Moore et al., 
2011, pp.61-63): 
• Pre-acquisition data, including biospecimen type, anatomical or collection site, 
retrospective or prospective designation, pertinent SOPs, and biorepository 
contact information. 
• Acquisition data, including collection mechanism, time of collection, time and 
temperature from collection to stabilization, visit number, and specific collection 
vial. 
• Stabilization or preservation data, including mechanism of stabilization, type of 
long-term preservation, concentration and constitution of fixative or preservation 
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solution, temperature during time in preservation solution, specimen size, and 
aliquot volume. 
• Storage or transport data, including storage parameters (with temperature and 
duration), type of storage container, storage container ID, shipping parameters 
(with temperature and duration), type of transport container, and freeze-thaw 
parameters (such as the number of freeze thaw cycles, duration of thaw events, 
time from last thaw to processing, and temperature between last thaw and 
processing).  
• Data on quality assurance measures, including specification of the measures used 
to assess biospecimens, when these methods are utilized, and the results. 
The biorepository is committed to work with investigators in the design of the study 
to ensure they consider and capture relevant BRISQ data in the investigator’s respective 
databases.  Other data may include biospecimen disease status, clinical data of the 
participants, vital state, disease state, diagnosis, pathology, reproductive status, and other 
participant demographic information.  Alternatively, if the biorepository were to consider 
managing clinical annotation for biospecimens, the database may require modification in 
order to support BRISQ data as applicable to research study requirements. 
Specimen Collection Kits   
In order to help plan the capture of some of the previously discussed pre-analytical 
data as well as to assist in the execution of specimen collection, the biorepository will work 
with investigators and sponsors to create standardized collection methods for prospective 
samples.  Such collection methods should preserve sample integrity while also maintaining 
and tracking the identity of samples throughout the collection, processing, storage, and 
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distribution life cycle.  To that end, the biorepository will design and manufacture study-
specific, barcoded specimen collection kits for investigator use. 
Specimen collection kit description.   The biorepository’s pre-designed specimen 
collection kits will include the following features:  
• The kit label number will be unique not only to the specific study but also to all 
studies served by the biorepository.  
• A block of kit and corresponding sample label numbers will be provided based on 
the expected number of kits. An additional 25% of label numbers will be provided 
in anticipation for possible study expansion. 
• Sample vials and other kit components will be pre-labeled with the study ID, kit 
ID, sample type, barcode, date of collection, and visit number (if applicable). 
They will also include an alphanumeric representation of the barcode in case the 
label is somehow damaged or unable to be scanned. These labels will be affixed 
to the sample vials in a consistent manner to facilitate efficient scanning and 
processing. 
• Labels also contain a colored circle to correspond with the sample type (e.g., red 
for serum, yellow for urine).  Caps are similarly colored as an added QA measure 
during processing. 
• The kit will include a specimen collection log that will list the sample type, 
specific barcodes, and the alphanumeric representation of the barcode for vials 
and vacutainers.  This log will capture the date and time of collection, the number 
of vacutainers used, and the number of aliquots collected. It may also contain 
specific processing instructions for study personnel.  Most importantly, the log 
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
108 
will provide the mechanism for study personnel to link the kit to participant 
identification number maintained at the clinical site. The log will also list 
biorepository contact information for questions, assistance, or future kit orders.  
• Cryovials and vacutainers will be carefully selected for specimen, stability, 
suitability for storage conditions, and analysis. Manufacturer’s specifications and 
certificates of quality will be documented and included in the kits. 
• Lot numbers and expiration dates of kit components will be recorded and tracked 
so that kits containing the same lot of component may be recalled, if applicable, 
and site personnel notified. 
• The sample type will be validated as appropriate for the specific method of 
analysis. 
• The volume of sample and subsequent aliquots will be appropriate for intended 
use.  A sufficient number of aliquots for present and future studies will be 
incorporated. 
In order to ensure specimen collection kits will meet study specific requirements, 
mock specimen collection kits (using paper labels) will be provided to investigators, study 
personnel, and the sponsor, if necessary, for review.  Multiple revisions may be necessary as 
studies evolve, sponsor and investigator requirements change, and study personnel have the 
opportunity to contribute to the process. Written approval from both the investigator and the 
biorepository director will be required prior to finalizing the requisite procedures, and 
subsequent manufacture and release of specimen collection kits. 
Kit inventories and inventory management.  The biorepository cannot slow or 
impede participant recruitment and subsequent specimen collection due to an inadequate 
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supply of ready-made specimen collection kits or kit components.  In order to meet study 
objectives, the operations manager must maintain effective communication, cooperation, and 
flexibility with study personnel regarding the number of kits they require on a monthly basis, 
the method and timing of the kit shipments or deliveries, and their projections over time.  The 
experience of this author suggests that an automated system of kit orders cannot replace the 
personal contacts and the relationship building that professional, courteous, individualized 
service provides. 
In order to meet customer requirements, the biorepository will ensure adequate 
supplies of kits will be readily available for both routine and expedited shipments.  The 
operations manager should anticipate a need for an excess number of specimen collection 
kits that may be needed on a monthly basis. This particular task becomes easier with 
experience over time.  The biorepository should maintain a two- to three-month kit reserve 
whenever possible.  In order to accomplish this goal, the operations manager must implement 
an effective inventory management system.  The biorepository must maintain an accurate 
inventory and ensure an adequate supply of materials and die-cut label stock in order to 
manufacture kits whenever necessary.  Label sets must be created from the database and sent 
to the selected printer in order to keep printed label materials ready for kit manufacture as 
well.  The author recommends securing a six-month inventory of supplies at all times.  
Maintaining such an inventory requires that standing purchase orders and supply contracts be 
utilized.  The manager must also have experience with supply vendors, their turn-around 
times, and their ability to ship supplies.  Close attention to all aspects of the supply chain will 
ensure the biorepository can maintain a well-stocked inventory.   
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Labeling issues.   Proper labeling of samples will be absolutely vital to ensuring the 
integrity of sample collection and analysis. As such, the biorepository will consider a number 
of factors as it chooses its specific labeling methods. 
Barcodes, die-cut label stock and printing labels.  One dimensional (1D) or linear 
barcodes (using Code 128 symbology, for example) are composed of a series of numerics or 
alpha and numerics (Cosentino & Schoenborn, 2008).  Such identifiers will be acceptable at 
the proposed biorepository provided they are unique both to a particular study and specimen.  
However, the biorepository will pursue two-dimensional (2D) barcodes as they are smaller 
and more flexible than linear barcodes.  They also have the advantage of additional available 
embedded data within the barcode, improved data redundancy and scanning accuracy, and 
the capability to employ any language (e.g., Data Matrix symbology) or even a combination 
of languages. Studies sponsored by the National Cancer Institution likewise favor such 2D 
barcodes (Cosentino & Schoenborn, 2008). 
When selecting vendors, biorepository management should select an experienced 
printer with demonstrated experience obtaining die-cut label stock. Other printing vendors 
may be identified for backup purposes.  Die-cut specifications must be determined according 
to the size of select cryovial or vacutainer and specified to the vendor providing the label 
stock.  
Ordering label materials.    Prior to use, label materials and their printing must be 
rigorously tested under all processing and storage conditions. The results of these tests must 
be validated and documented before orders are placed. Label files can then be generated from 
the database, tracked for both manufacturing and billing purposes, and sent to the printer.  
Although bulk orders of die-cut label material can take several months to fill, large orders are 
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both cost effective and ensure that labels are readily available. Once obtained, die-cut label 
stock must also be properly stored at an ambient temperature or problems with the adhesive 
may occur. 
Additional technical information on label material, barcodes, label configuration, 
printing technology, and recommended barcode scanners may be found in the white paper, 
“Labeling of Biological Specimens” (Cosentino & Schoenborn, 2008). 
Quality checks on printed label materials.  To perform quality checks on labels 
generated by the database and subsequently received from the printer, personnel may use a 
procedural worksheet to ensure the correct label set, i.e., the next label set in the series, will 
be manufactured. This worksheet should include a record of the kit type, label series, and 
date the labels were received.  If labels or log sheets are missing or poorly printed, those 
specific items should be listed on the worksheet and segregated so the printer may be 
contacted and corrections made.  
Kit manufacture.  Kits will be assembled using the appropriate series of labels and 
the necessary kit components. These kits will be prepared to contain the number and type of 
vacutainers and sample vials according to the instructions in the standard operating 
procedure.  Assemblers should utilize the specimen collection log included in the kit as it 
details the specific barcodes and the corresponding type of vial in the individual kit. Two 
example kits should also be maintained and readily available for reference and training 
purposes. 
Assembly.  Assemblers first place a matching label on the bag or vial according to the 
corresponding specimen collection log sheet.  (All labels should include the appropriate kit 
identification number.)  Scotch tape should be applied over all the vial labels to ensure the 
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label will continue to adhere to the tube throughout collection, processing, and storage. A 
blood draw bag should contain the study-specific supplies necessary for blood collection 
such as labeled vacutainers, a vacutainer needle, a vacutainer holder, an alcohol wipe, 
bandages, gauze pads, and pipets.  An aliquot bag should contain the barcoded vials 
appropriate for the sample type, such as serum or plasma.  The barcoded labels on the kit 
bag, draw bag, aliquot bag, and all the sample vials and vacutainers must match the log sheet.  
The kit should be checked to ensure it contains the correct number of vials and appropriate 
vacutainers (e.g., size, additive, freeze dried or liquid additive, or plastic or glass) and other 
collection supplies as identified on the log sheet. Specific specimen collection kit numbers, 
lot numbers, and expiration dates of the vacutainers and other specific supply information 
should be recorded in the laboratorian’s notebook as the database. 
Preparation of preservatives for specimen collection kit manufacture.  A procedural 
worksheet will provide directions and check boxes for the preparation of sample-appropriate 
preservative (e.g., a 50% glycerol solution may be used for urine samples). The worksheet 
will also provide a mechanism to assign a lot number and expiration date, and record the 
corresponding chemical manufacturer, the manufacturer’s lot number, and the expiration 
date.  Preservatives should be stored in secondary reagent containers and labeled accordingly.  
Biorepository personnel will add preservative to the vials and cap the vials as appropriate. 
Sites should be provided with corresponding Safety Data Sheets as well as any hazard 
information and instructions in case of chemical spill. 
Absorbent material (i.e., dry mop) will be included as part of the specimen collection 
kits in case of spillage.  This material causes eye irritation, so assemblers and study personnel 
should be formally trained in handling this material. 
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Quality control of specimen collection kits.  Personnel must complete quality 
control (QC) procedures for specimen collection kits at each stage of the specimen life cycle, 
from preparation of the kits to their final use by investigators. 
QC prior to release.  All specimen collection kits must go through a QC process prior 
to release.  Kits will be disassembled one at a time to ensure that components from multiple 
kits will not be unintentionally mixed during the QC process.  The barcoded labels on the kit 
bag, the draw and aliquot bags, and each vial must match that information on the 
corresponding specimen collection log sheet.  Each kit will be checked for the correct 
number of vials and additional collection supplies. Two example kits (including sample kits 
for every version or modification of the kit) will be readily available for reference purposes. 
The QC date will be recorded in the database and kits will be appropriately labeled by the 
next available series of kit numbers and QC date.  
QC at time of shipment.  Before shipment, the following information must be 
recorded with respect to manufacture and shipment of specimen collection kits: kit number; 
kit components (including lot numbers and expiration dates); lot and date of expiration of 
preservative (if applicable); QC date; staff ID performing QC; the number of kits and the 
identifying kit numbers contained in the shipment; date, method, and cost of shipment, if 
applicable; staff ID releasing or shipping kits; site personnel receiving kits; and date and time 
of receipt.  Kits will be made available via pick up, delivery, or preferred courier service.  If a 
courier service is utilized, the tracking number will be recorded in the database as well.  The 
study-specific specimen collection kit SOP contains the preferred method of shipping kits 
and the contact information. 
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QC by clinical site personnel.  Study personnel should be strongly encouraged to 
perform their own quality control check of specimen collection kits prior to use. The 
Biorepository will assist study personnel by providing training and a SOP that may be 
included in their study-specific manual of operations. Study personnel can then use the 
specimen collection log to verify the correct number and type of components,check to ensure 
all vials have the appropriate kit identification number and unique barcode number, and 
check that included vacutainers have not expired.  The SOP will include instructions on what 
to do should kit components become mixed or elements of the kits be deemed incorrect. 
These instructions will include the immediate labeling and segregating of the incorrectly 
assembled kit in order to prevent its use. 
Possible QC issues.   Although all personnel will follow detailed procedures 
whenever performing QC on specimen collection kits, errors may occur on rare occasions.  
For this reason, certain procedures should be in place to address QC issues whenever 
possible.  Any errors discovered during the manufacture and distribution process, including 
any necessary recalls, reports of lost kits, or inquiries from sites, must be documented.  These 
reports will aid the operations manager in providing consistent responses to queries, writing 
progress reports, and improving the quality control and quality assurance process.  
Recall of specimen collection kits.   Should an identified discrepancy in a kit or batch 
of kits necessitate a full recall, clinical sites will be notified at once and asked to return the 
kits with the understanding that the biorepository will either pick up the kits or cover any 
incurred shipping expenses.  The operations manager should be sure to express thanks to 
affected clinical site(s) for their patience and cooperation.   
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Upon receipt of the recalled kit(s), biorepository personnel should label them with all 
appropriate information, including the purpose of recall and the date of receipt. This 
information should also be recorded in the database.  The entire kit will then be checked 
according to the appropriate kit manufacturing QC procedure and all findings recorded and 
reported. If the identified discrepancy can be corrected, the corrected kit may be redistributed 
to the previous site or a different site entirely.  If the discrepancy cannot be corrected, the kit 
must be discarded and any salvageable components recycled.  The kit numbers, date of 
receipt, date of QC, staff ID performing QC and then shipping kits, date of shipment, 
tracking number, and destination or final disposition will all also be recorded in the database. 
Tracking lost specimen collection kits.  Whether by courier or biorepository delivery, 
shipments of kits must be tracked and the receipt verified and recorded.  If a shipment of kits 
was delayed, delivered to an erroneous address, or lost in transit, the courier may be able to 
assist in retrieving the package.  If the courier cannot locate or retrieve the kit shipment, the 
kits must be recorded as lost in the database. Another set of kits should be sent to the clinical 
site in the requested time frame at no charge. 
Redistribution of specimen collection kits.  In multisite studies, if a clinical site 
experiences an unexpected or unanticipated shortage of kits and none are available, the 
biorepository may contact other clinical sites for assistance.  Another site may be able to 
spare a number of kits until such time that replacement kits are available.  Biorepository 
personnel should request that these sites send the kits back to the biorepository via a 
convenient carrier with the understanding that the biorepository will cover any incurred 
expense.  Again, the operations manager should take extreme care to ensure that assisting 
clinical site staff are thanked for both their patience and cooperation.  
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Upon receipt, the shipping box should be labeled as returned from the specific site for 
the purposes of redistribution and the date of receipt. The receipt date of the kit shipment will 
be recorded in the database. The entire kit contents will be checked according to the 
appropriate QC procedure for kit manufacture.  The specific kit numbers, the site, and the 
date of return will be recorded.  If personnel must make any changes to the kit, the changes 
(e.g., replacement of vacutainers, for example) will be recorded. Prior to redistribution, all 
kits must undergo a second full QC, and the date the QC is performed and staff ID must be 
recorded.  Finally the redistributed kits will be shipped to the new site. All shipment 
information (carrier, tracking number, and date) will be recorded in the database, and the 
clinical site will be notified of the impending delivery. 
Change management procedure in specimen collection kits.    During the course 
of a study, particularly in longitudinal studies, the number or type of kit components may 
change due to study requirements or the discontinuation of a product by a manufacturer.  Any 
proposed changes to previously approved kit specifications must be thoroughly tested, 
discussed with clinical sites, approved, documented, and implemented.  Implementation of 
any such changes must proceed through the following steps: 
1. Recommendations or proposed changes in kit manufacturing must be discussed 
among all concerned parties, including investigators, study personnel, 
manufacturing personnel, and IT (who may be required to reconfigure or 
reprogram the database).  
2. Any changes in labor or manufacturing supply costs must be determined.  
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3. If deemed appropriate, a test protocol may be designed.  Necessary materials will 
be obtained, the cost of the test protocol determined, and the protocol performed 
(including a time study, if applicable).  
4. The results of the test protocol and the changes in labor and manufacturing costs 
will be reviewed internally by biorepository management before being presented 
to investigators, study personnel, and sponsors for their consideration. 
5. If proposed changes in kit manufacturing are accepted, written approval will be 
endorsed by the study PI and sponsor as well as the biorepository director prior to 
procedural change and implementation. 
6. Two new examples of the revised specimen collection kit will be prepared and 
stored at the biorepository for reference.  
Retrospective samples.  Prior to accepting studies using retrospective samples, 
biorepository management must determine the sample identification method utilized by the 
client and obtain the following information in order to accept samples and offer biorepository 
services:   
• What information is available on the sample label? The name of participant, 
abbreviated Protected Health Information (PHI), demographic data, participant 
ID, or a barcode?  For acceptance at the biorepository, the name of the participant, 
demographic data, and PHI should be redacted, though the unique sample ID 
should be protected. 
• What type of barcode, if any, was utilized?  If the samples used a 1D or linear 
barcode, what barcode symbology was used?  
• What provider or BIMS system was used to generate the barcodes? 
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• Did the provider or BIMS have protections in place to prevent multiple users 
(within the same institution, for example) or multiple studies (by the same 
sponsor or investigator) from generating and utilizing the same set of barcode 
SIDs? 
• What are the barcode SIDs or range of SIDs?  
• Do these barcode SIDs or range of SIDs conflict with those used at the 
biorepository? The biorepository must actively prevent duplicate barcodes from 
multiple studies in the database.  
• Is the client’s barcode system compatible with the biorepository barcode 
system/database?   
i) If the systems are compatible but barcode SIDs overlap with other 
biorepository studies, study and biorepository personnel must consider risk 
mitigation and develop a plan of action is required. 
ii) If the systems are incompatible or barcode SIDs overlap with other 
biorepository studies, study and biorepository personnel must perform a 
feasibility study and risk assessment to determine whether samples can be 
relabeled while preserving sample identification.  Any developed workflow 
and protocol must be approved and endorsed by both the client and 
biorepository director. 
Sample Shipment 
Shipment of biospecimens to and from the biorepository can be one of the most 
tenuous and unpredictable stages of the sample storage and processing life cycle.  Rigorous 
procedures, QA strategies, site communication and training regarding sample notifications 
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and shipments must be in place long before the first shipment is sent to or accepted by the 
biorepository. 
During the initial design phase of any study, sites should plan to collect multiple 
aliquots of any given sample for back up purposes and further potential future analyses.  
Samples may then be divided into different shipments to the biorepository in order to prevent 
potential loss or accidental thawing. 
Shipment instructions for clinical sites.   Clients will be instructed to send any 
shipments via Federal Express Priority Overnight service on Monday through Wednesday 
only. This shipment method will allow for next day delivery but also provide an additional 
weekday in case of a shipment delay.  The biorepository will inform clients of holidays or 
other days of closure to allow them to plan in advance for shipments.  The biorepository will 
also provide training, supply recommendations, and procedures for shipping Category B 
Biological Substances, UN3373 according to IATA and DOT shipping regulations, or 
transporting biological substances via motorized vehicle.  
Additionally, all clients will be instructed to include a printed shipping manifest, i.e., 
a list of the specimens’ barcodes (identification) and specimen type as well as send an 
electronic copy of the manifest via email. Biorepository staff assigned to sample check-in 
will utilize this document to QC any incoming shipments. 
Sample notifications.   In order to ensure safe receipt of biospecimens and minimize 
the risk of thawed or partially-thawed shipments, the biorepository will treat communication 
with its clients as a highest priority.  Sites will be instructed to notify a designated group of 
biorepository staff (including the sample check-in lead and the operations manager) of their 
intent to ship and wait to receive a confirmation statement prior to sending the shipment.  
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This system will ensure that biorepository personnel will be available to receive the 
shipment.  This same procedure will be followed for shipments that are picked up by 
biorepository personnel or dropped off at the biorepository.  All intakes must be agreed upon 
by the biorepository and its clients in advance.   
Upon receiving a message from a site indicating their intent to send a shipment 
(including an intended carrier and tracking number), biorepository staff will send an e-mailed 
“received shipment” message that will confirm delivery details with all biorepository and 
site-specific personnel.  Should the site not indicate a carrier or tracking number, 
biorepository staff will request this information in the text of the message.  This email 
communication will then be posted on the sample check-in corkboard so that sample check-
in personnel can track the shipment through the shipping carrier to determine its location and 
status.  If an expected shipment is delayed, the operations manager and site will be promptly 
notified and any information or status updates communicated accordingly.  Any such email 
communication should be marked with the word “Delayed.”  
At the time the shipment arrives, biorepository personnel will send a “Notification of 
Receipt” message to the site indicating that the shipment was received, the shipping carrier, 
and the tracking number.  The previous email communication will be posted on the sample 
check-in board and checked to ensure the appropriate shipment (and the correct number of 
boxes) has arrived.  At that time, the word “Received” will be written on hard copy of the 
email message posted on the board.  As an extra QC measure, all the messages posted on the 
corkboard will be checked each day at 2 p.m. to determine whether they have been 
appropriately marked as “Received” or “Delayed.”  If delayed, the operations manager or 
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designated biorepository personnel will track and retrieve shipments from another location or 
the courier’s facility, if necessary, to secure shipments in as timely a manner as possible.  
The biorepository will continually monitor shipment communications and conditions 
and communicate the quality of specimens to clients in order to alert them of damage, 
compromised samples or protocol deviations. Any issues identified during this process can 
be addressed to resolve ongoing issues, eliminate likely sources of error, and improve the 
process moving forward.  
Sample receipt.  All samples accepted, processed, and stored at the biorepository 
should be considered potentially infectious.  Therefore, Universal Precautions and the 
appropriate PPE (such as lab coat, safety glasses, waterproof cryo-gloves, or non-latex 
gloves) will be required at the time of check-in.  Sample racks and boxes will be placed on 
dry ice at all times during the sample check in process to ensure samples stay frozen.  
The biorepository will employ an electronic biospecimen chain of custody form in 
order to track the shipments and samples from the moment of receipt to check in, processing, 
analysis, storage, and redistribution.  This form will include the name and signatures of any 
biorepository staff members and study personnel involved in any shipment of samples to or 
release of samples from the biorepository.  
Once a shipment is accepted, personnel will check that the shipment arrived in good 
order.  The shipping container should be intact, supplied with adequate dry ice or liquid 
nitrogen, and filled with the correct number of samples (according to the client’s manifest).  
Samples should be tightly capped with vials intact (not cracked or broken). Sample labels 
must be legible, and samples should be completely frozen with no evidence of sample thaw 
or partial thaw.  Sample vials will be marked using an indelible pen (such as a permanent 
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marker) with a ‘P’ or a ‘T’ for partial or potentially thawed and noted as such in the database 
upon check-in. 
Check-in personnel should record any discrepancies between the number of samples 
listed on the site manifest and the actual number of samples received in the shipment as well 
as any damage and/ thawing that may have occurred en route. These notes should be 
communicated to the site upon receipt and further investigation conducted as appropriate. 
Likewise, personnel should record shipment information in the database and electronically 
assign the shipment a shipment identification (ID) number.  All the following information 
must be recorded when documenting such shipping information: the date of receipt, shipping 
carrier or method of shipment, tracking number (if applicable), clinical site, key 
investigator’s ID, study name or identifier, number of samples, sample type(s), size of vials 
(2 mL, for example), and shipping conditions. Evidence of thaw, partial-thaw, or damage of 
any kind should be recorded both in the database and in the laboratorian’s notebook.  
If the check-in process is delayed at any time (perhaps due to an excess of shipments 
arriving at once or shipments arriving later in the day), samples may be labeled with the 
shipment number, site information, and date of receipt. These samples may then be stored in 
a temporary alarmed freezer (with generator backup) at the required storage temperature.  
The temporary storage location should be recorded in the database and the laboratorian’s 
notebook. 
Sample acceptance criteria.  Samples should be evaluated for vial integrity, sample 
label security and accuracy, barcode legibility, and gross sample condition.  Each individual 
study will have pre-established procedures, including sample acceptance and rejection 
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criteria as well as necessary subsequent instructions. Policies and procedures including 
correcting information on sample labels and relabeling sample vials will also be established. 
Sample check-in.  The number and type of samples recorded at the biorepository will 
be compared to the site’s provided manifest.  If discrepancies between the site manifest and 
the actual shipment exist, that information should be communicated to the site immediately.  
Once samples have been compared to the manifest, they will be individually checked 
in to the database.  The shipment ID must be selected so that the shipment and corresponding 
samples are linked.  The staff ID must also be selected, but date and time stamps will be 
updated in the database automatically as individual samples are scanned.  The following 
information must then be recorded: sample ID, vial type and size, sample type, sample 
volume, and any relevant sample observations (such as evidence of hemolysis or thawing).  
Explicit instructions will be provided to check-in personnel in documented project-specific 
check-in procedures. 
Some studies may have their own databases for managing samples and corresponding 
participant demographic and clinical data. In these instances, they may request the 
biorepository store their samples for a fee without need on the biorepository’s part for 
checking in samples at the individual vial level.  Other studies may have the biorepository 
QC the study samples by granting biorepository personnel access to restricted portions of 
their database through a password protected and encrypted website. Both of these services 
may be provided as appropriate.   
The currently proposed biorepository will follow procedures currently in favor at 
Johns Hopkins. For projects in which biorepository staff will check samples into the database 
before transferring the samples into barcode-labeled boxes, the staff will place a uniquely-
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barcoded indicator tube in the first row and column position of each box and check this tube 
into the database to create a permanent record.  If the indicator tube experiences an increase 
in temperature, the pH will change and the tube will change color, thereby alerting personnel 
that a temperature excursion occurred and samples stored in that box were subject to the 
same circumstance. When temperature excursions are recorded in the database, biorepository 
staff will conduct a further investigation to check all other freezer storage boxes in that 
freezer.  Management will also contact the investigator and study personnel to inform them 
of the situation.  Indicator tubes will be routinely checked as part of the quality assurance 
audits. Results of these audits will be permanently documented. 
Each investigator and study will have individual storage boxes; samples from 
multiple projects will never be stored in the same storage box.  This procedure will prevent 
delays when personnel are required to pull samples from storage in a timely and efficient 
manner.   
As an additional QA strategy, the proposed biorepository will split and store 
replicated samples among different freezers.  During sample check-in, samples will be 
assigned alternatively into even and odd numbered storage boxes. Even numbered boxes will 
be stored in one freezer and odd numbered boxes will be stored in another.  Personnel may 
then proceed to scan the barcode label of the vial, weigh the vial (to obtain sample volume 
determination), record the weight, and assign the sample to a specified storage location. The 
row and column position within the storage box as well as the storage box ID (a unique 
barcode) will be recorded in the database.  
Each barcoded vial must have a unique identifier. The database will not accept 
duplicate samples.  Procedures must be in place to address duplicate samples with 
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consideration for IT issues, site issues, and laboratory issues.  Furthermore, the risk of 
misidentification must be routinely monitored and subject to continuous quality 
improvement. 
Sample QC after check-in.   When sample check in is complete, a list of the sample 
IDs, box numbers, row and column positions, freezer rack IDs, and freezer IDs will be 
printed and storage boxes placed in the freezer.  All shipments will be subject to a full quality 
control check. After check in procedures have been completed, a different staff member will 
take the list of entered samples, pull the samples from storage, and compare all recorded data 
to ensure 100% accuracy.  Corrections to the database will be made if necessary and QC of 
the shipment will be recorded as complete in the database along with the second staff 
member’s initials and a date and time stamp.  Finally, the list generated by the 
biorepository’s QC will be checked again against the clinical site’s manifest.  If there are 
discrepancies, the clinical site will be notified so it may investigate further and resolve the 
issue.   
Once the check-in and QC processes are complete, an electronic list of the sample 
IDs, sample type, size of vial, and sample volume will be sent electronically to the clinical 
site in a “Confirmation of Receipt” email.  Other means of checking samples the 
biorepository received (after the check-in process is complete) may be available to clients as 
appropriate. A list of samples successfully checked into system will be emailed to study 
personnel for their review.  
Sample audits.  The biorepository will also perform monthly audits of sample IDs 
and their respective locations to ensure the correct information is recorded in the database. 
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Discrepancies will be corrected. Results of such audits will be reviewed, documented, and 
incorporated into ongoing QMS reports. 
If during an audit a sample entered into the inventory system cannot be located, staff 
will first search the same freezer storage box for the sample. If the sample is not found within 
the same storage box, the samples list from the corresponding shipment will be re-examined 
for possible clues to its location.  Personnel will also conduct an electronic search of sample 
pick lists, as the sample may already have been pulled for a processing request.  If not, 
personnel will query the database and conduct an electronic search of previous pick lists to 
determine if the sample was used in its entirety for derivatives or aliquots or destroyed.  If 
necessary a full search of the inventory starting with the same rack and freezer will be 
conducted until either the sample is located or the operations manager is satisfied the sample 
is not stored at the biorepository. 
Tracking shipment and sample data.   The majority of tracking functions will be 
documented via licensed LabVantage software.  This software package is equipped to handle 
all of a biorepository’s tracking needs with respect to sample management. These specific 
fields are outlined in Figure 3.  Should the biorepository consider collecting and annotating 
clinical data to support investigator studies in future, however, management may consider 
further customization of LabVantage or purchase of the full version of the software. 
Any modifications made to LabVantage’s database must be completely documented, 
including information on the original date of implementation, the date any information was 
modified, the name of the staff member or staff ID who made the modification, the reason for 
the modification, the specific data that was modified, and how the modification was made. 
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Additional details regarding LabVantage functionality and requirements are described 
in “Informatics.” (page 55).  
 
Figure 3. List of data fields in LabVantage for tracking purposes. 
Storage  
Storage of biospecimens must be of primary concern to biorepository personnel. 
Failure to maintain biospecimens in specified, consistent temperature and environmental 
conditions can lead to biospecimen degradation and loss of potency and, furthermore, reduce 
the reliability, quality, and scientific integrity of research study results.  
Environmental conditions.  Room temperature and humidity must be monitored in 
order to provide consistent and favorable environmental temperature and conditions for 
freezer storage, laboratory activities, and, should the need arise, assay conditions.  
ü Sample Receipt 
o Shipment ID 
o Shipping carrier 
o Tracking ID, if applicable 
o BR staff name who accepted shipment 
o Clinical staff name who handed off shipment 
o Clinical site name 
o Study name 
o Study ID  
o Date shipment received 
o Time shipment received 
o Shipment accepted, yes/no 
ü Sample Check-In 
o BR Staff name checking in samples 
o Date sample checked in 
o Time sample checked in 
o Unique sample ID 
o Sample material type 
o Sample vial type 
o Sample volume 
o Sample observations on receipt, drop down 
menu 
ü Temperature Excursions 
o Temperature excursions, yes/no 
o Date(s) of temperature excursions 
o Circumstances/Details of temperature 
excursion 
o Staff ID who reported temperature excursion 
ü Quality Check (QC) 
o QC check completed, yes/no 
o Date QC check performed 
ü Sample Retrieval 
o Date sample pulled from storage 
o Sample parent ID/child ID 
o Sample parent volume, updated 
o Sample child volume, new 
o Date sample frozen/refrozen 
o Number of freeze/thaw cycles 
o Date sample returned to storage 
o Number of times sent for storage 
o Number of times sent elsewhere for 
testing/ final distribution 
o Missing sample or inventory update 
ü Sample Delivery 
o Date sent 
o Shipment ID 
o Tracking ID 
o Recipient name/institution 
o Location of recipient 
o Date shipment received 
o Time shipment received 
o Date sample returned to clinical site 
ü Sample Destruction 
o Date sample destroyed 
o Method of destruction 
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Laboratory and storage equipment can expel an excessive amount of heat.  Exceedingly 
warm temperatures can cause equipment to fail. Therefore, the biorepository must be certain 
to control the temperature to ensure proper equipment performance and operation. Further 
equipment damage through condensation, rust, or erosion of components may occur if proper 
environmental humidity is not maintained.  Temperature and humidity readings will therefore 
be recorded at the beginning, middle, and end of each working shift, and this data will be 
reviewed on a routine basis.  If necessary, corrective action may be implemented and service 
records maintained. 
Freezer setup and validation.  All specimen storage equipment must be approved 
for use under the intended storage conditions.  Mechanical refrigerators, freezers and -80 
degree C ultralow freezers must be positioned and hooked up accordingly to appropriate 
electrical requirements and specifications. An uninterruptible power supply (UPS) backup is 
recommended (ISBER, 2011).  Liquid nitrogen freezers must then be connected to liquid 
nitrogen feeds. If individual LN2 tanks are employed, tanks must be secured to the wall or 
the floor using specifically designed stands to prevent falling.  Once monitoring equipment 
has been installed, high and low temperature set points as well as alarm set points will be 
programed. After they are initially switched on, freezers must run for a minimum of ten days 
to validate proper function prior to use.  As they are successfully installed, equipment 
locations should be added to existing floor plans or schematic diagrams before freezers are 
placed into service.  
A freezer log must maintain the following information: freezer identification number, 
model and serial number, institutional tag ID, required amperage and voltage, the 
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corresponding power panel, circuit number, and whether the outlet is supported by primary, 
secondary, or tertiary backup systems.  
Verification of freezer temperature consistency.  When freezers are placed into 
service or repaired, personnel must conduct temperature mapping to verify and document 
that proper temperature is maintained consistently throughout the freezer.  During this 
temperature mapping, personnel must utilize a procedural worksheet to capture the freezer 
ID, the equipment used in the verification process, and its respective calibration information, 
as well as the results of the mapping (including raw data), and finally review and approval 
indicating freezer temperatures are within acceptable, previously defined tolerance limits.  
Temperature mapping logs will be utilized to list the freezers checked and the date for 
reference and routine review. 
Freezer monitoring.  A freezer monitoring log lists the freezer ID and corresponding 
monitoring ID and ensures appropriate data collected is for a specific freezer and its 
corresponding samples.  The log should be updated any time a freezer or monitoring unit is 
moved or replaced.  Personnel should routinely perform quality assurance checks ensure the 
freezer ID and corresponding monitoring ID are correct.  Resulting information should be 
entered or downloaded in the database in order to link samples with their respective storage 
temperature history. 
All freezer temperatures are monitored by three complementary methods: 
1. Designated staff will check temperatures listed on the display panel of the freezer 
and record data manually on the freezer log attached to each unit. Acceptable 
temperature ranges will be posted on the logs. Staff members will record their 
initials when recording the temperature.  This manual check will occur twice daily 
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seven days a week. Levy-Jennings graphs of temperature vs time points will be 
constructed from this data and reviewed by the operations manager on a monthly 
basis for trend analysis. 
2. With a probe placed inside the freezer itself, staff will record temperatures from 
an independent NIST certified thermometer. This method will verify that the 
temperature on the display panel of the freezer is accurate within a few degrees 
Celsius (C).  This data will also be recorded on the freezer monitoring log.   
3. Freezer temperatures will be automatically monitored at all hours via an 
independent wireless monitoring system.  A calibrated probe placed inside the 
freezer will report temperature measurements to monitoring units attached to the 
outside of a freezer.  
Alarm system.  Acceptable temperature ranges will be pre-defined for refrigerators, 
-20 degree C freezers, ultralow freezers, and vapor phase storage in liquid nitrogen freezers.  
Alarm set points will be adjusted to trigger before the temperature falls outside the acceptable 
temperature range to allow for adequate staff response time before samples experience any 
temperature deviation.  The temperature monitoring units will be battery-operated to prevent 
a system failure should power be interrupted. These batteries will be routinely checked to 
ensure proper functionality, and the check will be documented, initialed, and dated. 
The operations manager must provide the contracted monitoring company with an 
approved procedure for setting the alarm set points and the appropriate response protocol. 
The manager must also obtain written verification that the program has been set up according 
to the specified requirements.  The alarm system must be thoroughly validated (including 
quantification of the response time) prior to initial use.  After it has been implemented, the 
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system will be tested every week by pulling a probe from alternating freezers rather than 
repeatedly checking the same freezer.  Staff will then document proper function, response 
time, and protocol adherence.  A procedural worksheet will provide instructions for 
performing the alarm system test. It will also outline follow-up actions required should the 
response protocol not be followed or if response time is outside acceptable limits. After 
collecting data, staff will use the worksheet to capture the freezer and monitoring ID, the 
date, and the initials of the staff member. 
Freezer alert and response.  If freezer temperature falls outside the acceptable range, 
the alarm company will contact staff via home phone, cell, text, beeper, and email.  On call 
staff will report as quickly as possible to the biorepository and utilize the procedural 
worksheet for freezer alert and response. This worksheet will provide a mechanism for 
recording the date and time of the occurrence, define the acceptable temperature ranges for 
all storage equipment, list contact information, provide step-by-step instructions on how to 
most efficiently assess the situation, and determine whether the problem is a freezer failure, a 
tripped circuit breaker, or a full power outage. In case of freezer failure, instructions will be 
provided on identifying back up freezers, efficiently transferring samples to back up freezers 
on dry ice, and recording the transfer of freezer contents both on the worksheet and in the 
database the latter within a specified time period.  In case of power outage, the secondary 
generator, powered by natural gas, should automatically provide emergency lighting and 
sufficient power to mechanical storage equipment and critical laboratory equipment.  A third 
backup system may be available through the use of a diesel-powered generator.  Staff will be 
trained on such emergency procedures, but additional support will be available contractually 
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through a commercial provider. Depending on circumstances, the procedure for standby 
generator connection to freezer loads may also be utilized.  
Benefits of LN2 freezers in sample preservation.  LN2 freezers not only reduce 
dependence on electricity required for mechanical freezers but may also be utilized in a 
power outage to freeze samples that are currently thawed for sample processing (ISBER, 
2011).  These freezers may draw LN2 from outdoor bulk LN2 tanks and dewars may be 
filled from an indoor LN2 filling station (constructed from the LN2 supply in the bulk tank) 
as needed.  
LN2 usage in each LN2 freezer will be measured daily using either a sturdy wooden 
dipstick or, if available, a LN2 level indicator on the freezer display panel.  Such 
measurements not only assist in anticipating LN2 needs for the facility but also may detect 
potential leaks.  A three thousand gallon bulk LN2 tank can accommodate twenty to forty 
large LN2 freezers for approximately thirty days depending on the rate of usage.  A battery-
operated telemetry system will also automatically monitor LN2 levels and send a dispatch to 
the supplier to refill LN2 when the tanks are at 30% capacity.  Additional LN2 can therefore 
be obtained the same day. Individual cryoports may be filled or tanks obtained as well. 
Alternative vendors should always be identified.  
Benefits of vapor-phase liquid nitrogen storage.  Storing samples in the vapor 
phase (less than or equal to -150 degree C) of liquid nitrogen offers several advantages apart 
from offering an alternative temperature (from -80 degree C, for example) for sample 
preservation.  Storage in vapor phase of LN2 also prevents safety hazards that arise from 
storing samples in liquid phase LN2 storage. Furthermore, it maintains temperatures below 
the glass transition temperature of -132 degree C (ISBER, 2011).  
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Alternate freezer storage box inventory.  In addition to the database maintaining 
specimens and their respective freezer storage locations, a simple yet practical box inventory 
will be maintained and posted on each freezer.  If the database becomes unavailable due to a 
power outage or scheduled maintenance, personnel can determine the number of boxes, the 
box IDs, and the relative box position in each freezer at a moment’s notice.  The manual 
inventory should be updated with box ID, date, and staff ID each time a box is added to or 
pulled from the freezer.  Just as the database will be temporarily checked for accuracy, the 
manual inventory will also be subject to quality checks on a routine basis, the results of 
which will be documented. 
Storage capacity.  The biorepository should follow Best Practices and strive to 
maintain a minimum of 10% backup freezer storage capacity (ISBER, 2011) regardless of 
freezer type (mechanical or LN2). Incoming and outgoing samples will be closely monitored 
for storage capacity, facility and equipment planning, and monthly billing purposes.  Initial 
projections, communications with clients, and study progress reports should all be taken into 
account when considering remaining capacity.  Specimen collection kits manufactured and 
utilized by clients will also provide a strong indication of their recruitment and sample 
collection pace as samples make their way to the biorepository for storage. 
A summary of available freezer space will be updated and posted weekly.  This 
posted summary will also be available in case of emergency so staff will not need to open 
freezers or access the electronic inventory system during power outages.  These summaries 
will also aid management in monitoring available freezer space over time.  Analysis of these 
summaries may prompt communication of freezer storage capacity to investigators and study 
personnel. 
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
134 
Backup power.  Periodic load testing will ensure that the electrical requirements or 
“load” of the mechanical freezers, refrigerators, and critical laboratory equipment remain 
adequate. In cases of heavy load, power usage may be automatically transferred (in stages, if 
necessary) to the generator. These required load tests must be performed and documented at 
six month intervals. 
As previously mentioned, two generators will be utilized: the secondary backup 
generator, powered by natural gas, and the tertiary backup generator, powered by diesel.  
Procedures detailing routine maintenance and service should be followed periodically to 
ensure both generators will be ready when needed.  Designated staff will perform weekly 
maintenance; a licensed, reputable contracted vendor will perform more substantial monthly 
and yearly maintenance. Service records will be documented and a log will detail performed 
maintenance checks. 
Freezer maintenance.   Freezers must be routinely defrosted. A procedural 
worksheet describes the defrost schedule, the defrost criteria and the requisite materials. It 
also documents the freezer ID, date, temporary storage location, staff ID, and provides step 
by step instructions including the acceptable criteria for returning freezer contents. A log is 
utilized to track the freezer IDs, the corresponding date and staff ID.  
Freezers must be properly maintained according to manufacturer’s specifications. 
Preventive maintenance is conducted on a routine basis according to approved procedures. 
Condensers, filters, and gaskets are cleaned and checked. Leaks are often indicated by a 
streak of frost which forms at the point of gasket failure, so gaskets must be checked around 
the door or lid for punctures or tears. Lid and door gaskets must be kept clean and frost free. 
Freezer alarm batteries are replaced when indicator lights begin to flash. Electrical cords are 
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routinely checked for damage; if damage is discovered, the unit is taken out of service until 
repairs are made. A log is utilized to track preventive maintenance activities, the 
corresponding dates and staff ID. All preventive maintenance activities including defrosting 
freezers will be listed on the master schedule calendar. 
When freezers require repair, preferred service providers, their respective contact 
information and current service contracts or warranty information is listed in the procedure 
for freezer repair. In addition, a freezer repair log is utilized to document the freezer ID, the 
model and serial number, the date the freezer is taken out of service, the date the unit leaves 
the facility (if applicable) for repair, the problem and subsequent resolution (for tracking and 
evaluation purposes), the date of return, and finally, the date the freezer is placed back into 
service. Service records are also maintained with the repair log. In addition, a procedural 
worksheet is utilized to capture the specific box IDs that are transferred as well as the 
temporary storage location. Designated personnel are required to enter this information in the 
database within 48 hours and sign and date the procedural worksheet; the operations manager 
will verify the information is entered in the database and sign the procedural worksheet as 
well.  
Sample storage room security.   Freezer rooms will remain closed and locked 
except when work is conducted in those rooms.  Freezers will remain locked except at times 
when staff actively pull or place samples in storage.  Freezer locks will be checked at the end 
of each workday.  A log will maintain records of all activity.  Procedures for keys are 
described in “Equipment selection, qualification, maintenance, and replacement.,” (page 53). 
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Analytic Variables  
Established procedures govern all sample processing; however, a few added 
precautions are of paramount importance. The identity of the specimen must be maintained 
through all processing steps and the sample parent/child relationship must be linked at all 
times. The risk of misidentification is continually monitored.  
Secondly processing must occur in an efficient manner; samples must be processed 
and stored at the appropriate temperature. Samples that experience temperature excursions 
beyond recommended storage requirements will be tracked during routine processing and 
distribution. 
Sample retrieval (pull) from a specified storage location.  Whenever necessary, the 
database will generate pick lists and list their prioritized SIDs, their freezer storage location, 
and the requested service.  The pick list should also contain adequate space for each SID so 
staff responsible for performing the processing can note sample observations to be linked to 
the sample during every processing and storage step.  Samples will generally be pulled the 
day before the requested service is performed, whether that service is thawing, aliquoting, 
analyzing, or shipping samples.   
Universal Precautions must be observed at all times during sample processing, 
including as when pulling samples from storage.  Staff will place the freezer box and the 
processing test tube rack or shipping box on dry ice to prevent thaw and ensure sample 
integrity.  They will then proceed to pull the required number of samples and the matching 
SIDs specified on the pick list.  They may also pull the appropriate quality control 
preparations, if applicable.  By visual inspection the sample IDs are checked against the pick 
list.  If any sample ID does not match the pick list, staff must immediately return the frozen 
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sample to the location specified on the pick list and alert the operations manager to either 
resolve the issue or give further instructions.  When samples are pulled, they will be placed in 
the specified storage location, generally a temporary ultralow mechanical freezer, and the 
temporary storage location, date, and staff ID will be recorded on the pick list.  Personnel 
will record the date a sample is removed from storage as the date the sample is thawed or 
shipped.  Staff will alert the laboratorian responsible for the next processing step and check 
off this step on the procedural worksheet for daily biorepository activities.  
Quick-thaw and preparation of clinical research samples.  Personnel should 
follow all documented procedures for quick thawing samples and preparing samples for 
processing or potential analysis. These documents will detail the steps necessary to thaw 
samples in tepid, running water; to thoroughly mix, vortex, or centrifuge samples (if 
applicable); and to record sample observations according to processing requirements. 
Aliquoting samples.  Thawed samples require rigorous vortexing to ensure 
homogeneity.  Researchers have previously reported that insufficient mixing of samples prior 
to aliquoting has led to erroneous results. (Zhu, Pinsky, Huang, & Purdue, 2014).  
Recording sample observations.   At any time during the pre-analytic, analytic and 
post-analytic process, personnel should link appropriate information with samples and ensure 
any relevant information regarding specimen quality is available to both biorepository staff 
and clinical site for future consideration, selection, and value in continued storage.  Staff 
enter the sample identification number (SID) in LabVantage and select “comment history” to 
verify whether the sample observation was previously recorded.  If relevant information was 
not previously noted, the current comment, date and staff ID should be recorded.  
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Snap freezing clinical research samples.  After samples have been processed and 
analyzed (if applicable), samples will be snap frozen according to an approved procedure 
using liquid nitrogen.  
Returning samples to a specified storage location.   After samples have been snap 
frozen, the samples may be returned to their original storage location as specified by the 
appropriate pick list.  Staff will pull the sample’s original freezer box from storage, place it 
and the test tube rack with the samples on dry ice to prevent thaw, and return the samples to 
the original storage location according to the pick list.  
Staff will record their ID and the date samples are returned to the specified storage 
location. This data will then be entered in the database.  Designated staff will check to ensure 
the data was entered and sign off on a procedural worksheet.  
Assessing the quality of samples.  The biorepository will also conduct audits on an 
annual basis to assess the quality of samples collected, processed, analyzed (if applicable), 
and stored. The operations manager will select samples from all sample types that have been 
stored for specific time periods.  Sample identification and selection criteria will be listed in 
the appropriate procedural worksheet.  Samples will then be evaluated for sample location, 
vial integrity, sample label security, sample label accuracy, and gross condition of sample 
(e.g. hemolysis, sublimation) determined by direct observation.  Samples may also be 
evaluated through examination of research record integrity or feedback from investigators, 
depending on their specific study requirements, the types of samples stored, and their 
respective analyses.  Investigators may agree to comparative analysis and request retest 
samples for specific analytes to determine potency after specific storage conditions and 
duration of storage. If potency has decreased to an unacceptable level, further evaluation may 
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be required for the same type of samples that have been stored under similar conditions for 
the same duration.  The operations manager or director will consult with investigators on an 
individual basis regarding the feasibility of a requested analysis, method of evaluation, and 
subsequent results. Sample identification, method of evaluation, and the subsequent results 
will be recorded on the procedural worksheet and incorporated into QMS reports for 
evaluation and future consideration. 
Temperature checks using NIST certified thermometers will be conducted on all 
temperature dependent equipment or instrumentation prior and during use; results will be 
documented for review. Temperature probes are also calibrated and expiration dates are 
documented. 
All laboratory equipment will be validated prior to initial use. Equipment will be 
calibrated according to procedures and manufacturer’s specifications and instructions. 
Personnel will document calibration date, staff ID, the name of the device used for 
calibration, as well as the results.  
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Post-Analytic Variables 
Returning samples to sponsors or investigators.  Category B Biological 
Substances, the only category of samples the proposed biorepository will receive, process, 
and store, will be transported or shipped via commercial carrier according to approved 
procedures (including IATA and DOT Regulations).  Personnel will be certified in shipping 
biological substances on an annual basis.  Category B certified shipping containers, dry ice 
and packing materials will be available at the biorepository. In the case of vapor-phase liquid 
nitrogen storage, cryostorage containers will also be readily available for transport. 
The same communications detailed in Sample notifications are applied to returning 
samples to clients.  An electronic copy of the shipping manifest will be included in the 
“Intent to Ship” email sent to the client.  A hardcopy of the shipping manifest will also be 
included in shipments, whether transported by a shipping carrier such as FedEx or delivered 
by biorepository personnel.  If samples are delivered directly to the client, staff will obtain an 
electronic signature using the electronic biospecimen chain of custody form.  
Shipping freezers to sponsors or other repositories.  Sponsors of research may 
require transfer and storage of a large volume of biospecimens to previously specified 
locations post collection, post analysis, or at study termination.  For example, transfer of 
specimens may be necessary to establish the highest quality, fit-for-purpose biospecimens 
(those preserved and under the protection of the biorepository) as reference set material, in 
order to facilitate future research.  
Shipping a large volume of biospecimens via a shipping carrier such as Federal 
Express is often cost prohibitive and also has a higher risk assessment due to the number of 
shipments and lack of control.  After many successful years of receiving and shipping 
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clinical research samples, the author recommends Federal Express as a trusted carrier. 
However, the average cost of a FedEx shipment of ten to thirty sample storage boxes- 
depending on the size of the storage boxes, the size and weight of the certified Category B 
shipping container, and the destination- may exceed $280-$350, not including the relatively 
small cost of dry ice.  For instance, the author has had notable experience and success 
coordinating the shipment of twenty-one full freezers from the University of Michigan to a 
commercial biorepository (selected by the NIH) located in Rockville, MD over the course of 
several years.  Individual shipments of four fully loaded freezers at that time averaged 
$3,500. 
In order to ship full freezers in the most efficient and cost effective manner the 
following safeguards will be necessary:  
• IRB approval. 
• Participant consent documentation, located at the clinical site(s) that specifies the 
potential for future utilization or final disposition of samples. 
• Due diligence in investigating transportation companies and the respective costs 
of their services. 
• Rigorous procedures to select biospecimens for shipment, prepare and QC 
inventories, and manage the coordination, process and safe transfer of freezers. 
• An adequate budget to cover the management of this process and the associated 
costs. 
IRB approval must be verified prior to acceptance and onboarding of any study. The 
sponsor routinely reviews documentation of participant consent at the clinical site(s) during 
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monitoring activity.  It is also important to note that material transfer agreements (addressed 
in “ 
Limitations/Delimitations of the Study,” page 179) may be applicable in specific 
project circumstances. 
Biorepository information technology (IT) personnel will be responsible for 
performing a database-driven QC procedure on samples or entire freezers selected for 
shipment. They will also be responsible for generating an electronic inventory of the selected 
samples.  Biorepository staff support IT procedures through verification of a subset of 
samples previously checked samples and their respective locations as well as providing a 
separate yet complete box ID inventory as an additional QA step. All procedures will be well 
documented as part of the biorepository manual of operations.  
For shipping purposes, the biorepository will select a reputable firm that has notable 
and demonstrated experience transporting freezers using back up power or liquid nitrogen 
tanks on board as well as temperature monitoring capable of ensuring proper temperature and 
storage conditions are maintained throughout the entire route.  Such temperature information 
must be documented and readily available for review by the operations manager. This 
information will likewise be shared with the client or sponsor.  The biorepository will 
maintain a log of freezers shipped to clients or other repositories with the following 
information: freezer manufacturer, model and serial number, tag number, freezer ID, date 
shipped, delivery date, and date freezer returned to the biorepository (if applicable).  Invoices 
and methods of payment (purchase order numbers, for example) will also be documented.  
The operations manager will ensure the proper tracking of capitalized equipment and 
coordinate the shipment and receipt of freezers with the client and the shipping company.  
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Additional considerations.   If transferring samples from biorepository freezers into 
cold recipient freezers, the size and configuration of rack systems may be (and very likely 
will be) different.  All biorepository freezers will have approved rack systems for storage 
equipment.  Freezers will likewise be required to have rack systems for transport.  However, 
personnel must recognize that some biorepositories may not have sufficient funding and 
therefore simply stack boxes in mechanical freezers in order to save the cost of purchasing 
freezer racks. Transferring samples from one freezer to another without the benefit of a rack 
system will take additional time and effort.  Lack of racks can also cause safety concerns.  
Bending over freezers in order to reach boxes on the bottom of the freezer exposes staff to 
cold temperatures.  Personnel may also suffer from lack of oxygen or additional stressors on 
the back and arms.  Staff will use the appropriate PPE and wear oxygen-monitoring sensors.  
The operations manager will provide close supervision and support and will ensure safety 
and staff rotation.  The operations manager must insist on reviewing freezer and rack 
specifications in order to plan the workflow and the specific transfer of boxes IDs well before 
the planned shipment date.  Under close supervision, biorepository personnel would then be 
able to systematically and efficiently load or transfer boxes between freezers using dry ice 
chests or cryocarts. These personnel will also inventory the box IDs of each freezer and 
perform a 100% QC of the box IDs prior to the operations manager releasing the shipment 
for transport.  The operations manager will maintain control of the number of freezers per 
shipment.  When transferring samples from biorepository freezers to cold recipient freezers, 
two experienced staff teams may sufficiently manage a two- to four-freezer workload.  
Personnel should also plan to utilize a biospecimen chain of custody form during the process.  
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Shipping freezers can cause equipment considerable strain.  Transport companies 
may be required to provide extra packing and shipping material to protect freezers from dings 
or scratches.  Tipping mechanical freezers may cause operational problems, but freezer fluids 
tend to return to normal within 48 hours.  
Parking large trucks will require coordination. The operations manager should 
confirm that the recipient’s facility has a dock available with an automatic lift in order to 
accommodate moving one fully loaded freezer from the truck at a time.  Parking and dock 
requirements should be addressed well in advance of the shipment. 
Upon receipt of the samples, the client or sponsor will likely assess if a full inventory 
of samples is necessary on their part from their own risk assessment.  Given the level of 
communication, quality assurance, and access to biorepository procedures, clients may 
decide not to re-inventory samples; however, they are likely to re-inventory the box IDs. 
Final disposition of samples.  Upon request of the clients, samples may be destroyed 
according to approved procedures as well as applicable local, state, and federal regulations.  
Sample destruction may be necessitated by any number of reasons: study termination, end of 
funding period, depletion of sample, research participant’s request for discontinuation, 
informed consent issues, IRB issues, discrepancies between any clinical data and samples (as 
reported by clinical sites), or quality of the physical sample.  A permanent record must be 
established via a signed letter to investigators or clients. This letter must specify the date and 
the sample IDs and include a written assurance that the samples were properly disposed 
according to approved procedures as well as applicable local, state, and federal regulations.  
Copies of such letters will be maintained as part of the study records. 
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
145 
Chapter 10: Emergency Preparedness and Disaster Response 
Emergency preparedness includes preparation, planning, training, and procedural and 
system validation to prevent or minimize consequences of a potential situation or event that 
could interrupt biorepository operations and place biospecimens at risk.  As part of an overall 
business continuity plan (see page 31), emergency preparedness must include risk assessment 
and risk mitigation.  Any emergency preparedness plans must prioritize the safety of 
personnel and visitors who may be present, and then identify and addresses all critical 
functions of the biorepository so that emergency response procedures can be initiated.  
Having established procedures and validated systems in place will allow the biorepository to 
protect the invaluable biospecimens entrusted to its care; support management in planning for 
potential emergencies, events, or planned shutdowns; and provide the appropriate resources 
and instructions in order to respond to such unforeseen circumstances in an efficient and 
timely manner. 
When an unexpected event or emergency occurs, the type of emergency and resulting 
interruption of service will precipitate the implementation of established procedures as 
defined in any comprehensive response plan. Standard operating procedures will outline 
specific measures to be taken in a biorepository emergency. A subsequent review of actual 
events and subsequent responses can also contribute to continuous quality improvement. 
Sharing experiences from natural or man-made disasters and their subsequent 
outcomes should be encouraged within the biorepository community (Simeon-Dubach, 
Zaayenga, & Henderson, 2013).  Shared problem-solving strategies, creating alliances to 
foster partnership, and sharing resources may be instructive and beneficial to all involved.  
However, some organizations may be reticent to share experiences due to real or perceived 
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business consequences leading from loss of confidence  or diminished reputation.  Therefore, 
this chapter will detail recommendations and considerations that have been published in the 
literature. 
Fire Response 
In Learning by Erring: Fire!, Roger Bjugn and Jarle Hansen (2013) asserted that even 
the most thorough planning could not have anticipated all the information learned at the time 
of their emergency: a fire that took place in a biorepository located in a hospital in Norway.  
In an attempt to improve organizational learning and emergency response, the authors 
conducted an analysis of crisis management.  They examined both the events preceding the 
emergency situation and reviewed the resulting crisis situation.  They concluded that “An 
organization’s emergency preparedness is its readiness to react constructively to threats from 
the environment in a way that minimizes the negative consequences of impact” for both the 
safety of people and facilities and systems (p. 202).  
Pre-event risk analysis.  Before the fire, a formal risk analysis had identified fire as 
a possible disaster and communication with the local fire department confirmed all resources 
were committed to saving lives and excluded biospecimens entirely.  As part of risk 
planning, fire detectors and extinguishers were installed, flammable material was limited in 
the facility, and freezers were required to have annual maintenance checks.  
Water, foam, and gas fire extinguishers were considered for use; however, water 
extinguishers were deemed inappropriate since flooding could cause mechanical failure in all 
the freezers.  The foam extinguishers contained water, so they presented the same problem.  
Consequently, the hospital installed a gas fire extinguishing system that used a mixture of 
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“argon and nitrogen whereby the oxygen concentration in the facility is reduced to 12%, 
thereby causing fires to extinguish in less than one minute” (Bjugn & Hansen, 2013, p. 203). 
The event.  On November 7, 2007, a fire alarm sounded in the building, followed by 
a second manual fire alarm activated by a person in the hallway who saw smoke coming 
from under the doors and heard alarm bells going off inside the biorepository.  Written 
warning signs informed the passerby this was a restricted area and therefore did not enter.  
As patient evacuation began in the hospital, the fire department arrived and found smoke and 
a smell of burnt plastic.  Fortunately, the fire had already been extinguished by the automatic 
fire extinguishers. At the same time, staff arrived in response to an electronic alert for a 
freezer failure, and found a power supply unit had caused two wires to burn. They discovered 
that the power supply unit had been damaged by a blown fuse. After fire department 
approval, staff members were able to enter the area and move specimens to a back up freezer.  
Post-event analysis.  In later analysis, management determined that ISBER Best 
Practice guidelines had been followed, and a formal risk analysis had put risk reduction 
measures in place.  All predefined procedures had been followed at the time of the fire.  Staff 
found no injuries and no damage occurred to the building or facilities.  However, an after-
action investigation did identify two immediate concerns that needed to be addressed:  
• Communication with local entities.  The local fire department had intended to use 
water to extinguish the fire because they were unaware of the gas-based 
extinguishing system.  If the fire had been more extensive and water had been 
utilized, all twenty-seven freezers may have been damaged. 
• There were no back up contingency plans to relocate that many biospecimens. 
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The communication issue was addressed by installing large signs on the doors of the 
biorepository with instructions to emergency responders.  The signs alerted responders that a 
nontoxic gaseous fire extinguishing system was in place and only carbon dioxide could be 
used in fire-fighting efforts. 
The post-emergency investigation also identified problems with refilling the gas 
extinguishers that had not been anticipated.  The hospital did not have a contract in place for 
refilling the gas extinguishers, and staff from the company that provided the gas were away 
on an out-of-town business trip.  No other suppliers were available, and for 48 hours the 
biorepository had to have a fireguard on watch.  To alleviate this gape in emergency response 
plans, the biorepository entered a refill contract with the supplier of the gas mixture, and 
wall-mounted manual extinguishers were also installed.   
As part of their post-disaster analysis, Bjugn and Hansen (2013) found that most 
emergency plans had too much emphasis on emergency response rather than risk analysis 
and mitigation.  Recognizing that the most comprehensive planning cannot prevent a disaster 
from happening, they recommended that any emergency management process must include 
more emphasis on prevention, risk analysis and mitigation. Their recommendations for 
complete emergency planning guidelines include:  
1. Mitigation and preparedness (the pre-crisis): the steps taken to prevent an 
emergency from happening and a predetermination of the correct response for the 
emergency. 
2. Response (the acute crisis): actions necessary at the time of emergency, including 
methods of controlling damage to facility and property beginning the recovery 
process. 
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3. Recovery (the post-crisis): the actions necessary for conditions and infrastructure 
to return to normal.  
Applicable lessons to proposed biorepository model.  The fire emergency as 
described by Bjorn and Hansen (2013) identify several strategies that any proposed 
biorepository should apply when creating an emergency preparedness plan.  As a longtime 
biorepository manager, I highly recommend creating stable working relationships with local 
fire and police departments by sharing contact information, emergency response procedures, 
and special precautions and hazards unique to the biorepository.  This exchange of 
information and relationship building also provide an opportunity to promote the importance 
of the facility and its services and may help in the prioritization of emergency response.  
Likewise, establishing contracts with primary and back up providers for LN2, fuel, dry ice, 
and supplies ensures that resupply is a priority.   
In this particular biorepository model, fire safety training must include training in 
extinguisher operation (see “Fire Safety,” page 69).  External signage for the facility has also 
been addressed in “Exterior and interior signage,” page 61).  
Natural Disaster Response: Hurricanes 
Hurricane Isabel.   In “How Is Your Biobank Handling Disaster Recovery Efforts,” 
Baird et al. (2013) addressed the issues of protection and recovery after Hurricane Isabel, a 
Category 2 hurricane, struck the East Coast in September of 2013. A comprehensive 
emergency preparedness plan allowed Fisher BioServices to operate 15 separate locations 
with over 30 million biospecimens used for cancer and AIDS research during Hurricane 
Isabel without losing a single sample, even though commercial power was out for up to 5 
days at some of the biorepository locations.  
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Fisher BioServices needed to ensure open communication with staff and customers to 
keep them informed of the status of biospecimens.  The company set up landline telephones 
and back up computer support at company headquarters (off-site from its multiple 
biorepository locations) where diesel-powered generators maintained internet connection and 
other services. However, the generators had limited diesel fuel supply, and no system was in 
place with vendors identifying off-site locations as critical for refueling.  Staff members took 
5-gallon containers to gas stations in order to procure diesel fuel, but many stations had run 
out of gas or were without electricity to run pumps.  
All sites had generators that were routinely checked, and part of the emergency 
preparedness plan (before the hurricane) included filling diesel tanks and liquid nitrogen 
freezers.  No freezer thaws took place, and staff members were able to monitor the 
biorepository sites 24 hours a day until the hurricane was over.  
Post-event modifications to emergency plans.  In order to mitigate the damage 
caused by future disasters, Fisher BioServices established priority fuel supply contracts and 
approached utility companies requesting prioritization of restoration of electricity (after 
hospitals and life support services).  Furthermore, the company procured all new “duel fuel” 
generators, which can be powered by natural gas and propane or by diesel and propane, 
providing more flexible options for refueling in emergency situations.  As further precaution 
against freezer failure, Fisher BioServices installed pre-wired connectors so mobile 
generators could be brought in by trailer if necessary. 
Hurricane Sandy.  The Coriell Institute for Medical Research, located in Camden, 
New Jersey, examined how quality improvement can be accomplished in post-disaster 
planning after Hurricane Sandy struck the East Coast of the United Sates in October 2012.  
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Established in 1953 as a nonprofit research center, the Coriell Institute established the first 
biorepository in the United States in 1964 with a collection of biospecimens for the National 
Institute of Health, and currently manages hundreds of thousands of cell lines and DNA 
samples that have been used for research in 65 countries (Mintzer et al., 2013).  
In “Preparedness for a Natural Disaster: How Coriell Planned for Hurricane Sandy,” 
Mintzer et al. (2013) state that “Management of biomaterials is not simply a laboratory 
process; their long-term survival is dependent on both the laboratory preparation and the 
infrastructure designed for maintenance, safety and security” (p. 216).  Coriell implemented 
an aggressive Emergency Operations Plan (following both ISO 9001 Quality Management 
standards and Homeland Security guidelines) that emphasizes backup systems, 
communication solutions, and employee training.  The plan was utilized to prepare for 
Hurricane Sandy, a category I hurricane that was considered to be the deadliest storm of 2012 
and caused an estimated $50 billion in damage (Mintzer et al., 2013). 
Pre-planning.  Coriell’s Disaster Preparedness Plan was vital in protecting the 
biospecimens in their biorepository in the wake of Hurricane Sandy.  The Institute houses 
nearly 110 liquid nitrogen-filled cryogenic stainless steel freezers, more than 80 ultra-low -80 
degrees C freezers, a dozen -20 degrees C freezers and two -20 degrees C walk-ins freezers, 
in addition to over 20 refrigerators (4 degrees C) and eight walk-in refrigerators (Mintzer, 
et.al., 2013).  In the wake of Hurricane Sandy, Coriell was without electrical power for over 
50 hours and had to rely exclusively on their backup system in order to protect the 
biospecimens.  As part of their preparations before the storm, Coriell purchased extra fuel for 
its diesel generator and tested its four gas generators to make sure all biobank functions, 
including computer needs, would be covered.  
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Procedures employed by Coriell require regular documented inspection of all 
laboratory equipment, such as freezers, that are essential for operations to continue in an 
emergency.  Disaster preparedness planning also included checking all vital facility systems, 
including water supply and purification, steam and electrical service, and mechanical systems 
and alarms. Detailed planning by Coriell management also included preparing for evacuation 
by identifying locations of important elements, such as data, and making sure backup disks 
were stored off-site at varying geographic locations.  The locations of electrical outlets 
powered by back-up generators were identified as well. Finally, a formal chain of command 
specified the assignment of individual tasks, such as turning off equipment, to all available 
personnel.  Because Coriell received advance notice of the hurricane, the staff was able to 
review their emergency preparedness plan, ensure all freezers were powered using back-up 
outlets, duplicate data for safe storage and initiate phone trees before the storm. 
The event.  A State of Emergency was declared in New Jersey as Hurricane Sandy hit 
the East Coast.  Transportation was limited, and in the interest of safety for its employees, 
Coriell closed.  Although the biorepository lost electricity for over 50 hours, back-up 
generators provided uninterrupted power to computers and freezers and no biospecimens 
were compromised.   
Post-event discussion.  Thorough emergency preparation and planning, both long-
term and just before the hurricane, led to Coriell’s successful response.  Although post-
outcome discussion identified areas for improvement, Mintzer et al. (2013) are correct in 
stating, “The combined preparation both ‘years in advance’ and ‘immediately prior to the 
event’ were both essential to achieve the positive outcome” (p. 219). 
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Natural Disaster Response: Earthquakes 
New Zealand earthquake swarms.  Morrin and Robinson (2013) examined 
priorities in emergency situations in “Sustaining a Biobank Through a Series of Earthquake 
Swarms: Lessons Learned from our New Zealand Experience.”  The profound earthquake 
swarms occurred in Christchurch, New Zealand.  They began September 4, 2010 with an 
initial earthquake registering 7.1 on the Richter scale.  In less than two years, the city 
experienced continuing volcanic and seismic movements, including over 10,000 earthquakes 
and aftershocks (Morrin & Robinson, 2013).  Many of these seismic events necessitated 
evacuation of all personnel in the biorepository facility, followed by the attempt to preserve 
all biospecimen samples. 
Fortunately, the biorepository was located within a hospital that could provide 
essential supplies such as liquid nitrogen and carbon dioxide. However, a state of national 
emergency was declared, and only emergency and medical personnel had access to the 
hospital.  Even after biorepository personnel were allowed to return to the facility, they were 
forced to relocate as their space had been repurposed.  Damage from each earthquake 
required engineering inspections for safety before operations could be relocated, and 
essential equipment had to be moved every time.  By February, 2013, the biorepository had 
moved five times.  They were finally able to return to their original location in the hospital 
after almost two years. 
Morrin and Robinson had to examine damage to infrastructure and disruption of 
essential resources and supplies as they initiated responses to the continued earthquake 
disaster.  For example, power in the city was lost for five days after the original earthquake, 
and both of the hospital generators were damaged.  The water supply was contaminated, 
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pipes were broken, and the sewage system was compromised.  The hospital received 
emergency supplies, such as water and utilities, which allowed the biorepository to continue 
to preserve specimens.  The authors state, “both our generators were damaged during the 
quake, but liquid carbon dioxide provided cover for the 4-hour period, particularly as our 
freezers were full, providing a large thermal mass. Our liquid nitrogen freezer has an 
automatic refill for vapor phase storage with a holding time of over 3 months” (Morrin & 
Robinson, 2013, p. 213).  Morrin and Robinson concluded that using smaller freezers was 
advantageous, as piping and outside tanks were less likely to be damaged, and liquid nitrogen 
delivery was able to continue from the supplier. Only one mechanical freezer failed, and that 
was a year and a half after the initial earthquake.    
Some temporary closures of the biorepository were necessary due to aftershock 
evacuation, loss of personnel, and loss of business access due to construction.  Morrin and 
Robinson thoroughly examined personnel issues, with the resulting recognition of how 
traumatic and challenging a disastrous event can be on staff.  They remind managers that 
personnel oftentimes “face damage and distress at home as well as at work, have distressed 
family members to support, and fears for loved ones and for safety were reactivated with 
every aftershock” (Morrin & Robinson, 2013, p. 213). Post-traumatic stress disorder (PTSD) 
resulted in loss of personnel, as did continuing mental and physical fatigue from the 
repeating earthquakes. 
Conclusions.  Several conclusions were drawn as a result of the New Zealand 
experience, including the recognition that a major earthquake is not an isolated event, as 
damage can continue through aftershocks for an unlimited length of time. The authors also 
note the importance of the location of the biorepository within a hospital or supporting 
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institution, which allowed them to have utilities restored quickly.  Their suggestion of having 
back up generators available in nearby cities, and discussions on how to transfer 
biospecimens and equipment in the event of a disaster, should be included in any emergency 
response plan. A long-term operations and contingency plan calls for consideration of the 
following priorities that Morrin and Robinson (2013) suggested:  
• Prioritizing safety of personnel first, then biospecimens. 
• Evaluating the possibility of return to the facility. 
• Checking accessibility for re-supply and generator power. 
• Considering locations within a medical center.  Medical centers will be given first 
priority with regard to receiving emergency supplies, such as power and water, as 
life safety is always a top priority for first responders. 
• Preparing for loss of autonomy.  Biorepository management may have to step 
aside for emergency personnel, and any damage to the construction site may 
require repairs, the timing of which may be delayed depending on community 
needs. 
• Storing at least one month of supplies away for an emergency situation.  
Management must recognize that resupply may be limited due to state of 
emergency regulations, which will vary depending on the type of disaster, the 
hazardous conditions, and limited physical access to facilities or vendors. 
• Acknowledging the personnel may be traumatized. Staff trauma may result in 
PTSD or even simply physical or mental fatigue.  Staff, even vital staff, may 
choose to leave under such circumstances, as disasters can significantly diminish 
quality of life. 
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• Making preparations for relocation should equipment and specimens need to be 
relocated to another facility or city.  
• Preparing for long-term operation and contingency plans in the wake of a massive 
natural disaster. 
A comprehensive risk assessment must also take geographic location of the 
biorepository into account, as certain types of natural disasters may be more likely in certain 
areas.   
Examples of Freezer Failure 
Harvard Brain Tissue Resource Center.   Baird et al. (2013) also detail a less 
successful example of biospecimen preservation.  In June of 2012, the Harvard Brain Tissue 
Resource Center located in McLean Hospital in Belmont, Massachusetts experienced a 
complete freezer failure that unfortunately destroyed all tissue samples stored in that 
particular freezer.  Not only did the display on the freezer unit itself fail (it displayed an 
acceptable temperature despite the actual freezer temperature being at ambient temperature), 
the independent freezer monitoring system which utilized a probe inserted into the freezer 
also failed to notify personnel of the rising temperature.  In response they reviewed all SOPs 
and implemented a third alarm continuous monitoring system that utilizes wireless 
technology to alert staff. 
Sanford Health.  Sanford Health, the largest not-for-profit health care system in the 
nation with locations in eight states, purchased multiple ultralow mechanical freezers 
(identical models) for both primary storage and back up capacity for its biobank.  Baird et al. 
(2013) discuss how, after several months of service, multiple freezers began to “experience 
temperature fluctuations followed by first stage compressor failure.  The vendor identified an 
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issue with a manufacturing defect in a specific lot of compressors” (p. 196), and the units 
were repaired with new compressors.  A few months later, however, one of the freezers with 
the newly installed compressor failed.  The vendor then informed Sanford Health that the 
design of the original compressor was faulty.  The vendor then offered to repair the freezer 
using a completely different compressor design that had been thoroughly tested and that 
repair solved the issue.  
The biobank at Sanford Health utilized an independent wireless temperature 
monitoring system, a liquid CO2 back up system, and requested and received loaner freezers 
when necessary.  The biobank performed an analysis of recorded temperatures that identified 
multiple temperature fluctuations in the weeks leading up to the compressor failure, thus 
giving the biobank an opportunity to correct the issues before tissue samples were lost. 
Additionally, the biobank pro-actively had all faulty compressors replaced rather than 
waiting for another failure.  Effective communication with the vendor provided more detailed 
information regarding the issue and provided a resolution, and the open dialogue played a 
large part in maintaining the business relationship.  The biobank “instituted weekly 
maintenance schedules that include a review of temperature logs to spot potential problems, 
tests of the liquid CO2 back-up system, and visual inspections of all door seals and 
compressor filters” (Baird et al, 2013, p. 197).  An annual preventive maintenance program 
servicing the compressors and refrigeration systems was also established.  
Applicable lessons to proposed biorepository model.  Because of the importance of 
consistent temperature in biospecimen preservation, monitoring freezer temperature must 
always be of highest priority in biorepository functioning.  I highly recommend a three-level 
temperature monitoring system, including the built-in temperature display on the freezer 
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itself, utilization of an independent NIST thermometer, and a separate independent wireless 
temperature monitoring system. With three separate methods of monitoring freezer 
temperature, such freezer failures as present at McLean Hospital are far less likely to occur. 
Furthermore, staff should plan to validate all temperature monitoring systems and test 
their functions and response times on a weekly basis (prior to the weekend) to ensure the 
system captures these planned temperature deviations and alerts staff according to 
established procedure in a timely manner.  This procedure is discussed in greater detail under 
“Verification of freezer temperature consistency” (page 129). 
Additionally, I highly recommend routine review of temperature records plotted over 
time, (utilizing Levy-Jennings graphs, for example) to detect temperature fluctuations and 
trends.  Any abnormal fluctuations can be examined and their root causes analyzed in 
ongoing improvement efforts.   
Proposed Biorepository Model Emergency Preparedness Plans 
In “Disaster and Recovery: The Importance of Risk Assessment and Contingency 
Planning for Biobanks,” Simeon-Dubach, Zaavenga, and Henderson (2013) suggested that 
Disaster recovery plans include the availability of the right monitoring equipment, 
backup systems for storage and data, and redundant spare parts and supplies, testing 
of standby equipment, on-call staffing, quality control and safety plans; tested 
standard operating procedures for each of the risk scenarios, and financial plans and 
insurance. (p. 133)   
Biorepository management has a fundamental responsibility to protect both the health 
and safety of biorepository personnel and visitors as well as the biospecimens entrusted to 
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their care.  That responsibility can only be met through effective planning for unforeseen 
circumstances.   
An effective emergency preparedness and disaster recovery plan requires thorough 
risk analysis, mitigation, planning, and preparation; implementation of the plan according to 
established procedures; creating procedures for recovering data and re-establishing services; 
and finally performing a post-event assessment and evaluation for the purposes of continuous 
quality improvement.  With all of the previous anecdotes and recommendations in mind, I 
have assembled essential components for a comprehensive emergency response strategy that 
demonstrate an organization’s commitment to safety, quality assurance, emergency 
preparedness and disaster recovery.  
Emergency response measures must always begin with considerations of safety in all 
areas of biorepository operations.  As such, several of the items have been addressed in other 
sections of this document, including in “Chapter 7: Resource Management-Work 
Environment” (page 60).  However, for ease of reference these considerations have also been 
addressed here. 
LN2 hazards.  Biospecimens for this facility would be stored primarily in vapor-
phase LN2, so a bulk source of LN2 is necessary for that purpose. Safety and operational 
training must include freezer room safety, freezer safety and operation, LN2 training 
(including required PPE), training in evacuation, clean up in the event of an LN2 spill from a 
bulk source, and the immediate treatment of an individual overcome by toxic fumes.  The 
cryogenic system (encompassing the bulk source of LN2) and the delivery system (pipes to 
individual LN2 freezers, shut off valves, and the filling station) must be properly designed, 
constructed, and maintained.  Records and results of inspections, maintenance and repairs on 
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the system must be reviewed and documented.  (See “Principle Chemical Hazards in this 
Biorepository Model” on page 87 for further information.) 
Freezer monitoring.  (Also detailed in “Freezer monitoring,”page 129.) As 
suggested earlier, freezer temperatures will be monitored both manually and electronically 
using three independent methods, including the built-in temperature display on the freezer 
itself, utilization of an independent NIST thermometer with probe, and a separate 
independent wireless temperature monitoring system.  The wireless monitoring system will 
be battery-operated, and a pre-determined number of backup batteries will be maintained at 
all times. 
All freezers will be labeled with unique ID numbers.  These IDs (and in the case of 
mechanical freezers, their respective electrical requirements and corresponding electrical 
panels, circuits, and outlets) will be linked to freezer monitoring logs.  If a freezer warms 
beyond established parameters and alarms have sounded, the specific freezer in question will 
be easily identifiable by that ID.  Temperature deviations for the freezer and all the samples 
stored within it will be recorded in the database. The log will be continuously maintained and 
will be updated any time a freezer or monitoring unit is moved or replaced.   
A quality assurance check will be performed on a routine basis to ensure the freezer 
IDs and their corresponding monitoring IDs are correct.  All information will be entered or 
downloaded into the database in order to maintain a link between individual samples and 
their respective storage temperature history.   
Alarm system.  Acceptable temperature ranges will be pre-defined for refrigerators, -
20 degree C freezers, ultralow freezers, and vapor phase storage in liquid nitrogen freezers.  
Alarm set points will be adjusted to trigger before the temperature falls outside the acceptable 
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temperature range to allow for adequate staff response time before samples experience any 
temperature deviation.  The temperature monitoring units will be battery-operated to prevent 
a system failure should power be interrupted. These batteries will be routinely checked to 
ensure proper functionality, and the check will be documented, initialed and dated. 
The operations manager must provide the contracted monitoring company with an 
approved procedure for setting the alarm set points and the appropriate response protocol. 
The manager must also obtain written verification that the program has been set up according 
to the specified requirements.  The alarm system must be thoroughly validated (including 
quantification of the response time) prior to initial use.  After it has been implemented, the 
system will be tested every week by pulling a probe from alternating freezers rather than 
repeatedly checking the same freezer.  Staff will then document proper function, response 
time, and protocol adherence.  A procedural worksheet will provide instructions for 
performing the alarm system test. It will also outline follow-up actions required should the 
response protocol not be followed or if response time is outside acceptable limits. After 
collecting data, staff will use the worksheet to capture the freezer and monitoring ID, the 
date, and the initials of the staff member. 
Freezer alert and response.  If freezer temperature falls outside the acceptable range, 
the alarm company will contact staff via home phone, cell, text, beeper, and email.  On call 
staff will report as quickly as possible to the biorepository and utilize the procedural 
worksheet for freezer alert and response. This worksheet will provide a mechanism for 
recording the date and time of the occurrence, define the acceptable temperature ranges for 
all storage equipment, list contact information, provide step-by-step instructions on how to 
most efficiently assess the situation, and determine whether the problem is a freezer failure, a 
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
162 
tripped circuit breaker, or a full power outage. In case of freezer failure, instructions will be 
provided on identifying back up freezers, efficiently transferring samples to back up freezers 
on dry ice, and recording the transfer of freezer contents both on the worksheet and in the 
database.  In case of power outage, the secondary generator, powered by natural gas, should 
automatically provide emergency lighting and sufficient power to mechanical storage 
equipment and critical laboratory equipment.  A third backup system may be available 
through the use of a diesel-powered generator.  Staff will be trained on such emergency 
procedures, but additional support will be available contractually through a commercial 
provider. Depending on circumstances, the procedure for standby generator connection to 
freezer loads may also be utilized.  
Benefits of LN2 freezers in sample preservation.   The proposed Biorepository 
model will predominantly use LN2 freezers that store samples in the vapor phase of LN2. 
These freezers not only reduce dependence on electricity required for mechanical freezers but 
may also be utilized in a power outage to freeze samples that are currently thawed for sample 
processing (ISBER Best Practices, 2011).  These freezers may draw LN2 from outdoor bulk 
LN2 tanks and dewars may also be filled from an indoor LN2 filling station (constructed 
from the LN2 supply in the bulk tank) as needed.  
LN2 usage in each freezer will be measured daily using either a sturdy wooden 
dipstick or, if available, a LN2 level indicator on the freezer display panel.  This not only 
assists in anticipating LN2 needs for the facility but also may detect potential leaks. A three 
thousand gallon bulk LN2 tank is able to accommodate twenty to forty large LN2 freezers for 
approximately thirty days depending on the rate of usage. A battery-operated telemetry 
system also automatically monitors LN2 levels and sends a dispatch to the supplier to refill 
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LN2 when the tanks are at 30% capacity. Additional LN2 can be obtained the same day. 
Individual cryoports may be filled or tanks obtained as well. Alternative vendors have been 
identified.  
Benefits of vapor phase liquid nitrogen storage.  Storing samples in the vapor phase 
(less than or equal to -150 degree C) of liquid nitrogen offers several advantages apart from 
offering an alternative temperature (from -80 degree C, for example) for sample preservation.  
Storage in vapor phase of LN2 also prevents safety hazards that arise from storing samples in 
liquid phase LN2 storage. Furthermore, it maintains temperatures below the glass transition 
temperature (-132 degrees C) (ISBER Best Practices, 2011).  
Specimen storage capacity.  The biorepository will follow Best Practices and strive 
to maintain a minimum of 10% backup freezer storage capacity (ISBER Best Practices, 
2011) regardless of freezer type (mechanical or LN2).  Incoming and outgoing samples will 
be closely monitored to manage storage capacity, facility and equipment planning, and 
monthly billing purposes.  Initial projections will be combined with communications with 
clients and study progress reports to determine overall storage needs.  Specimen collection 
kits manufactured and utilized by clients will also provide strong indications of their 
recruitment and sample collection pace as samples make their way to the biorepository for 
storage. 
Alternate freezer storage box inventory.  In addition to the database maintaining 
specimens and their respective freezer storage locations, a simple yet practical summary of 
available freezer space in each freezer will be updated and posted weekly. If the database 
becomes unavailable due to a power outage or scheduled maintenance, personnel can 
determine the number of boxes, the box IDs, and the relative box position in each freezer at a 
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moment’s notice. The manual inventory should be updated with box ID, date and staff ID 
each time a box is added to or pulled from the freezer. Just as the database will be 
temporarily checked for accuracy, the manual inventory will also be subject to quality checks 
on a routine basis, the results of which will be documented.  
A summary of the total available freezer space will be updated and posted weekly. 
This posted summary will also be available in case of emergency so staff will not need to 
open freezers or access the electronic inventory system during power outages. These hard 
copy tools will also aid management in monitoring available freezer space over time, 
prompting communication of freezer storage capacity to investigators and study personnel. 
Backup power.  As previously mentioned, two generators will be utilized to support 
all mechanical freezers, critical equipment, portable HVAC and cooling units, and the 
emergency lighting system.  The secondary backup generator will be powered by natural gas; 
the tertiary backup generator will be powered by diesel.  Should the biorepository experience 
a supply disruption of natural gas, the diesel-fuel powered generator will be utilized; this 
switch will involve connecting the generator to a pre-existing connection according to 
established procedure.  
In order to confidently rely on the operation of both generators when needed, 
procedures detailing routine maintenance and service will be followed.  Designated 
biorepository staff will perform weekly generator maintenance and the generators will be 
tested on a weekly basis and run for a half hour to an hour to ensure proper function.  A 
licensed, reputable vendor (under contract) will perform monthly and yearly maintenance.  
The biorepository will also vet various back up providers as well. Service records are 
documented and a log captures maintenance checks.  
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Load testing will ensure the electrical requirements or “load” of the mechanical 
freezers, refrigerators and critical laboratory equipment, are adequately met and may be 
automatically transferred (in stages, if necessary) to the generator. Load tests will be 
required, performed and documented at six-month intervals. 
Additional emergency preparedness measures.  The following additional risk 
mitigation processes should be in place prior to the opening of any biorepository: 
Utilities.  In the event of utility failures, the biorepository should enter into advanced 
planning, communication, and agreements with utility companies to ensure that utilities for 
the Biorepository are given highest priority after medical centers.  Flashlights and flashlight 
batteries are required to supplement emergency lighting. 
Natural Gas.   The tertiary generator (maintained as an extra contingency plan in the 
event of electrical failure) will be powered by diesel fuel should natural gas (the designated 
fuel for the secondary generator) become unavailable.  However, many gas stations do not 
have emergency power in order to keep pumps running should a power outage occur, or 
stations may exhaust fuel supplies quickly.  Maintaining fuel supplies should remain a 
priority in order to operate all fuel-powered equipment. However, responding quickly to 
unplanned power outages should also be considered a necessity. Gas cans and a petty cash 
fund must be available in case credit card and ATM machines are not available and 
identifying stations with backup power to maintain pump operations is recommended. 
Equipment-generated heat.  Depending on the time of year, outside environment, 
and the availability and functionality of windows, portable HVAC/cooling units and fans to 
circulate air should be made available to combat heat generated by equipment.  Instruments 
and equipment may be temperature and humidity sensitive and thus may need to be taken 
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off-line according to established procedures.  All nonessential equipment will be shut down 
and disconnected according to procedure.  Conversely, if heat is unavailable to the building, 
particularly in colder months, temperatures in the building may become unacceptably cold 
and the facilities may be closed. 
Water loss.  In the event of loss of water utilities, laboratory processing may halt.  
Reagent grade water may be obtained from other accredited laboratories.  As available, water 
may be obtained from external sources or other municipalities. 
Forced building closures.  In extreme circumstances, an official law enforcement 
officer or a fire marshal may close the building. Should that occur, no access to the building 
will be granted for operational activities.  However, staff must be available to ensure freezers 
and critical equipment continue to function properly whenever the building reopens.   
On call staffing.   Designated staff must remain on call around the clock in case of a 
power outage or freezer failure.  Additional technical staff should likewise be available for 
assistance at any time necessary.  Proper supervision from management and other personnel 
support will be provided whenever necessary. 
Communication planning.  The biorepository will utilize a communication plan for 
both biorepository personnel and clients to ensure proper communication and timely 
response in the event of any emergency or disaster event.  Emergency contact lists should be 
posted throughout the facility for easy access.  Current names, addresses, phone numbers, 
and contract numbers should also be readily available for maintenance providers, equipment 
manufacturers, and suppliers. In the case that cell towers become unavailable, staff should be 
prepared to communicate via beeper or e-mail.  
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Chain of command.    In preparation for an emergency event, personnel should be 
assigned clearly defined roles and responsibilities for potential events.  A chain of 
communication, including appropriate supervision and defined workflows will be vital to 
ensuring all personnel remain aware of individual responsibilities for communicating with 
clients or powering down (or starting up) equipment, for example. All personnel will have 
important roles and will contribute to biorepository operations and to interpersonal support.  
Emergency preparedness training.    All staff should be thoroughly trained in fire 
safety; freezer room safety; chemical or biological spills; evacuation; first aid; emergency 
response; freezer alert and response; and freezer, generator, and equipment maintenance. 
Staff must also be trained to respond in the event of an LN2 spill from a bulk source and the 
immediate treatment of an individual overcome by toxic fumes.  Additionally, staff must be 
evaluated annually on their training on validated, documented manual processes that may be 
utilized when instrumentation and automated processes are unavailable.   
Resupply of LN2 or dry ice.  The biorepository should maintain contractual 
agreements with LN2, fuel, dry ice, and other critical suppliers should an emergency require 
an immediate replenishment of these resources.  The biorepository should also identify back 
up vendors should primary vendors be unable to deliver needed resources promptly. 
Support for staff.    Bottled water, provisions, and support services are necessary for 
staff who may have to work for extended periods of time, even overnight. 
Equipment protection and calibration.   To the greatest extent possible, staff will 
ensure instruments and equipment are protected and maintained according to established 
procedures. Instruments and equipment shall be recalibrated prior to resumption of routine 
operations/ processes.  Additionally, documentation should be maintained and readily 
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available regarding each piece of equipment and its corresponding outlet with equipment 
cords labeled, if necessary. 
Disaster recovery.  Once an emergency or catastrophic event has passed, the 
Biorepository must have pre-determined procedures for bringing the Biorepository back into 
operation.  These processes must address: 
• Clean up. 
• Reconnection and restarting of all equipment. 
• Data recovery and verification. 
• Assessment of damage, losses, and documentation, as applicable. 
• Re-establishment of services. 
• Resuming the normal state of operations. 
• Communicating re-opening to clients with both a report of the incident and the 
status of any samples in ongoing research studies. 
• Debriefing all personnel on post event recovery. 
• Assessing, with participating staff, any potential improvements to be made on 
pre-established emergency preparedness procedures. Every crisis presents a 
unique opportunity for reflection and continuous quality improvement of current 
Biorepository practices. 
Proactive Measures in Emergency Preparedness   
In conclusion, a successful response to any emergency or catastrophic event depends 
upon proactive measures established by an organization before the event occurs.  To that end, 
the current biorepository model identifies four proactive measures that should be taken when 
planning for emergency response. 
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1. Identify critical resources and supplies, current suppliers and their respective 
contact information, as well as alternate suppliers and their contact information.  
Plan for obtaining supplies or stockpiling whenever appropriate (e.g., liquid 
nitrogen, diesel fuel for generator, and dry ice). 
2. Identify essential contract services, their contact information, their procedures and 
contingency plans in order to continue services (such as generator maintenance) 
in the event of an emergency. 
3. Implement an effective communications plan in order to maintain contact with 
staff and clients, including readily available contact information for all parties and 
all pertinent information for building and facility management. 
4. Consider critical functions that will not be able to be performed in the event of 
loss of an essential utility.  Identify contingency plans for maintaining critical 
operations, consider critical utility load list, and include locations and room 
numbers in any documented plans (e.g. electricity, generator, natural gas, water 
loss, potable water loss, HVAC, telephone system including paging, network and 
information systems, other IT systems, and facility or building damage). 
Businesses thrive or crumble when presented with moments of crisis. Proactive 
planning, established procedures, and effective teamwork can bring a biorepository and its 
personnel through a crisis situation.   
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Chapter 11: Methods of Assessment, Analysis, and Improvement 
ISO 9001:2008 requires that organizations “apply suitable methods for monitoring 
and, where applicable, measurement of the quality management system processes.  These 
methods shall demonstrate the ability of the processes to achieve planned results” (p. 13).  
The current proposed biorepository model will take into account a number of methods of 
assessment to ensure that the QMS adequately provides the structure necessary to meet the 
quality objectives of the organization. 
Quality Management System Review  
The biorepository director and the operations manager will review the quality 
management system once per year (or more frequently if warranted) in order to ensure the 
QMS is effectively achieving biorepository objectives and requirements. These reviews 
ensure compliance with respect to policies and procedures; ensure proper documentation and 
product conformity; expose weaknesses in the QMS; identify potential improvements; note 
accomplishments; evaluate the effectiveness of corrective and preventive actions; identify 
issues that may require root cause analysis; identify trends; review customer requirements, 
suggestions, or complaints; review results of internal audits and external inspections; identify 
additional resource needs; and reassess organizational and quality objectives and 
management review.  
Key performance indicators.   The four key performance indicators (KPIs) of the 
biorepository’s performance and services will be quality, dependability, time, and cost.  KPIs 
will be closely monitored through a monthly review of business productivity (i.e., a balance 
sheet), routine audits, and customer feedback.  Expected outcomes and indicators of previous 
problems will be evaluated against benchmarks.  New programs will be evaluated. These 
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evaluations will include potential impacts of service.  Plans of action will be developed as 
needed. 
Publications and grants.   A key indicator of the biorepository’s quality of services 
will be the number of publications that cite the biorepository as well as the number of grants, 
investigators, and biotech/pharmaceutical companies that utilize the biorepository for 
research support services, particularly if such individuals or organizations become repeat 
customers. 
Peer review.   Peer review will be an important indicator of quality as well. The 
biorepository will benefit from site visits and inspections from the National Institute of 
Health, pharmaceutical companies, investigators, and other sponsors, as well as laboratory 
oversight committees and consultants. 
Customer feedback and surveys.   The biorepository will strongly encourage the 
evaluation of customer feedback through the use of customer survey instruments.  The results 
of these instruments will play an important role in assessing the quality of biorepository 
services and measuring client satisfaction.  These instruments will capture researcher input, 
issues, concerns, and suggestions for continuous quality improvement.  The results of these 
instruments will be reviewed and incorporated into business practices and the QMS as 
deemed appropriate. A lost business analysis will capture data that may be useful as well 
(ISO 9001:2008, p. 12).  
ISBER Self-Assessment Tool.  The biorepository will participate in the International 
Society of Biological and Environmental Repository (ISBER) Self-Assessment Tool (SAT), 
which evaluates how well a repository follows ISBER’s Best Practices.  The SAT 
furthermore identifies areas in need of improvement.  The assessment is confidential.  SAT 
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results will be reviewed, and areas of potential improvement will be identified and 
incorporated in the QMS and operations. 
External Review of QMS 
In addition to the application of several internal processes, the biorepository will also 
use external standards when evaluating effectiveness of implemented QMS techniques. 
These external processes may include such assessments as external audits or accreditation 
procedures. 
College of American Pathologists’ Biorepository Accreditation Program.   A 
biorepository may apply for accreditation through the College of American Pathologists by 
submitting an application containing the following biorepository information: 
• Contact information. 
• The organization chart. 
• The floor plan. 
• The director’s curriculum vitae. 
• The Master Activity Menu. 
• The responsible person for each service (e.g., sample receipt, processing, and 
storage would be considered one service). 
• The annual volume or units processed. 
• The number of full time employees. 
• The number and type of temperature-controlled storage equipment. 
• An agreement to the Terms of Accreditation.  
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Once receipt of the application has been acknowledged, the CAP Biorepository and 
Laboratory General Checklists are sent to the biorepository. (N.B.: These checklists detail the 
requirements for accreditation and may not be shared.)   
Generally six months after the CAP Accreditation application is accepted, an 
inspection is scheduled with a CAP staff inspector and one or more repository experts, 
depending on the size of the biorepository and the scope of its services.  At the conclusion of 
the inspection, a debriefing session is held. Inspectors will provide management with an 
inspector summation report, which may include Phase I or Phase II deficiencies that require 
satisfactory responses.  A Phase I deficiency requires a written response detailing the 
corrective action taken. A Phase II deficiency requires not only a written response but also 
supporting documentation demonstrating compliance with the requirement.  Such supporting 
documentation may include new or revised policies or standard operating procedures with 
evidence of review and approval; evidence of staff training or retraining on new, revised, or 
existing policies and SOPs; quality control records; log sheets including specific data; and 
floor plans, photos, diagrams, purchase orders, or work orders.  Within thirty calendar days, 
biorepositories must address and correct these deficiencies and submit any necessary 
documentation (including the Deficiency Response Signature Page, signed by the director) to 
CAP for final review.  At the inspector’s discretion, some deficiencies may be corrected on 
site and do not require a later written response. In such an instance, the inspector will note 
“corrected on site” on the inspection summation report.   
If CAP grants accreditation to the biorepository, the decision is communicated via 
written letter and a certificate of accreditation is provided to the biorepository management. 
The biorepository must then add a policy addressing compliance with the terms and 
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conditions of CAP Accreditation to the biorepository’s manual of operations. Biorepository 
accreditation is valid for three years. After the first year of accreditation, a member of 
biorepository staff must conduct a self-inspection. This inspection should be conducted by 
someone in the organization that is knowledgeable in operations and the accreditation 
requirements and should be a personnel member other than the director (ideally the 
operations manager or quality assurance manager). The second year, a desk review of 
documentation by the director is required.  Unlike as in laboratory accreditation, subsequent 
inspections will be scheduled; they are conducted every three years within a three- month 
window leading up to the third anniversary of the initial date of accreditation.  
CAP inspectors are a valuable resource both at appropriate moments during the 
inspection and post-inspection debriefing session; they are pleased to make recommendations 
based on their considerable experience, share insight and answer questions. The inspection 
can be a learning experience because the idea is to not only meet the standards but also 
demonstrate continuous quality improvement.  
Dash et al. (2012) stated, “Many of the critical steps in establishing and running a 
biorepository fall within existing procedures in today’s CLIA-certified laboratories or can be 
implemented with modifications to existing procedures in use in CLIA-certified laboratories” 
(p. 670).  For those who have not managed or have significant work experience in a CAP 
accredited, CLIA-certified laboratory, I have developed a list of items that a Biorepository 
should have in place or be prepared to address prior to a CAP inspection. The list is based on 
five consecutive successful CAP Laboratory Accreditation Cycles and one successful CAP 
Biorepository Inspection.  This list of accreditation items that operations managers should 
prepare for inspection can be found in Figure 4. 
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Figure 4. Author-recommended CAP Items Checklist. 
Audits.  The biorepository will conduct both internal audits and be subject to external 
audits and inspections on a routine basis.  Some of these audits may be unannounced.  The 
operations manager and trained staff will perform internal audits to assess compliance with 
policies, procedures, best practices, and applicable regulations.  External audits will be 
conducted by well-qualified representatives from OSHA, inspectors from the College of 
American Pathologists (CAP), as well as designated representatives from sponsors and 
ü Quality	  Management	  System	  or	  Quality	  
Management	  /	  Quality	  Improvement	  Plan	  	  
ü Organizational	  chart	  
ü Designated	  task	  form	  
ü Employment	  records	  
ü Personnel	  files	  	  
o Curriculum	  vitae	  
o References	  
o Letter	  of	  acceptance	  
o Job	  description	  
o Copies	  of	  degrees,	  certificates,	  licenses,	  
continuing	  education	  
o Initial	  and	  annual	  review	  records	  
o Competency	  evaluations	  
o Summaries	  of	  qualifications	  
o Disciplinary	  actions	  
ü Personnel	  Evaluation	  Roster	  
ü Chemical	  Hygiene	  Plan	  
o Safety	  Data	  Sheets	  	  
o Chemical	  inventory,	  Chemical	  storage	  	  
ü Exposure	  Control	  Plan	  
ü Lab	  Bio-­‐Safety	  Manual	  
ü CAP	  Lab	  Patient	  Safety	  Goals	  
ü Training	  records	  including,	  but	  not	  limited	  to:	  	  
o DoT/IATA	  shipping	  Category	  B,	  Biological	  
Substances	   	  
o Ergonomics	   	  
o Fire	  Drill/Extinguisher	  	  	  	  	  
o Lab	  Safety	  	  
o Centrifuge	  
ü IT	  Issues	  Documented	  
ü Website	  Vulnerability	  test	  records	  
ü Document	  Control	  Plan	  	  
ü Operation	  manuals	  reviewed	  
ü Quality	  control	  /	  Quality	  assurance	  records	  	  
o Temperature	  monitoring	  
o Thermometer	  calibration	  dates	  
o Temperature	  probe	  calibration	  dates	  
o Freezer	  maintenance	  	  
o Generator	  checks	  
ü Secondary	  reagent	  labeling	  	  
ü Glassware	  washing	  
ü Water	  purification	  system,	  	  
ü Eye	  wash	  and	  emergency	  shower	  
ü Noise	  levels	  
ü OSHA	  Inspection	  records,	  OSHA	  
Communications	  
ü Safety	  committee	  review	  of	  all	  safety	  
procedures	  
ü Equipment	  certified:	  pipets,	  centrifuge	  speeds	  
ü Equipment	  preventive	  maintenance	  and	  
service	  records	  
ü Validation	  records	  
ü Calibration	  verification	  
ü Proficiency	  testing	  records	  
ü Validating	  performance	  where	  graded	  
Proficiency	  Testing	  is	  unavailable	  
ü Examples	  of	  audits	  
ü CAPA	  Records	  
ü All	  previous	  CAP	  self-­‐deficiencies	  addressed	  
and	  documented	  
ü Proficiency	  Testing	  Survey	  Records	  
ü Standing	  Operating	  Procedures:	  
o SOPs	  reviewed	  bi-­‐annually	  
o SOP	  Log	  
o SOP	  sign	  off	  sheets	  
o SOP	  Table	  of	  Contents	  
o Reviewer’s	  &	  Lab	  SOP	  Notebook	  
o SOPs	  posted	  on	  Website	  
DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008) 
176 
stakeholders.  Results of all audits will be thoroughly reviewed and documented.  Positive 
results will be recognized, and nonconformance to established standards will be appropriately 
addressed with any subsequent actions documented. 
Incident Reporting and Corrective and Preventive Action (CAPA) 
Once internal and audits have been completed, management will turn to correcting or 
adjusting any unfavorable results.  The QMS will therefore contain a program to identify, 
report, and document errors, non-conformities, incidents, illness, injury, or complaints that 
could potentially impact safety, operations, or research result integrity. Should errors or 
complaints occur, the biorepository will perform further investigation, including a root cause 
analysis.  Corrective and preventive action shall be taken in a timely manner to eliminate 
potential or existing nonconformance.  All instances of CAPA will be evaluated, 
documented, monitored, and tracked for trend analysis and effectiveness.  
Quality Risk Management Program 
In order to identify, assess, minimize, monitor, and document risks associated with 
research services, the biorepository will implement a quality risk management program. 
Risks will be logged and assessed.  Risk mitigation strategies will be considered and, if 
beneficial, procedures will be revised and approved, training conducted, and changes tracked 
through implementation.  Documentation of these revisions will be subject to document 
control and will be readily available to all personnel and inspectors. ISO 9001:2015 Quality 
management systems-Requirements, due to release later this year, will incorporate risk 
management principles into the new standard (ISO 9001:2008).  In the interim, principles of 
quality risk management may be derived from the ISO standard, ISO 31000:2009, Risk 
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management – Principles and guidelines, and the International Conference of Harmonisation 
(ICH) Quality Risk Management guideline (Q9, 2005). 
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Chapter 12: Conclusion 
In the context of a biorepository organization, an effective quality management 
system will define the requisite quality policies, processes, and strategies in order to assure 
potential stakeholders and clients that operations will perform to the highest quality 
standards.  A well-conceived and implemented QMS will ensure that samples are collected, 
processed, and stored in standardized ways.  This standardization will in turn allow the 
Biorepository to maintain the highest standards of biospecimen quality, integrity, and data 
throughout the collection, processing, cryopreservation, storage and distribution lifecycle.  
A quality management system based on ISO 9001(2008) may go even further, 
however, in that it can establish the necessary framework and provide a “roadmap” for 
building and operating a state-of-the-science, accredited, commercially successful 
biorepository.  Such a roadmap may prove beneficial to the scientific community, as it 
addresses a gap in current literature.  As demonstrated in the example presented in this paper, 
such a QMS can address a plethora of procedural components: authority, responsibility, 
commitment and communication; organizational structure; customer focus, documentation 
requirements; business considerations; resource management, including human resources and 
facility infrastructure and maintenance; equipment selection, qualification, maintenance and 
replacement; property control and disposition; informatics; and work environment; safety; 
security; product realization; emergency preparedness and disaster response; business 
continuity; procurement; regulatory considerations; and quality management methods of 
assessment, analysis, and continuous quality improvement. Strengthened with the addition of 
procedures, processes and specific quality assurance strategies in order to meet customer 
requirements, a QMS can help establish a successful commercial BSL-2 biorepository and 
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ensure the highest quality, fit-for-purpose biospecimens for clinical and translational 
research. 
Limitations/Delimitations of the Study 
Material transfer agreements (MTAs) have not been addressed in the current study.  
Both ISBER and NCI Best Practices include introductions to MTAs; furthermore, the NCI 
Best Practices includes a sample material transfer agreement in their appendices. I would 
refer any parties interested in reading more about MTAs to these specific documents. 
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Appendix A: Personnel Sanitation and Safety 
As adapted from Biosafety Manual in Microbiology and Biomedical Laboratories (U.S. 
Department of Health and Human Services, 200, pages 30-38). 
 
The following protocols must be followed at all times personnel are working in or 
visitors are touring the proposed biorepository: 
Food / Drink / Personal Hygiene and Attire 
• Food and beverages will be strictly prohibited in refrigerators or freezers 
designated for specimens only according to 29 CFR 1910.1030(d)(2)(x). 
• Food, beverages, and chewing gum will be banned from all laboratory rooms 
designated for biospecimens. 
• A separate refrigerator in a clean room will be designated for food for human 
consumption only.  No biological materials may be taken into a clean room or 
stored in the clean room/ break room refrigerator. 
• Eating, drinking, smoking, applying cosmetics or lip balm or handling contact 
lenses will be prohibited in accordance with 29 CFR 1910.1030(d)(2)(ix).  The 
application of cosmetics and lip balm as well as the manipulation of contact 
lenses is prohibited in the laboratory. 
• Mouth pipetting will be prohibited in accordance with 29 CFR 
1910.1030(d)(2)(xii).  
• Laboratory personnel will not be permitted to wear open toe sandals, shorts or 
other apparel that leave the legs exposed while handling biohazard material or 
performing any laboratory activity.  
• Staff should avoid working alone in the laboratory, particularly when working 
with hazardous material. 
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• Headphones will be prohibited in the lab; staff must be able to hear alarms and 
respond appropriately. 
• Computer workstations, specifically keyboards, will be labeled either “clean” 
(i.e., free from biological or chemical contamination) or “not clean.”  If a 
computer workstation is labeled “not clean,” staff must touch the keyboard only 
when wearing gloves.  
• Universal Precautions must be followed in the laboratory at all times and these 
precautions are detailed in the Procedure for Universal Precautions as well as all 
specific procedures involving biospecimens.  All biospecimens, and biological 
materials, e.g. reagents, quality control pools and preparations are to be 
considered potentially infectious.  
• Laboratory work surfaces are to be decontaminated with an appropriate germicide 
when work is complete or after a spill. A good germicidal agent is sodium 
hypochlorite (household bleach) prepared fresh daily in concentrations of 1:10. 
The daily preparation of bleach is to be labeled according to procedures for 
labeling secondary reagent containers. Scientific instruments should also be 
decontaminated after use according to established procedures. 
Proper Needle Handling Procedures 
• The Needlestick Safety and Prevention Act of 2001 was intended to promote the 
selection of safer needle devices and prevent needlesticks. Needles must never to 
be manipulated (purposefully bent, recapped, or removed) by hand.  Staff may 
only use approved mechanical devices or scoop the needle cap with the needle 
itself.  
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• Procedures must be followed for safe handling and disposal of sharps (needles, 
pipettes, broken glassware). 
Personal Protective Equipment (PPE) 
• Personal protective equipment (PPE) must be utilized according to The PPE 
Standard, 29 CFR 1910.132. Staff shall complete training regarding the selection, 
proper utilization, care and disposal of PPE prior to performing laboratory 
activities.  
• Eye and face protection (full face shield and goggles) must be used to protect 
staff’s mucous membranes when the potential exists for splashes or sprays 
according to the Eye and Face Protection Standard, 29 CFR 1910.133.  
• Lab coats should never be worn while eating or drinking in clean rooms. Lab 
coats are to be laundered through the designated vendor only; staff may not take 
lab coats home or launder. 
• The Hand Protection Standard, 29 CFR 1910.138, requires the appropriate hand 
protection for exposure to hazards in the workplace. In addition, gloves must be 
worn when handling blood or working in contaminated areas according to 29 CFR 
1910.1030(d)(3)(ix).  Non-latex gloves may be utilized to protect those with latex 
(derived from plants) allergies or sensitivity according to 29 CFR 1910.1030 
(c)(3)(iii).   
• Gloves and other personal protective equipment (PPE) must be changed when 
contaminated or when integrity has been or may soon become compromised. 
Gloves are never to be re-used or washed for the purposes of re-use. 
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• Hands must be thoroughly washed after the removal of gloves. In addition, staff 
members are to remove protective clothing and wash their hands with an 
appropriate decontaminating/ germicidal soap prior to leaving the laboratory. 
• Gloves are to be properly disposed with other contaminated, solid lab waste.  
 
